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ABSTRACT 
Chronic heart failure (CHF) is the leading cause for hospital admission for adults over the 
age of 65 years. In spite of extensive research, no model exists that provides a prediction of 
absolute risk of rehospitalisation. The absolute risk reflects a person’s individual overall risk. 
Current models provide information pertaining to the relative risk of individual’s risk of 
rehospitalisation. Relative risk is a proportional measure of an individual’s risk within a 
given group. Furthermore, current risk prediction models are limited in their scope with an 
emphasis on biomedical factors. The research reported in this thesis has been labeled the 
“CHF-Risk Study” and examines the limitations within current risk models; the identification 
of risk prediction factors from the perspective of patient, provider and system; and the 
development of a risk nomogram using a derivation cohort of a contemporaneous 
Australian CHF population. The CHF-Risk Study was conducted in 3 phases with the aim of 
generating factors for the risk nomogram from a literature review, factors within current 
risk models, key stake holder consultation and testing within a prospective cohort of 
individuals with CHF. 
 The CHF-Risk Study received ethics approval from Curtin University Human 
Research Ethics Committee, approval code SON&M16-2010. The CHF-Risk Study was a sub 
study of a randomised control trial (RCT) funded by the National Health and Medical 
Research Council, Which Heart failure Intervention is most Cost-effective and consumer 
friendly in reducing Hospital care (WHICH?) Trial. The WHICH? Trial was undertaken in 
three teaching hospitals in Australia where recruited adult patients with CHF were 
randomised to either clinic based or home based CHF management. 
The 3 phases of the CHF-Risk Study were: 
1. Phase 1: 
A literature review was undertaken to determine factors predicting hospitalisation risk 
from the perspective of patient, provider and system. Studies reviewed were prospective in 
design and were conducted post beta-blocker boom of the late 1990’s which saw the 
management of CHF alter. However, the studies involved predominantly North American 
cohorts.  
2. Phase 2: 
Factors from current risk prediction models were identified. Furthermore, using an 
online survey, 119 CHF experts ranked (0-10) each identified factor as a predictor for 
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rehospitalisation. The experts also had the opportunity to add any additional factors that 
they thought predicted rehospitalisation.  
3. Phase 3: 
Phase 3 was the development of the risk prediction model for rehospitalisation within 
the prospective cohort of the WHICH? Trial. 
Phase1 
     Phase 1 identified 1963 articles for factors predicting the risk of hospitalisation for adults 
with CHF. Factors that predicted all cause or CHF specific hospitalisations were identified 
and classified into patient, provider or system categories. The majority of factors identified 
were patient focussed, and were obtained from N=159 studies. This was followed by 
provider factors identified from N=27 studies. The least amount of factors identified were 
system factors and these were obtained from N=25 studies.  
Phase 2 
     Consultation was undertaken via an online survey using the Survey Monkey platform, a 
secure online system, with key informants from multidisciplinary backgrounds providing 
input, critique and feedback regarding the CHF-Risk model items. Key informants were 
health professionals involved in heart failure disease management and/or research. The 
survey was distributed through Listserves of the National Heart Foundation, Australasian 
Cardiovascular Nurses College and the Cardiac Society of Australia and New Zealand. This 
was particularly important to derive health professional’s drivers for admission to hospital 
particularly within the context of the Australian health care system. However, no further 
risk factors for rehospitalisation were identified by the experts. Factors were rated from 1 
for low risk to 10 for high risk. Factors which scored high in predicting rehospitalisation with 
a mean score were poor adherence to medications (9.04) and prior hospitalisation for heart 
failure (8.33). Having private health insurance (4.8) and females (4.9) scored low for 
predicting rehospitalisation for adults with heart failure.  
Phase 3 
The development of a risk prediction model for rehospitalisation within the 
prospective cohort of the WHICH? Trial was undertaken as part of phase 3. Briefly the 
WHICH trial  (ACTRN12607000069459) was a multi-centre, randomised controlled study of 
two forms of CHF-MP (home based and clinic based) to determine which was most cost-
effective and if there was a difference in the mortality and morbidity rates between the two 
methods of program delivery.  Participants were recruited from three sites in Australia 
(Sydney, Adelaide and Brisbane). The study cohort consisted of patient’s with confirmed 
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CHF (systolic or heart failure with preserved systolic function) on echocardiography, with 
related, persistent, moderate to severe symptoms with at least one previous acute HF 
admission that were to be discharged home. In the WHICH? Trial, participants were 
followed up for 18 months and details of all the hospitalisations were documented. All 
hospitalisations were adjudicated by a blinded endpoint committee. The WHICH? Trial 
recruited 280 men and women between the ages of 23 and 98 years. From the cohort 37 
(13%) were rehospitalised for a cardiovascular event (including CHF) within 28 days, and a 
further 149 (53%) were rehospitalised during the follow-up period for a cardiovascular 
event. Phase 3 found, factors  associated with an increased risk of cardiovascular 
rehospitalisation were: age (HR 1.07, 95% CI 0.90-1.26) for each 10-year increase in age; 
living alone (HR 1.09, 95% CI 0.74-1.59); those with a sedentary lifestyle (HR 1.44, 95% CI, 
0.92-2.25) and the presence of multiple co-morbid conditions (HR 1.69, 95% CI 0.38-7.58) 
for 5 or more co-morbid conditions compared to individuals with one documented co-
morbidity).The C-statistic of the final model was 0.80. 
Conclusion  
This thesis has identified an absolute risk model for individualising the risk of 
rehospitalisation for adults with CHF. Phase 1 and 2 revealed limitations with current risk 
prediction models for rehospitalisation for adults with CHF. These were: no current model 
provides an absolute risk for rehospitalisation; models were all developed using cohorts 
from the United States of America and may therefore not be applicable to universal 
healthcare systems; risk factors identified for rehospitalisation were predominantly related 
to clinical factors. Phase 3 found factors associated with an increased risk of cardiovascular 
rehospitalisation were: age; living alone; a sedentary lifestyle and the presence of multiple 
co-morbid conditions. The C-statistic in prior models were no higher than 0.75. Therefore, it 
would appear that both in our model (C-statistic 0.80) and prior models, important risk 
factors for rehospitalisation have not been identified. The need for an accurate model, 
inclusive of patient, provider and patient factors incorporated into model design was 
identified. Developing an absolute risk model that identifies an individual’s risk of 
rehospitalisation may have the potential to target at risk individuals in the community more 
effectively than current risk prediction models do. Furthermore, streamlining disease 
management for at risk individuals for rehospitalisation has the potential to decrease 
hospitalisations, improve health status of individuals with CHF and decrease the financial, 
social and psychological burden associated with hospitalisation(s) for the individual and the 
community.  These data suggest that an initial hospitalisation for CHF signals a period of 
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high risk and the importance of implementing integrated and coordinated disease 
management strategies. 
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Introduction and Overview 
This exegesis and the supporting documents are submitted as a “Thesis by 
Publication.” This thesis is titled “Predicting risk: developing and testing of a nomogram to 
predict hospitalisation in chronic heart failure (CHF- Risk Study).” The CHF-Risk Study was 
a three phase sub-study of a randomised controlled trial (RCT) titled,  Which Heart failure 
Intervention is most Cost-effective and consumer friendly in reducing Hospital care 
(WHICH?) Trial.   
The WHICH? Trial (ACTRN12607000069459) was a prospective multicentre, RCT 
conducted at 3 tertiary referral hospitals in Australia. The WHICH? trial’s aim was to 
ascertain if multidisciplinary disease management of individuals within their homes was 
superior to care delivered within a specialist outpatient clinic[6]. Adults who were 
discharged home and had a diagnosis of CHF, with persistent moderate to severe 
symptoms were approached for inclusion into the trial. Following blinded randomisation, 
participants were categorised into the specialist CHF outpatient clinic or the nurse-led 
home-based intervention arm of the trail. A total of 280 patients, 73% male with a mean 
age of 71 ± 14 years were enrolled in the WHICH? trial[6].  Primary endpoints included: 
unplanned readmissions or all-cause death. The primary endpoint occurred in 102 of 143 
(71%) HBI versus 104 of 137 (76%) CBI patients (adjusted hazard ratio [HR]: 0.97 [95% 
confidence interval (CI): 0.73 to 1.30], p = 0.861): 96 (67.1%) HBI versus 95 (69.3%) CBI 
patients had an unplanned hospitalisation (p = 0.887), and 31 (21.7%) versus 38 (27.7%) 
died (p = 0.252)[7]. Data from the WHICH? trial was used for analysis within the CHF-Risk 
Study. Findings of the WHICH? trial found that home based intervention (HBI) was not 
superior to CBI in reducing all-cause death or hospitalisation. However, CBI was associated 
with significantly higher healthcare costs, attributable to additional days of hospitalisation.  
 
Five publications and one manuscript accepted for publication have been submitted as part 
of the CHF-Risk Study thesis.   
 
 The first publication[5] is titled “Australia’s health care reform agenda: Implications 
for the nurses’ role in chronic heart failure management.” The manuscript details the 
implications of Australia’s health care reforms on the management of individuals with 
chronic heart failure (CHF). The Chronic Care Model[8] (CCM) see figure 1, has been used to 
illustrate the complex and multifaceted approach required to improve disease management 
within an Australian context. Additionally, a solution is offered regarding chronic disease 
management of CHF in Australia with reference to the elements of the CCM.  
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Figure 1. 
The Chronic Care Model  
 
*[8]    (permission has been granted to reproduce the diagram above, evidence has been 
provided in the Appendices) 
 
The CCM views the health care system as an extension of the broader community. 
Within this system, a productive interaction occurs between system factors, providers and 
an active informed individual collaborating together in the disease management of an 
individual with a complex and chronic disease. To offer a holistic approach to disease 
management, the terms patient, provider and system have been used.  
 The second publication[2] is titled “Patient, provider and system factors influencing 
rehospitalisation in chronic heart failure: a literature review.”  The literature review 
itemises factors from studies that have been identified as risk predictors for 
rehospitalisation for individuals with CHF. The primary finding from this review was that 
current literature focuses on predominately clinical patient factors to predict the risk of 
rehospitalisation.  Such factors include: multiple co-morbidities such as diabetes and 
chronic obstructive pulmonary disorder; ejection fraction and renal function. A limitation 
with the literature suggests that a wider scope of study needs to be undertaken to identify 
provider and system factors that contribute to the risk of rehospitalisation for individuals 
with CHF.  
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 The third publication[4] is titled “What are the factors in risk prediction models for 
rehospitalisation for adults with chronic heart failure?” The rationale for this paper was to 
examine current risk prediction models for rehospitalisation and identify what factors had 
been incorporated into risk model design. What was evident from this review was that the 
majority of factors integrated into these current risk models were primarily biomedical 
patient specific factors. This therefore, possibly limits the accuracy of risk prediction due to 
the absence or insufficient number of provider and system factors that were incorporated 
in the risk model design.  
 
The fourth publication[1] is titled “An overview of risk prediction models and the 
implications for nursing practice.” The manuscript describes the value of incorporating 
patient, provider and system factors into risk model design. Also, the ramifications of 
nurses utilising risk prediction models in clinical practice to target individuals at risk is 
discussed.  
The fifth publication[3] is titled “Importance of predictors of rehospitalisation in 
heart failure: a survey of heart failure experts”. The purpose of the online survey was to 
obtain the opinion of experts within CHF disease management and/or research as to what 
they perceived to be factors that predicted the risk of rehospitalisation in individuals with 
CHF. Experts used were employed within Australia or New Zealand.  Having been employed 
within Australian and New Zealand facilities, the accuracy of risk factors identified would be 
more applicable and appropriate for a risk prediction model that was being designed to be 
tested within an Australian cohort. Furthermore, previous risk models had not undertaken 
broad expert consultation when being designed.  This was a unique component of the CHF-
Risk Study.  
The manuscript accepted for publication, 6 is titled “An absolute risk prediction 
model to determine unplanned cardiovascular readmissions for chronic heart failure.” The 
accepted manuscript, describes the development of an absolute risk model for the 
prediction of rehospitalisation for adults with CHF.  The model was developed using the 
integration of findings from the literature review, expert consultation and risk factors from 
current models. These were then tested using the cohort of the WHICH? Trial.  
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Flow diagram of the CHF- Risk Study 
• Main points within each study is provided below 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Publication 1[5] 
• Burden of CHF. 
• Health Care Reform in Australia. 
• Nurses role in CHF disease management. 
Publication 2[2] 
• Patient, Provider and System factors that 
influence rehospitalisation. 
Publication 3[4] 
• Risk factors in existing risk prediction 
models. 
Publication 4[1] 
• The value of risk prediction models. 
Publication 5[3] 
• Health professionals’ perception of risk 
factors for rehospitalisation. 
Accepted Manuscript 
• Development of the CHF-Risk model within 
a RCT. 
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Literature Review 
History  
Heart failure (HF) is a progressive complex syndrome. In 1872 Georg Ebers, an 
Egyptologist, purchased a 20 meter papyrus scroll found in Thebes (known today as Luxor), 
written in hieratic Egyptian inscription dating 1550BC[9]. The papyrus scroll contained 
medical information, including how to detect heart failure[10]. The papyrus scroll known as 
the Ebers papyrus, is the most primitive form of medical information relating to the 
diagnosis and management of heart failure.  Due to improvements in management of many 
heart conditions, chronic heart failure has emerged as a pressing health issue in 
contemporary society. 
Chronic Heart Failure definition 
Many definitions for chronic heart failure exist[11-13]. As this study focused on an 
Australian cohort the CHF definition as outlined by The National Heart Foundation (NHF) in 
conjunction with The Cardiac Society of Australia and New Zealand (CSANZ) was chosen.  
 
CHF is defined as: 
“CHF is a complex clinical syndrome with typical symptoms (e.g. dyspnoea, fatigue) 
that can occur at rest or on effort, and is characterised by objective evidence of an 
underlying structural abnormality or cardiac dysfunction that impairs the ability of the 
ventricle to fill with or eject blood (particularly during physical activity). A diagnosis of CHF 
may be further strengthened by improvement in symptoms in response to treatment, 
p6”[14]. 
Classifications of chronic heart failure 
Although descriptions of heart failure have varied over the years, commonly heart 
failure is now categorised on the basis of left ventricular systolic function.  There are two 
types of classifications for heart failure. The two types are referred to as systolic heart 
failure and diastolic heart failure. Systolic heart failure is predominantly referred to as heart 
failure with a reduced ejection fraction (EF). Whereas diastolic heart failure is now 
commonly being referred to as heart failure with a preserved EF (HFPEF). This classification 
is also referred to as heart failure with preserved systolic function (HFPSF). However, there 
is no consensus regarding the parameter for what constitutes a preserved EF[11]. 
Furthermore, the EF value is not included in the ACC/AHA[12] or the ESC[11] guidelines for 
systolic or  HFPEF. Whereas the NHF and CSANZ guidelines[14] define HFPSF as a left 
ventricular ejection fraction (LVEF) ≥45% on echocardiogram. The lack of consensus with EF 
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can be problematic. Within some RCTs, cohorts may be categorised according to HFPEF or 
heart failure with reduced ejection fraction (systolic heart failure). However, values for 
preserved and reserved EF differ amongst RCT studies. Owan and colleagues[15] 
categorised their cohort by using the value of > 50% for HFPEF and <50% for systolic heart 
failure.  Whereas, Yusuf and colleagues[16] used a EF >40% for HFPEF. This lack in 
consistency in EF cut offs alters interpretation of data.  
Systolic Heart Failure  
Systolic heart failure is the most common form of heart failure. Coronary artery 
disease (CAD) and hypertension are the main contributors to systolic heart failure. Systolic 
heart failure is a weak ability for the heart to contract in systole[14]. 
Diastolic Heart Failure - Heart Failure with Preserved Systolic Function (HFPSF) 
 HFPSF or diastolic heart failure can occur with or without systolic heart failure. The 
main contributors to HFPSF include: age; hypertrophy and ischemia. HFPSF is characterised 
by impairment of the left ventricle (LV) to fill during diastole as a result of slow or early 
relaxation of the LV, or as a result of increased stiffening of the myocardium which leads to 
higher filling pressures[14].  
Physical examination with abnormal clinical symptoms (identified below) is used for 
a provisional diagnosis of heart failure. For a definitive diagnosis of heart failure, diagnostic 
tools such as an electrocardiogram (ECG); echocardiogram; chest x-ray (CXR), full blood 
count (FBC) and urea, electrolytes and creatinine (UEC) levels are measured[14]. Individuals 
diagnosed with heart failure have the following clinical features:  
 
Symptoms 
• Breathlessness at rest or on exercise, fatigue, tiredness, ankle swelling[11]. 
AND 
Signs 
• Tachycardia, tachypnoea, pulmonary rales, pleural effusion, raised jugular venous 
pressure, peripheral oedema, hepatomegaly[11]. 
AND 
Structural or functional heart abnormalities 
• Cardiomegaly, third heart sound, cardiac murmurs, abnormality on the 
echocardiogram, a raised natriuretic peptide concentration[11]. 
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Heart failure classifications for severity 
Two classifications exist for grading heart failure severity. The first is a classification 
system based on symptom severity. This is known as the New York Heart Association 
(NYHA) functional classification[17]. Individuals are classified from Class I through to Class 
IV. 
• Class I – no limitation on physical activity. 
• Class II – Slight limitation of physical activity.  
• Class III – Marked limitation of physical activity 
• Class IV – Symptoms at rest. 
The second, classification system was formulated by the American College of Cardiology 
Foundation/American Heart Association (ACC/AHA)[12]. This system classifies individuals 
according to the structural abnormality of their heart. There are 4 stages A – D. 
• Stage A – No identified structural or functional abnormality. However, individuals 
are at high risk for developing heart failure. 
• Stage B – Developed structural heart disease that is strongly associated with the 
development of heart failure. 
• Stage C – Symptomatic heart failure associated with underlying structural heart 
disease. 
• Stage D – Advanced structural heart disease and marked symptoms of heart failure 
at rest despite maximal medical therapy.  
Incidence and prevalence 
The incidence and prevalence for heart failure is high. Approximately 5 million 
adults in the United States[18] and 15 million in Europe[11] have a diagnosis of heart 
failure. The exact figures for Australia remain unknown due to the absence of reliable data 
systems.  It has been estimated that within the Australian population of 21 million, 2.5% of 
Australians aged 55-64 years have CHF, with this figure rising to 8.2% for adults over the 
age of 75 years[19].  The prevalence of heart failure in European populations has been 
estimated at 2%[11]. However, this figure rises to 20% for adults aged between 70-80 
years[11]. In the United States approximately 10 per 1000 people over the age of 65 years 
have heart failure[20]. These figures reflect the Australian trend of an ageing population 
being diagnosed with heart failure. Furthermore, the older an individual becomes the 
greater their risk of developing heart failure. Heart failure is also associated with high 
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hospital admissions. Concerns are therefore raised for individuals who are at risk of being 
hospitalised.  
Metrics of assessing hospitalisation 
 There are inconsistencies in data being reported on the incidence of heart failure. 
As a result of these studies[21-24], it is difficult to identify if the incidence of heart failure is 
increasing, decreasing or has resulted in a plateau. Most incidence data for heart failure is 
obtained from the episodes of hospitalisation of participants within RCTs. However, many 
individuals are nowadays reviewed and possibly diagnosed in primary care settings, or as 
outpatients within clinics. As such, these individuals are not included in the incidence data 
for heart failure (collected from hospitalisation with RCTs) as they may have yet to be 
hospitalised.  Furthermore, due to the advancement in technology, diagnostic tools such as 
echocardiograms and guidelines provided by The European Society of Cardiology (ESC)[11] 
and  The  American College of Cardiology/American Heart Association (ACC/AHA)[12] and 
more recently the National Heart Foundation(NHF) and The Cardiac Society of Australia and 
New Zealand (CSANZ) have assisted with the diagnosis of heart failure now being made in 
community settings and not primarily in hospital. Ezekowitz and colleagues[25] identified 
the incidence and prevalence of heart failure diagnosis of patients made in the emergency 
department (ED) and in outpatient clinics.  These investigators have identified an increase 
in the volume of individuals being diagnosed with HF  in outpatient clinics (45.7%) 
compared to in hospital (36.6%)[25]. Furthermore, though the incidence of HF (per 100 
000) was shown to have decreased from 1999-2007, the prevalence of heart failure 
increased over the study period.  This coincides with previous literature of an increase in 
the prevalence of heart failure due to individuals living longer with CHF[15, 26]. A principle 
finding of the study by Ezekowitz and colleagues[25], was the identification that the highest 
proportion of all-cause hospitalisation occurred in individuals with previous ED 
presentations. The relevance of this for future research is the importance of identifying 
individuals in the community at risk of hospitalisation. Also, an ED presentation, should be 
viewed as a risk marker for hospitalisation and individuals targeted to prevent subsequent 
hospitalisations[27].  
Absolute and relative risk prediction 
There are generally two ways of expressing risk. One is absolute risk, and the 
second is relative risk. Absolute risk is an individual’s risk of developing a given event (such 
as rehopsitalisation) over a time period[28]. The figure for absolute risk is generally 
expressed as a percentage. The absolute risk is not compared to any other risk. Whereas 
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relative risk is comparing the risk in two different groups of people, (individuals with heart 
failure and those without heart failure). An important element of the relative risk is that it 
does not inform you of an individual’s actual risk. Relative risk (RR) is the probability that a 
member of an exposed group (individuals with heart failure) will experience an event 
(rehospitalisation) relative to the probability that a member of an unexposed group 
(individual with no HF) will experience that event (rehospitalisation)[28]. However, in CHF, 
the absolute risk of rehospitalisation may also vary depending on the individual’s clinical 
health status at the time of risk assessment. In other words, an absolute risk score for 
rehospitalisation for individuals with heart failure may fluctuate rather than be a constant 
value. This may be problematic for clinicians when treatment decisions are required. 
Furthermore, if an individual was only using an absolute risk score taken at a previous 
moment in time to determine their need to seek treatment at present, that absolute risk 
score may not be an accurate predictor and therefore, unsuitable to guide decisions. As a 
result, an absolute risk score for rehospitalisation should firstly be conducted at that given 
moment in time and not be used in isolation when deciding treatment options and HF 
disease management decisions but rather, as a tool to guide in management in conjunction 
with a holistic view of the individual considering patient, provider and system factors. 
Hospitalisation for heart failure 
CHF hospitalisation is common in the developed world.  The most universal chronic 
disease hospital diagnosis for adults is heart failure[13, 29].  In the United States of America 
(USA), approximately 80% of individuals with heart failure who are hospitalised are over 65 
years of age[30].  This figure is reflected in Europe and Australia.  In the USA, heart failure is 
responsible for 12 to 15 million clinic visits and 6.5 million hospital stays annually[31]. 
Hospital discharges with the diagnosis of heart failure have increased by 174% from 1979-
2003[20]. In a recent Western Australian (WA) study examining the trends in heart failure 
hospitalisations, it was revealed that the diagnosis for heart failure was higher in males 
than in females, with an overall rate of 111.3 per 100, 000[21]. Furthermore, over the 16 
year period of the study, heart failure hospitalisations increased by 4.2%[21].  The rise in 
hospitalisations occurred despite the advancement in pharmacological regimes that include 
ACE inhibitors and beta-blockers. Pharmacological interventions,  therapies and individual 
self management strategies post myocardial infarct have contributed to individuals with 
CHF living longer[32].  However, hospital admissions are occurring despite diverse 
interventions. Hospitalisation may occur as a result of heart failure disease progression; an 
exacerbation of an acute episode due to inadequate symptom management and control. 
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However, hospitalisation is a preventable event[33]. Furthermore, an emergency 
department (ED) presentation as a result of an exacerbation in heart failure symptoms that 
result in hospitalisation are possibly avoidable if an individual within the community at risk 
of deteriorating was identified early and interventions were targeted accordingly. An 
individual’s risk of hospitalisation can be determined from a risk prediction model. 
Currently, there are several models[34-42] that make predictions regarding an individual 
with heart failure at risk of hospitalisation. Unfortunately, current risk prediction models for 
hospitalisation do not accurately target individuals at risk of hospitalisation. This is because 
current risk models do not provide an absolute risk for individuals at risk of hospitalisation. 
Therefore, creating risk prediction models that accurately target individuals at risk is 
paramount. Risk models need to reflect realistic current practices and systems of delivery. 
Additionally, risk models need to expand their scope to include non medical factors other 
than patient specific characteristics[43]. With the ageing of the baby boomer generation, it 
is expected that the number of people diagnosed with heart failure will increase.  Teng and 
colleagues[21] in the WA study,  identified a 55.2 fold increase in the age specific rate of 
hospitalisation for adults over 75 years of age compared to the age group less than 65 
years. The rise in the risk of hospitalisation for adults as they age is alarming considering 
the ageing of the baby boomer generation has yet to peak. An ageing population and 
subsequent diagnosis of heart failure will intensify the burden to health care services and 
disease management programs for HF.   
Burden of hospitalisation 
The burden for hospitalisation is great. Financial, social and physical burdens 
influence, not only the individual who is hospitalised, but also their family as well as the 
community[44]. Loss of income from not being able to undertake employment occurs[45]. 
Physical burdens including depression, decrease mobility and fatigue result. Individuals with 
HF become reliant on family members and the community for assistance.  Within the larger 
community, hospitalisation is the primary area for health care costs and resource 
allocation. This is followed by expenses for pharmacological regimes. The direct and 
indirect expenditure of heart failure in the USA has been estimated at $30 billion[46].  
Compared to the UK where direct expenditure has been estimated at £716 million, 69% of 
which is directed to hospitalisation and pharmacological regimes[47].  In Australia, the 
direct and indirect cost for heart failure is over $1 billion[48]. With an ageing population 
and the risk of heart failure hospitalisation increasing with age, the projected volume of 
expenditure and resource allocation for heart failure disease management will rise. 
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Currently, the primary expenditure is for hospitalisation. If hospitalisation could be 
prevented, not only could funding then be reallocated elsewhere, such as primary health 
care, adverse events, such as falls or rehospitalisation that accompany hospitalisation may 
also be prevented. Hospitalisation is a risk factor for increased mortality[49].  In Australia, 
individuals who are not hospitalised have a 25% lower case fatality[50]. Furthermore, 
hospitalisation increases the risk of hospital readmission[18].  Once hospitalised, individuals 
have a 50% risk of being rehospitalised within 6 months[51]. At present, admissions for 
heart failure patients in the USA result in a length of 4-5 day stay in hospital[18]. However, 
premature discharge of patients, without follow-up into the community result in 
rehospitalisation[52]. Aims to reduce the risk of hospitalisation may also indirectly decrease 
the burden associated with hospitalisation.  
Hospital avoidance 
CHF hospitalisations exert a considerable burden on the health care system. An avoidable 
hospital admission is defined as an admission that may perhaps have been controlled or 
avoided[53]. Most CHF hospitalisations occur as a result of an exacerbation in symptoms, 
such as pulmonary oedema[54].  This deterioration in health status occurs as deteriorating 
signs and symptoms have not been detected by providers or services within the community 
(or even the patient). For example, patients will present to ED with pulmonary oedema, 
however, they may have been short of breath or may have increased their weight several 
days prior to presentation. Monitoring weight, fluid restriction, lowering their sodium 
intake and adjusting diuretics may have prevented the presentation to ED[55].  
Within the Cochrane Consumer Network, (an arm within the Cochrane 
Collaboration which produces systematic reviews based on healthcare interventions), level 
1 evidence is derived from systematic reviews of RCTs[56]. However, this can be 
problematic. RCT cohorts tend to be different to the majority of individuals who present to 
ED departments[46]. Additionally, the reluctance of individuals to participate in RCTs results 
in smaller participation rates[57, 58] and difficulty in replicating real world situations. Clark 
and colleagues[59] discuss in relation to heart failure-management programs, the often  
oversimplification in reporting of complex interventions, smaller sample sizes in RCTs that 
may lead to random error and short term follow up that may not identify mortality and 
morbidity as accurately as longer term follow ups. Furthermore, there may be limitations 
with generalizability of outcomes from RCTs to the wider community. One innovative 
method to perhaps overcome this limitation with generalizability was described recently in 
studies by Voss and colleagues[57] and Stauffer and colleagues[58].  Voss and 
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colleagues[57] replicated the Care Transitions Intervention[60].  The Care Transitions 
Intervention empowers individuals to contribute to the management of their health and 
inform their care provider of any concerns or alteration in signs and symptoms. Individuals 
who undertook the Care Transitions Intervention, reduced their risk of rehospitalisation. An 
absolute readmission rate of 12.8% was identified for the intervention group compared to 
20% for the control group[57]. Stauffer and colleagues[58] replicated a transitional care 
program led by an advance practice nurse. Outcomes of the study included a decrease by 
48% in 30-day readmission. Repeating outcomes from RCTs within real world settings has 
previously been encountered with obstacles. The studies by Voss and colleagues[57] and 
Stauffer and colleagues[58] have been identified as two studies that show positive effects 
of interventions derived from RCTs being replicated in real world settings and shown to be 
effective in reducing hospitalisations. 
Risk prediction for hospitalisation  
At present, risk prediction for hospitalisation is challenging.   The primary cause for 
hospitalisation in adults with existing CHF is an exacerbation[61]. Bonow[33] argued that 
currently, it is difficult to identify who is at risk of hospitalisation and emphasised that 
provider and system factors contribute to hospitalisation. Giamoutzis and colleagues[43] 
also stated the importance of non patient factors contributing to hospitalisation. However, 
the incorporation of non patient factors is not reflected in current risk models. Current 
models[34-38, 40-42] predominantly focus on patient characteristics such as age[39] and 
co-morbidities[37]. Furthermore, the numerous risk models that exist are evidence of the 
inability of one model to accurately predict hospitalisation. Complications do exist. 
Considering the complex and diverse heart failure population a risk prediction model for 
one individual may not be accurate for another. Furthermore, a model that identifies risk in 
one cohort may not accurately identify risk in another. Such an example of inaccurate risk 
prediction can be seen with the Framingham risk score for cardiovascular disease.  
The Framingham study was undertaken in North America[62]. When the 
Framingham risk score was tested within a German cohort, the Framingham risk score 
overestimated German male and female risk of developing cardiovascular disease[63].  This 
complication of accurate targeting of high risk individuals is also evident within the risk 
prediction of breast cancer[64]. Therefore, designing a risk prediction model with a scope 
extending to provider and systems may possibly more accurately identify those individuals 
at risk than current patient focused risk models. Furthermore, developing an absolute 
model that targets an individual’s risk for rehospitalisation rather than providing a relative 
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risk score for an individual may assist with improved disease management. Within heart 
failure management, identification of high risk individuals for hospitalisation is crucial. 
Targeting individuals at risk may prevent deterioration and hospitalisation, improve 
outcomes and decrease the direct expenditure allocated to heart failure.  
Fundamentally, it has been identified that the current literature is lacking in 
providing risk models that accurately target individuals with CHF at risk of rehospitalisation. 
Though several risk prediction models for hospitalisation of adults with CHF exist, their 
emphasis remains on patient specific characteristics, with a biomedical focus, and do not 
provide an absolute risk score for rehospitalisation. This limitation with scope and risk 
prediction may contribute to the challenges of targeting people with CHF at the greatest 
risk of hospitalisation. Developing an absolute risk prediction model for adults with heart 
failure may potentially target those at risk more accurately. 
Research Design 
The above review and consideration of the literature reveal a number of important 
questions that remains unanswered. 
These questions are: 
• What is the current state of heart failure disease management in Australia?  
 
• What patient, provider and system factors have been previously identified within 
studies that predict the risk of hospitalisation for adults with CHF but have not been 
included in existing risk models? 
 
• What risk factors for rehospitalisation have been incorporated into previous models 
and which of these factors are replicated when comparing the risk models? 
 
• What is the value of having risk models in clinical practice?  
 
• What is the perception of experts within CHF disease management and/or research 
as to the patient, provider and system factors that predict rehospitalisation for 
adults with CHF? 
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• How accurate is an absolute risk prediction model that is developed and tested 
using an RCT cohort compared to existing models? 
This thesis aimed to answer the above gaps in the literature by combining the 
findings from a literature review, factors from existing models, expert opinion and 
testing of the risk model within a prospective cohort. 
Aims of the study 
This study aimed to test an absolute risk model for predicting the risk of 
hospitalisation for individuals with CHF. The testing of the model was undertaken using the 
Which Heart failure Intervention is most Cost-effective and consumer friendly in reducing 
Hospital care, (WHICH?) Trial database as a derivation cohort.  Briefly, the WHICH? Trial is a 
randomised controlled trial of home based compared with clinic based management of 
individuals with CHF that was conducted in Australia[6].  
Objectives 
The specific objectives of the CHF-Risk study were to:  
1. Describe the current state of heart failure management in Australia. See publication 
1 for a discussion of a literature review. The nursing role in heart failure disease 
management and the implications of the National Health and Hospital Reforms 
Commission report on CHF management in Australia is discussed. 
2. Determine factors predicting hospitalisation risk from the perspective of patient, 
provider and system factors based upon the findings of a literature review. See 
publication 2 for a discussion of a literature review. Risk factors have been 
categorised into factors that increase the risk of rehospitalisation and factors that 
decrease the risk of rehospitalisation. 
3. Generate items for the risk prediction model through identifying independent 
predictors of the risk of hospitalisation from existing models. See publication 3 
where a breakdown of current risk factors within existing models has been 
identified and discussed. 
4. Describe the value of risk prediction models within the clinical area. See publication 
4 where a discussion is made related to risk models and their use by clinicians in 
clinical areas to target individuals at risk of adverse events. 
5. Generate items for the risk prediction model through expert consultation. See 
publication 5 where a discussion on how the items were generated for the online 
survey and the findings identified from the expert consultation. 
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6. Develop and test an absolute risk prediction model and assess for reliability and 
validity in a prospective RCT. See the accepted manuscript for a discussion of the 
CHF-Risk model development and testing using data obtained from the WHICH? 
Trial. 
 
Ethics Approval 
 Ethics approval for the CHF-Risk study was obtained from the Curtin University 
Human Research and Ethics Committee, approval code SON&M 16-2010. 
Data Analysis 
Data analysis was undertaken using the STATA 11 software package [65].  
The analysis was a three step process using two models, one that confirmed and one that 
explored prediction factors. 
• A Cox Proportional Hazard model was used to develop a prediction model based 
upon Phases 1 and 2.  
• The accuracy of the final predictive model (calibration and discrimination) was 
assessed using the methods suggested by Harrell and colleagues [66].  
Step 1: In the first instance, predictor items were identified in previously published series 
using prospective methods using a standardised data collection tool, (Current Risk Models + 
Review). 
Step 2:  Validity of these items and the clinician’s perception and ranking of relevance were 
determined in an online questionnaire (Survey). 
Step 3:  The second exploratory model used bootstrap methods to retain the factors that 
predict rehospitalisation, (testing using WHICH? data). 
 
Format of the Thesis                                                                                                     
The publications produced as part of this thesis are presented as the full text 
papers. A discussion chapter is provided to summarise, discuss the limitations and 
implications for future directions of the thesis findings.  The appendices provide statements 
from the co-authors, permission letters regarding copyright, evidence supporting the 
refereed status of the publications, ethics approval and the online survey questionnaire. 
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Abbreviations and Glossary of Terms 
Chronic Heart Failure (CHF): A complex clinical syndrome that is frequently, but not 
exclusively, characterised by an underlying structural abnormality or cardiac dysfunction 
that impairs the ability of the left ventricle (LV) to fill with or eject blood, particularly during 
physical activity. 
Nomogram: a chart representing numerical relationships. 
Risk factor: is any attribute, characteristic or exposure of an individual that increases the 
likelihood of developing a disease or injury. 
Randomised Control Trial (RCT): a trial that identifies if a cause-effect relation exists 
between treatment and outcome and for assessing the cost effectiveness of a treatment. 
Which Heart failure Intervention is most Cost-effective and consumer friendly in reducing 
Hospital care (WHICH?): the title of an Australian multicentre, randomised trial of home-
based versus clinic-based, nurse-led, multidisciplinary management of chronic heart failure. 
ACTRN12607000069459: Australian and New Zealand Clinical Trial registry identification 
number for the WHICH? Trial. 
Hazard: the rate at which events happen. 
Hazard Ratio (HR): the hazard in one group is a constant proportion of the hazard in the 
other group. This proportion is the hazard ratio. 
Confidence Interval (CI):  is an interval estimate of a population parameter and is used to 
indicate the reliability of an estimate and can be interpreted as the range of values that 
would contain the true population value 95% of the time if the survey were repeated on 
multiple samples. 
Receiver Operating Characteristic (ROC): a plot of (true positives) sensitivity versus (false 
positives) 1-specificity. 
C-index: the value for the measurement of discrimination. 
Absolute risk: probability that an outcome/event will occur as contrasted with the relative 
risk. 
Relative risk: is the risk of the endpoint, such as disease, death, readmission, among those 
exposed versus the risk of the endpoint among the unexposed.  
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Patient: relates to the multidimensional facets of individuals including physical, social, 
psychological, economic, cultural, and existential characteristics. 
Provider: denote health professionals providing formal care giving. 
System: pertains to factors relating to the organisation, funding and policy milieu of health 
care system delivery. 
B-type natriuretic peptide (BNP): A 32-amino-acid polypeptide secreted by the ventricles of 
the heart in response to excessive stretching of cardiomyocytes. 
N-terminal prohormone of brain natriuretic peptide (Nt-proBNP): 76 amino acid N-
terminus fragment of brain natriuretic peptide. 
Diabetes Mellitus (DM): metabolic disease caused by the body's failure to produce insulin 
or failure of cells to use insulin appropriately. 
Blood urea nitrogen (BUN): blood test that determines renal function measuring urea 
nitrogen, products which are formed when protein is broken down. 
Chronic Care Model (CCM): an organisational framework for chronic care management and 
practice improvement consisting of 6 concepts identified as: organisational support, clinical 
information systems, delivery system design, decision support, self-management support, 
and community resources. 
National Heart Foundation (NHF): a federated charity that funds cardiovascular research, 
promotes guidelines for health professionals, informs the public and assists people with 
cardiovascular disease management. 
Cardiac Society of Australia and New Zealand (CSANZ): is the professional society for 
cardiologists and those working in the area of cardiology including researchers, scientists, 
cardiovascular nurses, allied health professionals and other healthcare workers. 
Ejection Fraction (EF): volume of blood that is ejected from the left ventricle at the end of 
diastole that is then expelled during contraction. 
Heart Failure with a Preserved Ejection Fraction (HFPEF): (values vary) a left ventricular 
ejection fraction  >40%, >45%, or >50%. 
Heart Failure with a Preserved Systolic Function (HFPSF):  HFPSF is characterised by 
impairment of the left ventricle (LV) to fill during diastole as a result of slow or early 
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relaxation of the LV, or as a result of increased stiffening of the myocardium which leads to 
higher filling pressures. 
American College of Cardiology (ACC): non profit medical society dedicated to formulation 
of health policy, standards and guidelines, and cardiovascular research. 
American Heart Association (AHA): national voluntary health agency to help reduce 
disability and death from cardiovascular diseases and stroke. 
Coronary Artery Disease (CAD): hardening and narrowing of arteries due to 
atherosclerosis. 
Left Ventricle (LV): one of the four chambers of the heart. It receives blood from the left 
atrium. 
Electrocardiograph (ECG): graphic recording of electric potentials generated by the heart. 
Chest X-ray (CXR): radiograph of the chest. 
Full Blood Count (FBC): blood test that determines red blood cells, white blood cells and 
platelets. 
Urea, Electrolytes and Creatinine (UEC): blood test that determines renal function (urea 
and creatinine) and minerals that carry an electric charge Sodium(Na+), Potassium 
(K+),Chloride (Cl−). 
New York Heart Association (NYHA):  a member of the American National Heart 
Association. The New York Heart Association developed a scale for classifying the severity 
of heart failures known as the New York Heart Association functional classification. 
Incidence: the rate at which new cases occur in a population during a specified period. 
Prevalence: the proportion of a population that is affected by the disease at a specific time. 
European Society of Cardiology (ESC): a society representing European and Mediterranean 
cardiology professionals promoting scientific and educational activities. 
Emergency Department (ED): ward within a hospital specialising in acute care of individuals 
who present unplanned. 
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Rehospitalisation: an acute care admission within a specified time interval following 
discharge from hospital. Policymakers and researchers differ on the specified time and it 
varies between 48 hours, 28 days, 30 days, 60 days or 90 days.  
Western Australia (WA):  a state located on the West coast of Australia. 
STATA: a statistical software package.  
National Health and Hospitals Reform Commission (NHHRC): Commission established in 
2008 by the Australian Government with the aim of developing a long term health plan for 
Australia. 
Cumulative Index to Nursing and Allied Health Literature (CINAHL): a research database 
providing journals in the areas of nursing and allied health. 
Cardiovascular disease (CVD): a class of disease that involves the cardiovascular system 
(heart and blood vessels). In Australia the main types of CVD are heart failure, coronary 
heart disease and stroke. 
Chronic Heart Failure Management Programs (CHF-MPs): a disease management program 
involving specialty care and a multidisciplinary team that identifies and manages patients’ 
co-morbidities, optimises drug therapy, promotes patient education, and follow-ups with 
early identification of problems. 
Council of Australian Governments (COAG): the peak intergovernmental forum in 
Australia. The members of COAG are the Prime Minister, State and Territory Premiers and 
Chief Ministers and the President of the Australian Local Government Association. 
Registered Nurse (RN): professional nursing health care worker with a Bachelor degree and 
registered with a national regulatory body or agency.  
General Practitioner (GP): medical practitioner specialising in primary health care 
registered with a national regulatory body or agency. 
New South Wales (NSW): a state located on the East coast of Australia.  
United Kingdom (UK): is a sovereign state located off the North-Western coast 
of continental Europe. 
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Nursing and Midwifery Council (NMC): the former governing body for nursing registration 
in Australia. Currently referred to as the Australian Health Practitioner Regulation Agency 
(AHPRA). 
Beck Depression Inventory (BDI):  is a 21-question multiple choice self report inventory for 
measuring the severity of depression.  
National Health and Medical Research Council (NHMRC):  is Australia's peak funding body 
for medical research. NHMRC was established to develop and maintain health standards 
and is responsible for implementing the National Health and Medical Research Council Act 
of 1992. 
Statewide Planning and Research Cooperative System (SPARCS): is a comprehensive data 
reporting system that was established in 1979 in New York (USA) as a result of cooperation 
between the health care industry and government.  
International Classification of Diseases (ICD): is the standard diagnostic tool for 
epidemiology, health management and clinical purposes and is used by World Health 
Organisation member states. 
Outcomes of a Prospective Trial of Intravenous Milrinone for Exacerbation of Chronic 
Heart Failure (OPTIME-HF): is a randomised placebo controlled trial to assess the utility and 
safety of short-term intravenous milrinone in patients admitted with worsening chronic 
heart failure.  
Evaluation Study of Congestive Heart Failure and Pulmonary Artery Catheterization 
Effectiveness (ESCAPE): is a randomised control trial designed to test the long-term safety 
and efficacy of treatment guided by hemodynamic monitoring and clinical assessment 
versus that guided by clinical assessment alone in patients hospitalised with New York 
Heart Association class IV CHF. 
 Centre for Medicaid and Medicare Services (CMS):  is a federal agency within the United 
States Department of Health and Human Services (DHHS) that administers the Medicare 
program. The CMS works in partnership with state governments to administer Medicaid, 
the State Children’s Health Insurance Program (SCHIP) and health insurance.  
Acute Decompensated Heart Failure Registry (ADHERE): was designed to bridge the gap in 
knowledge and care by prospectively studying characteristics, management, and outcomes 
in a broad sample of patients hospitalised with acute decompensated heart failure. 
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Percutaneous Coronary Intervention (PCI): is one of the two revascularisation techniques 
currently used in the treatment of ischaemic heart disease by dilating the coronary artery 
involved. 
World Health Organization Commission on Social Determinants of Health (CSDH): a 
Commission established in 2005 by the World Health Organisation to provide advice on 
how to reduce the social determinants of health. The social determinants of health are the 
conditions in which people are born, grow, live, work and age, this also included the health 
system.  
Intensive Care Unit (ICU): specialised unit within a hospital providing critical care or 
intensive care medicine.  
Intensive Care National Audit and Research Centre (ICNARC): an organisation in the UK 
that aims to improve organisation and practice of care within critical care areas through 
audits and research. 
Acute Psychology and Chronic Health Evaluation (APACHE): severity-of-disease 
classification system applied within 24 hours of a patient being admitted to an intensive 
care unit. 
Simplified Acute Physiological Score (SAPS):  is a severity of disease classification system 
for patients admitted to an intensive care unit the 24 hours following admission. 
Mortality Probability Model (MPM): system to estimate the probability of hospital 
mortality for admitted patients. 
The Predicted Risk, Existing Diseases and Intensive Care Therapy model (PREDICT): long 
term survival of critically ill patients using clinical variables collected within the first 5 days 
of hospital admission.  
Angiotensin Converting Enzyme (ACE): conversion of angiotensin I to angiotensin II 
resulting in blood vessel constriction. 
Australian Cardiovascular Nurses College (ACNC): professional organisation that supports 
any nurse within Australia, New Zealand and the wider region of Asia who have  a major 
interest or role in caring for patients with cardiovascular disease. 
World Health Organisation (WHO): is a specialised agency of the United Nations (UN) 
concerned with international public health.   
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The chapter following this provides the actual journal article published in Australian Critical 
Care by Elsevier. The publication explores Australia’s health care reform strategies and the 
importance of the nursing role within chronic heart failure (CHF) disease management.  
Background 
• Australia has a health care system that offers universal health coverage for all 
citizens[1]. 
• Hospital funding by the Commonwealth government has been in a state of 
decline[2]. 
• An ageing population living longer with chronic diseases are currently a burden to 
the health sector due to hospitalisation[3]. 
• The highest expenditure for hospitalisation is related to cardiovascular diseases[3]. 
 
What this publication adds 
• This review delineates the Australian government’s plan for health care reform and 
refers to the reform goals of tackling access and equity, redesigning the health 
system and creating a system that is sustainable. 
• This review demonstrates the diversity of nursing roles in chronic heart failure 
management that can assist in identifying at risk individuals for hospitalisation and 
proposes that cross collaboration of a sundry of nursing roles can improve services 
offered within CHF disease management. 
• Elements of the Chronic Care Model have been applied to demonstrate the 
complex and distinct interventions required within chronic disease management in 
an Australian context. 
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Where to from here? 
• As part of the reforms the Commonwealth government will become directly 
responsible for funding basic community care for adults over the age of 65 years (in 
most States and Territories). 
• The identification of risk factors and targeting of individuals with CHF at risk of 
hospitalisation is paramount. 
• The identification of risk factors will enable the range of nursing roles particularly 
within primary care settings to target at risk individuals and implement or alter 
disease management strategies and prevent adverse outcomes. 
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Summary
Introduction:  The  importance  of  the  nursing  role  in  chronic  heart  failure  (CHF)  man-
agement  is  increasingly  recognised.  With  the  recent  release  of  the  National  Health
and  Hospitals  Reform  Commission  (NHHRC)  report  in  Australia,  a  review  of  nursing
roles  in  CHF  management  is  timely  and  appropriate.Nurse’s practice
patterns;
Aim:  This  paper  aims  to  discuss  the  implications  of  the  NHHRC  report  and  nursing
roles  in  the  context  of  CHF  management  in  Australia.
Method:  The  electronic  databases,  Thomson  Rheuters  Web  of  Knowledge,  ScopusAustralia and  the  Cumulative  Index  to  Nursing  and  Allied  Health  Literature  (CINAHL),  were
searched  using  keywords  including;  ‘‘heart  failure’’,  ‘‘management’’,  ‘‘Australia’’
and  ‘‘nursing’’.  In  addition  policy  documents  were  reviewed  including  statements
∗ Corresponding author at: The Centre for Cardiovascular and Chronic Care, Curtin Health Innovation Research Institute, Curtin
niversity, Faculty of Health Sciences, Curtin House, 39 Regent Street, Chippendale, Sydney, NSW 2008, Australia.
Tel.: +61 2 83997837.
E-mail addresses: v.betihavas@curtin.edu.au,  v.betihavas@uws.edu.au (V. Betihavas).
036-7314/ $ — see front matter © 2010 Australian College of Critical Care Nurses Ltd. Published by Elsevier Australia (a division of Reed International Books Australia Pty Ltd). All rights reserved.
oi:10.1016/j.aucc.2010.08.003
Journal Identification = AUCC Article Identification = 108 Date: July 21, 2011 Time: 6:42 pm
190  V.  Betihavas  et  al.
and  reports  from  key  professional  organisations  and  Government  Departments  to
identify  issues  impacting  on  nursing  roles  in  CHF  management.
Results:  There  is  a  growing  need  for  the  prevention  and  control  of  chronic  conditions,
such  as  CHF.  This  involves  an  increasing  emphasis  on  specialist  cardiovascular  nurses
in  community  based  settings,  both  in  outreach  and  inreach  health  service  models.  This
review  has  highlighted  the  need  to  base  nursing  roles  on  evidence  based  principles
and  identify  the  importance  of  the  nursing  role  in  coordinating  and  managing  CHF
care  in  both  independent  and  collaborative  practice  settings.
Conclusion:  The  importance  of  the  nursing  role  in  early  chronic  disease  symptom
recognition  and  implementing  strategies  to  prevent  further  deterioration  of  individ-
uals  is  crucial  to  improving  health  outcomes.  Consideration  should  be  given  to  ensure
that  evidence  based  principles  are  adopted  in  models  of  nursing  care.
e  of  Critical  Care  Nurses  Ltd.  Published  by  Elsevier  Australia
national  Books  Australia  Pty  Ltd).  All  rights  reserved.
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Health reform in Australia
The  Australian  health  care  system  is in  need  of
reform  to  respond  to  increasing  pressures  of  costs
and demand.  The  National  Health  and  Hospitals
Reform Commission  (NHHRC)  released  the  National
Plan for  Health  Reform  in  July  2009.1 Initially,  the
cost involved  for  implementing  the  NHHRC  strate-
gies was  estimated  to  be  between  $2.8  billion  and
$5.7 billion.1 However,  if  key  reforms  are  executed,
the government  is  projected  to  save  $4  billion
a year  by  2032.1 The  report  acknowledged  three
reform goals  that  would  assist  with  the  transfor-
mation of  the  Australian  health  care  system.  These
reform goals  are:
1.  tackling  major  access  and  equity  issues  that
affect  health  outcomes  for  people  now;1
2.  redesigning  our  health  system  so  that  it  is  better
positioned  to  respond  to  emerging  challenges;1
and
3.  creating  an  agile  and  self-improving  health  sys-
tem for  long-term  sustainability.1
With  an  ageing  population  living  longer  with
chronic diseases  such  as  chronic  heart  failure  (CHF),
implementation  of  the  NHHRC  goals  will  directly
impact on  management  of  individuals  with  CHF  in
the acute  and  community  settings.
Chronic heart failure in Australia
Chronic  heart  failure  is  burdensome  not  only  on
the individual  but  also  the  community.  The  preva-
lence of  CHF  rises  from  2.5%  for  people  aged  55—64
years to  8.2%  for  those  aged  over  75  years.2 Within
the Australian  population,  many  individuals  with
CHF are  living  longer  due  to  advancement  in  ther-
p
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$pies,  diagnostic  techniques,  and  chronic  disease
anagement.3
urden of cost
ustralia  is  supported  by  a  system  of  universal
ealth care  coverage  and  the  burden  of  health
osts increases  in  older  people  and  those  with
ultiple chronic  conditions.  In  2005—2006,  $86.9
illion or  9%  of  the  gross  domestic  product  was
pent  on  healthcare.2 Cardiovascular  disease  (CVD)
ccounted  for  the  highest  expenditure.  Eleven  per-
ent of  the  total  healthcare  budget  is  related  to
VD.4 Expenditure  can  be  divided  into  cost  for
reatment and  the  cost  for  prevention.  With  an
geing population  spending  on  health  treatment
s expected  to  soar  up  to  111%  by  2032.2 Cur-
ently, the  total  health  care  expenditure  for  CHF
s over  1  billion  Australian  dollars.5 The  majority
f this  expenditure  is  for  individuals  aged  85  years
nd over.  Eight  times  the  amount  was  spent  on
his age  group  compared  to  expenditure  for  indi-
iduals aged  45—54  years  with  CVD.5 Therefore,
he burden  of  cost  is  reflective  of  an  ageing  pop-
lation  with  multiple  chronic  illnesses  requiring
are.
Many patients  who  are  admitted  to  hospital  with
HF have  complex  co-morbidities.  The  interaction
f health,  social  and  psychological  issues  require
pecialist  care  with  input  from  multiple  special-
ies. Identifying  patients’  needs  and  employingital stay  in  acute  areas.  The  cost  of  hospitalised
atients in  acute  beds  is  $1100/day,  whereas  stay
n subacute  areas  costs  the  Australian  government
550/day.6
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pustralia’s  health  care  reform  agenda  
McAlister  et  al.  identified  in  a  systematic  review,
ost savings,  predominately  through  decreasing
ospitalisations,  were  apparent  when  CHF  disease
anagement  programs  incorporated  multidisci-
linary teams  and  patient  education.7 Through
dentifying early  signs  of  clinical  deterioration
trategies can  be  implemented  to  reduce  the  risk
f hospitalisation.  The  majority  of  health  related
xpenses  are  allocated  to  hospitalisation  partic-
larly  for  persons  over  85  years.5 This  means
hat there  is  an  increased  need  for  planning,  dis-
harge and  support  in  chronic  care.  Phillips  et
l.8 have  identified  that  improved  discharge  plan-
ing and  post  discharge  support  in  the  community
an decrease  rehospitalisation  for  individuals  with
HF. Similarly,  Chronic  Heart  Failure  Management
rograms (CHF-MPs)  are  an  evidence  based  strat-
gy for  community  based  care  based  upon  Level
 evidence.9 Due  to  complex  disease  management
f individuals  with  chronic  conditions,  the  National
ealth  and  Hospital  Reforms  Commission  (NHHRC)
ave prioritised  better  delivery  of  care  as  a  reform
oal.1 CHF-MPs  are  an  excellent  demonstration  of
ncorporating  evidence  based  principles  in  health
are reform.
This  paper  aims  to  first,  discuss  the  Australian
lan for  health  reform.  Secondly,  it  will  explore
ustralian nursing  roles  and  the  implications  these
oles have  on  future  chronic  heart  failure  manage-
ent.  Elements  of  the  Chronic  Care  Model  (CCM)10
ill  be  used  throughout  this  analysis  to  identify
reas for  reform.  The  CCM  has  empirically  derived
tems  of  interventions  to  improve  chronic  care.
here  is  an  increasing  recognition  of  the  need  for
revention  and  control  of  chronic  conditions  such
s CHF  and  an  emphasis  on  community  care.  This
mphasises  the  importance  of  the  nursing  role  in
oordinating  and  managing  CHF  care  in  both  inde-
endent  and  collaborative  practice  settings.
arly symptom recognition
arly  identification  of  chronic  disease  symptoms
nd disease  awareness  through  health  education  is
aramount in  chronic  disease  management.  An  edu-
ated, empowered  population,  making  informed
ecisions promotes  wellness  and  places  less  of  a
nancial burden  on  the  government  and  the  com-
unity.  With  an  ageing  population  living  longer  with
HF, the  importance  of  individuals  understanding
heir disease  and  disease  progression  will  permit
atients  to  monitor  their  symptoms  in  conjunction
ith health  care  teams.11 Health  literacy,  is  the
bility  of  individuals  to  access,  understand,  and
m
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se  information  for  health.12 Through  health  liter-
cy, support  is  advocated  for  greater  empowerment
n health  decision  making.  Collaboration,  particu-
arly between  CHF-MPs  and  the  individual  with  CHF,
romotes  communication  of  complex  medical  infor-
ation. Early  detection  of  CHF  deterioration  and
isease management  delivery  systems  will  provide
hronic  illness  care  for  individuals  with  CHF  and
ill potentially  decrease  financial  expenditure  in
he long  term.
The CCM  developed  by  Wagner13 provides  ele-
ents of  a systematic  approach,  with  responsive
nterventions and  cross-sector  interactions  with
he patient  as  the  focus  to  promote  high  qual-
ty chronic  disease  management.  There  are  six
ssential  elements  of  the  CCM  that  contribute  to
mproving  patient  outcomes.  All  six  components
f the  CCM  can  be  implemented  in  conjunction
ith the  NHHRC  recommendations  to  better  man-
ge individuals  with  CHF  in  Australia.  Elements  of
he CCM  are  discussed  below  in  relation  to  the  Aus-
ralian health  reform  agenda.
esources and policies
he  NHHRC  acknowledges  that  creating  resources
nd policies  that  foster  partnerships  within  the
ommunity  to  meet  the  needs  and  engage  com-
unity  involvement  of  its  individuals  is paramount.
ngaging the  community  is  dependent  on  increas-
ng access  to  information,  fostering  awareness
nd access  to  appropriate  health  care  personnel.
itry et  al.14 identified  a lack  of  dissemination
f resource  information  for  individuals  with  CHF,
ecommending  a national  move  towards  the  distri-
ution of  resources  and  the  access  and  availability
f material.  Providing  sufficient  funds  for  commu-
ity based  care  and  mechanisms  of  access  is  an
mportant  focus  of  the  health  care  reform  agenda.1
rganisational health care
rganisational  health  care  involves  endorsing  mod-
ls of  intervention  that  promote  safety  and  quality.
he NHHRC  report  emphasises  that  promoting
ommunication  between  health  and  aged  care  ser-
ices is  imperative  in  achieving  care  coordination.1
entral  to  achieving  this  is  increasing  sub-acute
acilities and  investment  in  support  services  for
eople at  home  and  communication  with  pri-
ary  care.  Evidence  based  discharge  planning  and
ndorsing  affordable  health  care  are  also  strate-
ies in  promoting  an  effective  and  accessible  health
are system.
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Significant  initiatives  are  being  undertaken  in
Australia  to  promote  primary  care.  The  Australian
government increased  expenditure  for  cardiovas-
cular diseases  in  Australia  by  18%  in  the  period
2000—2005, with  the  majority  of  expenses  being
allocated to  community  based  services.5 How-
ever, future  distribution  of  funds  may  need  to  be
increased  at  the  local  level  to  promote  suitable
chronic disease  management  for  the  growing  ageing
population.
Furthermore,  a  competency-based  framework  is
to be  the  foundation  for  health  curricula,  foster-
ing productive  partnerships  between  industry  and
education.  Curricula  that  are  competency  based
promote  safe  work  practices,  critical  thinking,
reflection and  allow  the  application  of  theory  into
clinical  practice.15
Self-management support
Self-management  is  a  naturalistic  decision-making
process.16 The  American  Heart  Association  (AHA)
has identified  several  behaviours  required  for
self-management  by  individuals  with  CHF.  These
behaviours  include:  adherence  to  prescribed  med-
ications,  diet  and  exercise;  symptom  and  weight
monitoring;  fluid  and  alcohol  restrictions;  the
cessation  of  smoking;  informing  their  physician
of any  non  prescribed  medication  they  may  be
administering  including  complimentary  therapies;
and  incorporating  preventative  behaviours  in  their
lifestyle such  as  regular  dental  care.16 However,
Riegel and  Carlson17 identified  in  an  North  Amer-
ican study  that  individuals  with  CHF  encountered
barriers to  self-management.  Barriers  included  a
lack of  understanding  of  CHF  symptoms,  complex
treatment regimes,  being  limited  in  undertaking
activities of  daily  living  and  emotional  wellbeing.17
Many  participants  acknowledged  an  inadequate
understanding  of  CHF.  However,  Carlson  et  al.18
identified  that  experience  aided  self-management
for participants  with  CHF.  Participants’  ability
and confidence  to  manage  their  care  improved
with time  and  familiarity  of  events.  Nevertheless,
strategies to  educate  individuals  regarding  self  care
including symptom  recognition  and  interventions
were identified  as  areas  in  need  of  improvement.
Decision supportDecision  support  is  evidence  based  quality  care
with input  and  feedback  from  patients  involved  in
management  of  their  disease.  It  involves  the  use
C
P
aV.  Betihavas  et  al.
f  practical  evidence  based  guidelines  to  govern
hronic disease  management  of  individuals.  Clark  et
l.19 identified  the  lack  of  adherence  to  guidelines,
iagnostic tests  and  implementation  of  interven-
ions in  rural  communities  compared  to  urban  areas
or the  care  of  individuals  with  CHF.  Furthermore,
he NHHRC  has  acknowledged  the  discrepancy
etween the  right  to  health  care  and  the  limita-
ion to  access  encountered  by  individuals  in  remote
ommunities.  Strategies  proposed  by  the  NHHRC
nclude  an  increase  in  workforce  supply,  funding  for
ervices, providing  for  patient  travel  and  accommo-
ation  as  well  as  training  opportunities  for  health
rofessionals  at  the  undergraduate  and  graduate
evel  in  rural  and  remote  communities.1
elivery system support
elivery  system  support  strengthens  effective,  effi-
ient care  and  support.  The  creation  of  a  National
ealth Promotion  and  Prevention  Agency,  aimed
t primary  prevention  and  early  interventions  will
romote education,  informed  health  choices,  and
arly detection  of  individuals’  deterioration.  Fund-
ng will  be  shifted  from  the  state  to  the  federal
overnment, and  will  result  with  the  Common-
ealth paying  100%  of  all  public  hospital  outpatient
ervices.1 Currently,  93%  of  chronic  heart  fail-
re management  programs  (CHF-MP)  exist  in  high
ccessible  areas.20 Clark  and  Driscoll20 exposed
he discrepancy  in  primary  health  care  programs
or individuals  with  CHF  living  in  remote  areas.
he Australian  Institute  of  Health  and  Welfare
AIHW)2 have  also  reported  that  life  expectancy
ecreases with  increasing  remoteness.  Therefore,
he NHHRC1 have  recommended  that  increased
unding and  training  for  clinicians  in  remote  areas
e a  priority.  Furthermore,  as  Australia  is  a country
ich in  diverse  cultures  and  customs,  streamlining
are should  be  structured  to  meet  the  needs  of
ndividuals  with  CHF.  Davidson  et  al.21 justified  the
nclusion of  family  members  of  individuals  with  CHF
n the  care  and  decision  making  process.  Other  fac-
ors that  need  to  be  considered  include  cultural
orms, individuals’  definition  of  illness,  and  health
are expectations  when  planning  CHF  management
rograms to  enable  appropriate  interventions  to
hen be  implemented.linical information systems
rovision  of  clinical  information  systems  permits
ccess to  key  data  to  efficiently  facilitate  resource-
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custralia’s  health  care  reform  agenda  
ul  and  high-quality  care.  Setting  national  access
argets  to  identify  if  members  of  the  community
re accessing  services  they  require  will  pinpoint
ndividuals in  need.  Introduction  of  an  electronic
ealth record  as  part  of  the  National  Health  and
ospitals  Network,  has  the  potential  to  increase
fficiency  and  safety  in  the  delivery  of  health
are and  decrease  reproductions  and  surplus  of
nformation.22 These  discrete,  yet  linked  elements
f the  CCM  need  to  be  considered  in  developing  and
dapting sustainable  models  that  are  responsive  to
he Australian  health  care  system.  Workforce  is  a
ritical issue  in  improving  chronic  care  and  nurses
lay a  crucial  role.  Below,  the  implications  of  CHF  in
he future  are  considered  within  nursing  roles  and
ssociated  scopes  of  practice.23
mplications for Australian nurses
he  World  Health  Organisation  has  identified  a
lobal crisis  regarding  the  health  workforce.  Edu-
ation and  training  with  concentration  on  nurses
nd midwives  has  been  identified  as  a  priority.24
ositive  outcomes  for  individuals  in  primary  care
r acute  care  settings  require  a  strong  foundation
n the  provision  of  nursing  services.  A  review  of
ustralia’s  health  workforce  was  described  in  The
roductivity  Commission  report.  The  report  iden-
ified the  shortages  of  workforce  supply,  and  the
ncrease  in  workforce  demand  primarily  in  remote
nd rural  areas.25 In  December  2009,  the  Australian
overnment established  Health  Workforce  Australia
HWA)26 which  has  signalled  a  process  of  work-
orce reform.  Managing  the  demand  and  increasing
he supply  of  Australian  health  care  providers  is
oth a  multifaceted  and  challenging  process.  One
uch focus  is  the  recruitment  of  individuals  to
he health  workforce  and  retaining  the  individuals
urrently employed  in  the  health  industry.  Fur-
hermore,  The  Council  of  Australian  Governments
COAG) have  affirmed  the  increase  in  funding  place-
ents to  undergraduate  health  discipline  training
ncluding  nursing  as  well  as  funding  for  supervision
f such  placements.27 This  is  beneficial  as  train-
ng at  the  undergraduate  level  will  expose  health
tudents  to  real  world  settings  and  improve  safe
ractice  and  efficiency  through  exposure  in  the  clin-
cal setting.28,29
Knowledge  gained  through  research  has  con-
ributed to  the  shaping  of  the  role  of  registered
urses in  chronic  disease  management.  However,
he scope  of  practice  of  the  CHF  nurse’s  role  includ-
ng education  and  training  is  varied.30 The  CHF
ursing  role  of  an  advanced  autonomous  clinician,
uided  by  assessment,  decision  making  based  on
g
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vidence  and  planning,  contributes  to  the  chronic
isease  management  within  a  healthcare  team  for
ndividuals with  CHF.  The  spectrum  of  CHF  disease
anagement  ranges  from  prevention  through  to
alliation.  In  Australia,  nursing  practice  is  guided
y the  guidelines  set  out  by  The  Australian  Nursing
nd Midwifery  Council.31 However,  the  span  is
eneric  aimed  at  all  Registered  Nurses  (RNs)  and
ot specific  to  CHF  nurses.
The scope  of  practice  for  the  CHF  nurse  may  also
iffer.  Practice  may  be  dependent  on  the  policies  of
n institution,  understanding  of  the  CHF  role  within
 multidisciplinary  team,  demographics  of  employ-
ent and  the  supply  or  number  of  CHF  nurses
vailable.30 In  the  acute  setting  the  nursing  role
s predominantly  assessment  and  acute  symptom
anagement.  Individuals  generally  present  with
n increase  in  shortness  of  breath  and  fatigue.32
hereas,  in  community  based  care  the  focus  is  on
rying to  prevent  an  individual’s  presentation  to
ospital. The  following  discusses  the  different  roles
egistered  nurses  have  in  community  based  man-
gement  of  individuals  with  CHF.
eart failure nurse specialists
eart  failure  nurse  specialists  work  within  a mul-
idisciplinary  team  to  deliver  evidence  based  care
o improve  patient  outcomes  and  address  the  needs
f patients  and  their  families.  CHF  nurse  specialists
equire  advanced  training  whose  aim  is to  identify
ppropriate  post  discharge  management  to  prevent
eadmissions  of  hospitalised  individuals.  The  eco-
omic benefit  of  the  CHF  nurse  specialist  has  been
hown, as  well  as  the  impact  of  their  role  has  in
educing  mortality  and  length  of  hospital  stay.33,9
urse practitioners
urse  practitioners  are  expert  leaders  with
dvanced knowledge  and  skill  providing
utonomous  care  to  individuals.  Commissioner
arling recommended  an  increase  in  the  funding
or nurse  practitioner  roles  as  a  strategy  to  work-
orce shortages  in  his  Special  Commission  of  Inquiry
nto Acute  Care  in  New  South  Wales  (NSW)  Public
ospitals.34
One  example  of  nurse  practitioners  working
ithin a  multidisciplinary  team  is  the  NSW  severe
hronic  disease  management  program.  This  pro-
ram targets  >65  year  old  and  >45  year  old
ndigenous population.35 The  service  attempts  to
ncrease the  quality  of  life  through  streamlining
ppropriate care  for  individuals  with  chronic  dis-
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eases.  Stromberg  et  al.36 identified  that  nurse  led
community  CHF  programs  empowered  individuals
and promoted  self-care  behaviour  in  their  dis-
ease management  and  improved  survival  of  CHF
patients.
Practice nurses
The  practice  nurse  is  a  nurse  employed  within  a
general practice  whose  tasks  often  includes  screen-
ing and  assessment  of  clients.37 As  the  practice
nurse role  is  in  its  infancy  in  Australia,  lack  of
clarity and  role  blurring  of  the  position  exist.  Ter-
tiary level  accreditation  requires  formulation  and
implementation  to  enhance  professionalism  of  the
role.38 Nonetheless,  Halcomb  et  al.39 showed  the
benefits of  practice  nurses,  located  within  general
practitioner  (GP)  clinics  made  access  to  members
of the  community  easier.  Practice  nurses  contribu-
tion  to  individuals  with  chronic  diseases  facilitated
a decrease  in  burden  of  disease;  decrease  read-
mission  rates  to  hospital  and  decreased  hospital
lengths of  stay.39 Political  imperatives,  commu-
nity needs  and  financial  outgoings  impact  on  the
attention  primary  nursing  receives.40 Therefore,
practice nurses  need  to  be  strategic  in  making  their
role/position  clear  in  formulating  a  niche  in  the
community.  This  will  facilitate  awareness  of  prac-
tice nurses’  role  amongst  community  members  and
health care  professionals.
The  practice  nurse  role  should  be  differentiated
from the  community  health  nurse  role  where  the
latter will  predominantly  review  and  assess  the
individual,  providing  complex  care  in  the  individ-
ual’s home.  The  practice  nurse  works  within  the
general  practice  setting.41 Similarly,  to  the  practice
nurse,  role  blurring  and  multiple  titles  of  the  com-
munity  health  nurse  exist.  These  terms  include  dis-
trict nurse  or  primary  health  nurse  and  have  led  to
an unclear  understanding  of  the  community  health
nurse position.42 The  review  by  Brookes  et  al.42 also
identified  an  increase  in  the  position  of  specialist
nurses within  community  health  nursing  services.
A shift  from  general  community  health  nursing
towards specialised  roles  has  been  influenced  by
evidence  based  research  and  a  chronic  ageing
population with  multiple  co  morbidities  requiring
specialised interventions  in  the  community.Specialist versus generalist approaches
Competency  standards  for  registered  general
nurses (RN)  in  Australia  are  overseen  by  the  Aus-
I
I
iV.  Betihavas  et  al.
ralian  Nursing  and  Midwifery  Council.  Competency
tandards are  the  basic  skills,  knowledge  and
onduct that  an  RN  must  adhere  by  to  retain
heir license  to  practice.  The  standards  relate  to
he appropriateness  of  care  and  are  divided  into
omains  of  practice.15 These  criteria  enable  safe,
ffective  and  proficient  care  to  be  delivered  by
eneral RNs  to  individuals  within  the  community
nd clinical  areas.  Though  these  are  domains  for
hich general  nurses  must  practice  under,  no  such
ational  domains  are  current  for  specialist  nursing
oles (apart  for  midwives)  in  Australia.  However,  in
he United  Kingdom  (UK),  the  Nursing  and  Midwifery
ouncil  (NMC)  which  oversees  the  registration  of
Ns and  midwives,  have  introduced  standards  of
ractice for  specialist  community  public  health
urses.43 The  NMC  stated  the  standards  were  cre-
ted due  to  the  role  of  community  public  health
urses being  distinctive  from  other  nursing  dis-
iplines.  It  was  stressed  that  community  public
ealth  nurses  worked  within  a  given  population  and
t times  were  required  to  make  clinical  decisions
hat impacted  on  a  given  individual  or  population
ithout having  consulted  every  member  of  that
ommunity.43 Furthermore,  in  a UK  study44 it  was
dentified  that  home  visits  post  hospitalisation  of
ndividuals with  CHF  by  specialist  nurses  decreased
he risk  of  rehospitalisation  through  early  detection
f deteriorating  symptoms.  This  is  also  reflected  in
ustralian studies.45,46 Therefore,  specialist  nurses
n chronic  care  such  as  CHF  have  developed  knowl-
dge and  skills  through  education  and  training
o practice  under  minimal  or  no  supervision  to
eliver safe,  proactive  care  and  thereby  decreasing
dverse health  outcomes.  In  order  to  promote  the
afety and  quality  of  patient  care,  domains  of  prac-
ice for  specialist  nursing  roles  should  be  considered
nd specific  competencies  be  addressed.  Further-
ore,  support  must  be  provided  for  consultation
o occur  with  relevant  authorities  and  professional
rganisations to  develop  and  monitor  standards.
pecialist and  generalist  approaches  should  not  be
iewed as  antagonistic  but  synergistic.  Developing
olicies  and  care  pathways  based  upon  patient’s
cuity and  needs  are  likely  to  generate  efficiencies.
odels of  nursing  care  include  home-based,  clinic
nd hybrid  approaches.  The  applicability  of  these
pproaches  is  likely  to  be  dependent  on  available
esources and  patient  characteristics.23ncreasing access and equity
n  Australia,  the  highest  prevalence  of  CHF  occurred
n areas  with  high  concentrations  of  people  over
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5  years  of  age  and  in  areas  with  higher  propor-
ions of  Indigenous  people.  At  this  time,  there  are
o CHF  management  programs  in  The  Northern  Ter-
itory or  Tasmania.47 Clark  and  Driscoll20 showed
hat no  CHF-MPs  had  been  established  outside  of
ities to  service  the  estimated  72,000  individuals
ith CHF  living  in  rural  and  remote  areas.  Fur-
hermore, in  community  settings,  the  majority  of
HF-MPs are  located  in  urban  areas  where  transport
nd access  issues  are  not  as  problematic  as  in  rural
nd remote  areas.  Therefore,  one  response  should
e for  the  government  to  recognise  and  utilise
esources that  are  already  available  to  individu-
ls in  rural  and  remote  communities.  Unlike  some
ealth professions,  there  is  more  equitable  distri-
ution of  nurses  across  urban  and  remote  regions.
n 2005,  the  supply  was  highest  in  very  remote  areas
ompared  to  urban  areas.2 Therefore,  implement-
ng health  care  management  and  assessment  with
rimary  nurses  leading  these  interventions  may  be
f benefit  to  individuals  in  rural  and  remote  areas.
owever,  equity  issues  surrounding  CHF-MPs  exist.
treamlining  care  should  be  based  on  practical,
vidence based  research  that  favours  optimal  end-
oints for  individuals  with  CHF.  Driscoll  et  al.48
emonstrated  the  variability  in  Australia’s  CHF-
Ps. Of  note,  was  30%  of  CHF  programs  had  no
ischarge  criteria.48 Inconsistencies  when  provid-
ng health  care  management  to  individuals  with  CHF
as the  potential  to  result  in  poorer  outcomes.  One
ethod of  overcoming  the  obstacle  of  access  and
ailure to  recognise  early  signs  and  symptoms  of
eterioration  is  telemonitoring  programs.  Clarke  et
l.49 identified  in  their  review  that  telemonitor-
ng in  individuals  with  CHF  reduced  admissions  to
ospital and  all  cause  mortality.  Nevertheless,  the
ollow up  period  for  the  studies  in  this  review  were
ess than  six  months  and  may  require  longer  fol-
ow up  periods  to  determine  if  the  findings  can  be
ustained  over  a  greater  period.
ross sector collaboration
ross  sector  collaboration  facilitates  early  recogni-
ion of  symptoms  and  implementation  of  strategies
o prevent  deterioration  for  the  individual  with
HF. This  pooling  of  resources  to  streamline  dis-
ase management  increases  access  of  the  individual
o health  care  and  is a  benefit  of  multidisciplinary
ollaboration.50 The  National  Heart  Foundation’s
NHF) components  of  multidisciplinary  care  include
lements  targeting  biomedical;  self-care  educa-
ion and  support;  psychosocial  care  and  palliative
are.51 The  diversity  of  needs  for  individuals  with195
HF means  that  management  should  be  tailored
o each  individual’s  situation  and  unmet  needs.
ultidisciplinary  disease  management  programs,
nderpinned  by  evidence  based  guidelines,  focusing
n the  identification  of  early  signs  and  symptoms
f health  deterioration  and  self-care  promotion
re fundamental  components  for  individuals  being
ncluded  in  management  of  their  disease.  Includ-
ng individuals  in  the  decision  making  process
s also  central  to  the  CCM  model  and  effec-
ive chronic  disease  management.13 Furthermore,
xploring patient,  provider  and  system  barriers
o collaboration  and  care  coordination  is  critical
ithin the  context  of  health  system  reform.
onclusion
his  paper  describes  considerations  for  CHF  nursing
odels  in  the  NHHRC  agenda  for  overhauling  Aus-
ralia’s health  care  system.  The  nursing  role  in  CHF
anagement  has  the  potential  to  increase  efficien-
ies and  improve  health  outcomes.  In  order  to  carve
 niche  in  the  newly  configured  health  care  system,
HF nurses  have  to  be  proactive  in  clearly  articu-
ating  models  of  care  and  their  scope  and  range  of
ractice.
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The chapter following this provides the actual journal article published in Contemporary 
Nurse by econtent Management. The publication explores the literature and identifies risk 
factors for rehospitalisation for adults with chronic heart failure (CHF). These risk factors 
have been categorised into patient, provider and system. 
 
Background 
• CHF is the leading cause for rehospitalisation for adults over the age of 65 years in 
developed countries[1]. 
• One in four patients who are discharged with the diagnosis of CHF will be 
rehospitalised within 30 days[2]. 
• The older an individual is, the higher the probability of them being 
rehospitalised[3]. 
 
What this publication adds 
• This review identifies patient, provider and system factors that influence disease 
management and contribute to rehospitalisation of individuals with CHF. 
• This review categorises patient, provider and system factors that lead to an 
increase in the risk for rehospitalisation. 
• This review categorises patient, provider and system factors that lead to a decrease 
in the risk for rehospitalisation. 
 
Where to from here? 
• Studies need to be undertaken to identify further provider and system factors that 
contribute to rehospitalisation of individuals with CHF. 
• Investigate the influence of patient, provider and system on health outcomes. 
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• Examine current models to identify predictors that have been incorporated into 
model design. 
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Heart failure (HF) is a heterogeneous syn-drome and a common cause of rehospitali-
sation. Not only is rehospitalisation costly for the 
community, it is also a marker of high risk for 
the individual declaring a new phase in the HF 
syndrome (Jaarsma et al., 2009). In Australia, HF 
is identifi ed in 8.2% of the population over the 
age of 75 years (Australian Institute of Health 
and Welfare, 2008). Furthermore, it is the most 
commonly diagnosed chronic disease in adults. 
Keenan and colleagues identifi ed that one in four 
patients with HF are rehospitalised within 30 days 
post discharge and many of these admissions are 
preventable (Keenan et al., 2008; Sochalski et al., 
2009). Hospitalisation, particularly among the 
elderly increases the risk of not only adverse car-
diac events but also non-cardiac events such as 
falls, infections and delirium (Oliver et al., 2007; 
Shah, Tsai, Klein, & Heidenreich, 2011).
Increasingly, rehospitalisations are identifi ed 
as a marker of quality of care (Foraker et al., 
2011). As a consequence, there is an increased 
scrutiny of processes and strategies to identify 
individuals at high risk. Seminal work in improv-
ing outcomes for chronic conditions has resulted 
Patient, provider and system factors infl uencing rehospitalisation 
in adults with heart failure
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Cardiovascular and Chronic Care, Faculty of Nursing, Midwifery and Health, University of 
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Abstract: Objectives: To identify patient, provider and system factors predicting rehospitalisation in adults with 
heart failure (HF). Method: The electronic data bases MEDLINE, Cumulative Index to Nursing and Allied Health 
Literature (CINAHL), Embase and PsychInfo were searched from 1996–2008 to identify studies identifying predictors 
of rehospitalisation from which the factors of patient, provider and systems were extracted. Results: A total of 62 elements 
were identifi ed. These elements were then sorted into patient, provider and system categories. Risk factors identifi ed for 
rehospitalisation were predominantly related to clinical factors. There were less factors identifying risk from the perspective 
of provider and health care systems. Conclusions: In people with HF it is likely that non-clinical factors including provider 
and system play an important role in rehospitalisation. There is a need to identify individuals at risk of rehospitalisation 
and tailor disease management programmes accordingly.
Keywords: nursing, risk factors, rehospitalisation and heart failure
in the need to consider patient, provider and sys-
tems issues in implementing disease management 
strategies (Bodenheimer, Wagner, & Grumbach, 
2002; McEntee, Cuomo, & Dennison, 2009). 
The chronic care model (CCM) developed by 
Wagner (1998) provides a framework for high-
lighting the interaction between the individual, 
health care providers and the health care sys-
tem. There is also a recognition that health and 
well-being is infl uenced by social determinants 
of health and that access to health care services 
and health care disparities can infl uence health 
outcomes (van der Wal & Jaarsma, 2008; WHO, 
2010).
Giamouzis et al. (2011) note that current risk 
prediction models provide limited information 
to clinicians as they lack sensitivity and acknowl-
edge the complexity of clinical management. 
Several factors contribute to this lack of utility, 
including the heterogeneity of the HF population 
(Giamouzis et al., 2011) and the emphasis on 
clinical factors identifi ed from derivation cohorts 
(Ross et al., 2008). To date, risk prediction mod-
els for rehospitalisation for individuals with HF 
(Chin & Goldman, 1997a; Felker et al., 2004; 
Patient, provider and system factors infl uencing rehospitalisation in adults with heart failure
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Allied Health Literature (CINAHL); Embase and 
PsychInfo were searched for the period 1996–
2008. Due to the advancement in therapies and 
the resulting alteration in the disease manage-
ment of chronic HF (CHF), literature following 
the late 1990s was selected. Bibliographic details 
and abstracts of the papers identifi ed through the 
search strategy were exported directly from the 
electronic databases into a bibliographic software 
package (Endnote XI). After duplicate items were 
removed, inclusion and exclusion criteria dictated 
which articles remained for the review. Three 
researchers independently completed the review 
by categorising the items into patient, provider 
and system factors.
Inclusion criteria
Types of studies
This review focussed on studies obtained from 
electronic databases; identifying factors that pre-
dict all cause or HF specifi c hospitalisation; and 
adults with HF.
Types of participants
The types of participants within the literature 
were adults (over the age of 18 years) with HF.
Exclusion criteria
The following were excluded: studies not writ-
ten in the English language, reviews and papers 
published prior to the year of 1996 and paediatric 
studies (populations < 18 years).
Quality appraisal
The process of evaluating the quality of the papers 
was a three stage process. Firstly, the papers were 
rated by the primary author (Vasiliki Betihavas) 
and identifi ed for inclusion or exclusion using 
the preset criteria. Manual searching of the lit-
erature occurred for the factors included in the 
fi nal model. Secondly, 20% of the papers were 
reviewed by a second reviewer (Phillip J Newton) 
and verifi ed to the accuracy of the analysis. Finally, 
a third reviewer (Patricia M Davidson) evalu-
ated the overall scrutiny of the fi nal factors that 
were identifi ed. Discrepancies between any of the 
reviews were discussed and resolved between the 
three reviewers.
Krumholz et al., 2000; Philbin & DiSalvo, 1999; 
Yamokoski et al., 2007) primarily include clini-
cal factors (Giamouzis et al., 2011). Therefore, 
these models do not always refl ect the complex 
relationship between physical, social, economic 
and psychological factors that impact on health 
outcomes (McDonagh et al., 2011; Schweitzer, 
Head, & Dwyer, 2007).
This paper seeks to summarise patient, pro-
vider and system factors predicting rehospitali-
sation in adults with HF. For the purposes of 
this paper, patient, provider and system will be 
defi ned as follows: patient relates to the multidi-
mensional facets of individuals including physi-
cal, social, psychological, economic, cultural, 
and existential characteristics. Providers denote 
health professionals providing formal care giv-
ing; and system pertains to factors relating to 
the organisation, funding and policy milieu of 
health care system delivery. Furthermore, the 
terms acute and chronic have been used to label 
or categorise HF within some of the literature. 
However, there are discrepancies with their uses 
within the literature and by clinicians in clinical 
settings (Dickstein et al., 2008). Acute HF has 
been used to refer to new onset HF. However, 
it has also been used to describe an exacerbation 
in symptoms of HF, such as pulmonary oedema 
that results is rehospitalisation. The individual 
is then labelled by some clinicians as having 
an acute exacerbation of a chronic condition. 
Therefore, the literature used for this review, did 
not distinguish between risk predictors for acute 
or chronic HF. We endeavoured to identify risk 
predictors for rehospitalisation for individual’s 
with HF.
METHODS
Research question
The research question for the review was: ‘What 
are the patient, provider and system factors infl u-
encing rehospitalisation in adults with HF?’
Search strategy
The MeSH terms that were used for the literature 
search included: ‘heart failure’; ‘hospitalisation’; 
and ‘heart failure congestive’. The databases, 
MEDLINE; Cumulative Index to Nursing and 
Vasiliki Betihavas et al.
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of individuals at risk of rehospitalisation. This 
decrease in oxygen carrying capacity will further 
compromise the individual and may result in 
further deterioration in other areas. An example 
of this is, confusion secondary to hypoxia which 
may affect an individual’s ability to titrate medica-
tions appropriately potentially increasing the risk 
of rehospitalisation.
Arrhythmia (Benza et al., 2004); dilation of 
the left ventricle and a reduced ejection fraction 
increase the likelihood of ventricular tachyar-
rhythmias, and death (Dickstein et al., 2008). 
However, recent implantable cardioverter- 
defi brillator (ICD) implantation has been used 
as a secondary measure to prevent or termi-
nate tachyarrhythmias, without the need for 
rehospitalisation.
An increase in the number of co-morbidities 
(e.g., diabetes, chronic obstructive pulmonary 
disease, osteoarthritis; Doughty et al., 2002; van 
der Wel et al., 2007) an individual has, the greater 
their risk of rehospitalisation.
Fluid overload (Bart et al., 2005); increases 
in weight are predictors of rehospitalisation. 
Individuals have been shown to have an increase 
in weight several days prior to their rehospi-
talisation (Chaudhry, Wang, Concato, Gill, & 
Krumholz, 2007).
Worsening renal function (Hillege et al., 2006) 
elevated blood urea nitrogen (BUN) levels, ele-
vated urea and creatinine and low glomerular fi l-
tration rate (GFR) are signs of worsening renal 
function and are associated with adverse events 
for individuals with HF. Factors contributing to 
worsening renal function have been identifi ed as 
male sex, a history of hypertension, a high cre-
atinine level on admission, elevated systolic blood 
pressure, presence of rales and a basilar pulse 
rate > 100 bpm (Krumholz et al., 2000).
Left ventricular function less than 45% is a 
risk factor for rehospitalisation (Smith, Masoudi, 
Vaccarino, Radford, & Krumholz, 2003; Sweitzer, 
Lopatin, Yancy, Mills, & Stevenson, 2008).
Disease progression New York Heart 
Association (NYHA) IV class (Glick, Michowitz, 
Keren, & George, 2006; McKee, Leslie, LeMaitre, 
Webb, & Denvir, 2003); the NYHA classifi es HF 
according to functional ability; the classifi cations 
RESULTS
A total of 2355 articles were identifi ed from the 
initial search. The majority of the studies identi-
fi ed from the review were conducted in North 
America. Follow up periods ranged from 21 
days–5.5 years. Most of the studies included 
mortality, HF specifi c hospitalisation, or the 
combined endpoint of all cause hospitalisation 
and mortality as primary outcomes. Data were 
categorised as patient, provider or system factors. 
Following review and data extraction 229 factors 
were identifi ed as predictors of rehospitalisation 
for adults with HF. Following consolidation of 
items, these were then collapsed into 62 catego-
ries. Item reduction was undertaken by combin-
ing items, such as the grouping of biochemical 
data. Risk factors for rehospitalisation are sum-
marised in Table 1 and key points are sum-
marised below as patient, provider and system 
factors. Further categorisation is made by iden-
tifying from the literature factors that increase or 
decrease the risk of rehospitalisation. These lists 
are not meant to be exhaustive but illustrative of 
factors contributing to increasing or decreasing 
the risk of rehospitalisation.
Patient factors
Factors that increase the risk of readmission
The majority of factors identifi ed predicting the 
risk of rehospitalisation for individuals with HF 
were patient factors. The patient factors are fur-
ther categorised into biological, psychological and 
social and these are listed below. Some factors 
such as race can be debated regarding whether 
they should be classifi ed as biological or social. 
The categorisation is meant to aid with identify-
ing the literature, rather than defi ning it.
Biological: Age, the risk of rehospitalisation 
increases with advancing age (Cowie et al., 2002; 
Kossovsky et al., 2000; Pocock et al., 2006). With 
the ageing of the baby boomer generation and 
the projected increase in individuals who will 
be diagnosed with HF, rehospitalisation for the 
elderly may further increase.
Anaemia (Anand et al., 2004; Felker et al., 
2004; Komajda et al., 2006; Silverberg et al., 
2002); low haemoglobin levels are indicative 
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(Cournot, Leprince, Destrac, & Ferrieres, 2007; 
Logeart et al., 2004; Verdiani et al., 2005).
Hypertension (Filippatos et al., 2008; Levy, 
Larson, Vasan, Kannel, & Ho, 1996); a history 
of hypertension and unmanaged hypertension 
increase the likelihood of rehospitalisation.
Hyponatremia (Gheorghiade et al., 2007) is a 
sign of disease progression and is associated with 
poorer outcomes.
Race (Afzal et al., 1999; Deswal, Petersen, 
Urbauer, Wright, & Beyth, 2006); African 
Americans have higher rates of HF diagnosis 
compared to Caucasians (Franciosa et al., 2002).
can be transient dependant on the individual’s 
symptoms at time of assessment.
History of HF (Jarnert, Edner, & Persson, 2007) 
with prior hospitalisation; previous admissions to 
hospital further increase the probability of rehospital-
isation. This may be due to the individual’s progres-
sion in HF severity or adverse events that occur whilst 
hospitalised increasing the risk of rehospitalisation.
Elevated B-type natriuretic peptide (BNP); 
 levels > 400 pg/ml and NT-pro BNP lev-
els > 450 pg/ml (Newton, Betihavas, & Macdonald, 
2009) on discharge have been shown to be predic-
tive of an individual at risk of rehospitalisation 
TABLE 1: EXAMPLES OF PATIENT, PROVIDER AND SYSTEM FACTORS PREDICTIVE OF HOSPITAL READMISSION
Patient factors: Multidimensional 
facets of individuals- including 
physical, social, psychological, 
cultural, and existential 
characteristics N = 159 studies
Provider factors: Health 
professionals providing formal care 
giving N = 27 studies
System factors: Relating to the 
organization, funding and policy 
milieu of health care system delivery
N = 25 studies
Individual factors Multidisciplinary* teams (Stewart, 
Pearson, & Horowitz, 1998)
Social service and insurance 
(Philbin & DiSalvo, 1999)
 Psychological: Depression 
(Jiang et al., 2001) 
Heart failure expertise knowledge 
(Jong et al., 2003)
Performance indicators (Luthi, 
Burnand, McClellan, Pitts, & 
Flanders, 2004)
Cognitive impairment 
(Trojano et al., 2003)
Qualifi cations and credentialing 
(Reis et al., 1997)
Social behavioural: Treatment 
adherence (Komajda et al., 2005)**
Health service coordination 
(Cleland et al., 2003)
Level of education 
(Sui, Gheorghiade, Zannad, Young, & 
Ahmed, 2008)
Setting and mode of care delivery 
(Riegel et al., 2002)
Income (Philbin et al., 2001)
Health literacy (Murray et al., 2009) Rurality (Clark et al., 2007)
Living alone (Luttik, Jaarsma, Veeger, 
& van Veldhuisen, 2006)
Race (Fang, Mensah, Croft, & Keenan, 
2008)
Biological: Co-morbidities 
(Braunstein et al., 2003)
Low haemoglobin (Go et al., 2006), 
sodium (Gheorghiade et al., 2007), 
albumin (Gerstein et al., 2001), renal 
dysfunction (Hillege et al., 2006)
Ejection fraction (Yusuf et al., 2003)
Sex (Adams et al., 1999)
*Multidisciplinary teams are comprised of a diversity of health specialties that are engaged in the delivery of 
comprehensive care to meet the widespread needs of individuals (Mitchell, Tieman, & Shelby-James, 2008); **Adherence: 
The World Health organisation has defi ned adherence as ‘… the extent to which a persons’ behaviour (taking medication, 
following diet, and/or executing lifestyle changes) coincides with agreed recommendations from a health care provider’ 
(Sabate, 2003).
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as well as health disparities contribute to this 
increased risk. Language, health literacy levels, 
and understanding of HF disease management 
(DeWalt et al., 2006) affect how an individual 
manages themselves in conjunction with their 
health care provider.
Factors that decrease the risk of readmission
Biological: Few studies have identifi ed a lower 
risk for women, although this is not consistent 
across studies (O’Meara et al., 2007).
Psychological: Major elements in preventing 
rehospitalisation within the psychological 
domain are social support from the community 
and patient education. Patient support 
regarding HF management pre discharge 
decreases the risk of rehospitalisation 
(Koelling et al., 2005). Furthermore, ongoing 
patient education in the community has been 
shown to decrease inappropriate resource 
utilisation (Heidenreich, Ruggerio, & Massie, 
1999). However, due to multi co-morbidities 
and cognitive dysfunction of the elderly 
population with HF, education of individuals 
regarding HF disease management needs 
to be targetted to meet the needs of this 
population (Stromberg, 2005). The overall 
aim of education sessions should be to provide 
individuals with options regarding disease 
management so that they may make informed 
choices regarding their health and adhere to 
management strategies thus decreasing their 
risk of rehospitalisation.
Social/behavioural: Adhering to treatment is 
an important consideration in HF management. 
Medication adherence decreases the risk of 
rehospitalisation for individuals with HF. 
However, it has been identifi ed that only 10% of 
individuals with HF adhere to their medication 
regimes (Leventhal, Riegel, Carlson, & De Geest, 
2005).
Provider
Factors that increase the risk of readmission
The quality of care, measured by guideline 
adherence, provided by clinicians infl uences the 
Psychological: Individuals who have depression 
and HF have an increased risk of being 
rehospitalised (Braunstein et al., 2003; Jiang 
et al., 2001; Rumsfeld et al., 2005). Individuals 
with high Beck Depression Inventory (BDI) 
scores (Sharp & Lipsky, 2002) have also been 
shown to have higher NYHA class (Ferketich, 
Ferguson, & Binkley, 2005). This may be due 
to infl ammatory mediators that contribute to 
disease progression (Pasic, Levy, & Sullivan, 
2003). Furthermore, Sherwood et al. (2007) 
identifi ed those who live alone have an increase 
risk of hospitalisation (Harris, Aboueissa, & 
Hartley, 2008; Stewart et al., 2006). Having a 
partner may prevent an individual from further 
deterioration as early symptom recognition 
may occur and management strategies are 
implemented.
Education (Koelling, Johnson, Cody, & 
Aaronson, 2005; Krumholz et al., 2002) and lit-
eracy levels (Baker et al., 2002) have an impact 
on self-management by individuals with CHF. 
Non adherence with medication administration 
(Chin & Goldman, 1997b) and current smok-
ing (Suskin, Sheth, Negassa, & Yusuf, 2001) 
are risk factors for rehospitalisation. Smoking 
cessation programmes incorporated into 
patient education sessions have been shown to 
decrease the risk of hospitalisation (Chouinard 
& Robichaud-Ekstrand, 2005). Furthermore, 
a multifaceted approach of affordable health 
care, particularly for pharmaceutical products, 
patient education and multidisciplinary care has 
the potential to increase adherence to medica-
tion regimes for the elderly with HF (van der 
Wal & Jaarsma, 2008).
Social: Socioeconomic status (Blustein, 
Hanson, & Shea, 1998; Philbin, Dec, Jenkins, 
& DiSalvo, 2001) and insurance status (Philbin 
& DiSalvo, 1999) is associated with an increased 
risk of rehospitalisation. Low health related 
quality of life can also infl uence rehospitalisation 
(Konstam et al., 1996). Culture and ethnicity may 
infl uence the individual’s risk of rehospitalisation. 
African American individuals have a higher risk 
than Caucasians for being rehospitalised for 
HF (Deswal et al., 2006). Biological factors 
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the higher the probability of rehospitalisation. As 
such, distance from a hospital will dictate how 
often an individual seeks treatment (Clark et al., 
2007). Furthermore, some individuals from rural 
areas are reluctant or unable to travel the distance 
required to access care. Individuals who wait until 
they have deteriorated before seeking treatment 
increase the risk of longer hospital stays, as they 
are admitted to high acuity areas due to the sever-
ity of their clinical condition.
Factors that decrease the risk of readmission
Discharge planning (Naylor et al., 2004) and 
quality of care by the provider particularly adher-
ence with guideline recommendations (Fonarow 
et al., 2008) decreases the risk of rehospitalisa-
tion. Discharge planning that begins immediately 
upon the hospitalisation phase and continues 
with follow up care post hospitalisation has the 
potential to capture patients at risk of deterio-
ration and intervene accordingly prior to dete-
rioration (Capomolla et al., 2002). The use of 
evidence based guidelines to guide and man-
age individuals with HF whilst in hospital also 
increases the likelihood of appropriate manage-
ment being implemented and preventing early 
rehospitalisation post discharge (Peterson et al., 
2006). CHF-disease management programmes 
with follow up care in the community post dis-
charge have also shown to decrease the risk of 
rehospitalisation (Stewart, Marley, & Horowitz, 
1999).
DISCUSSION
This review has illustrated that despite the 
increased emphasis on provider and system fac-
tors impacting outcomes for HF, current risk 
prediction models do not address these factors 
and individual clinical studies contributing to 
these derivation models do not collect or report 
these data (Giamouzis et al., 2011). It is also 
highly likely that patients, providers, fund-
ing and regulatory bodies may have varying 
priorities and perceptions of risk and adverse 
outcomes which may infl uence the validity 
and utility of risk prediction models. As HF is 
increasingly recognised as a cardiogeriatric syn-
drome, provider and system factors will increase 
individual’s risk of rehospitalisation (Keenan 
et al., 2008; Polanczyk, Newton, Dec, & Di 
Salvo, 2001). In addition, being managed by a 
carer provider who is not a HF specialist increases 
the likelihood of an individual being rehospital-
ised. The quality of inpatient care increases the 
risk of rehospitalisation (Keenan et al., 2008). 
Those individuals who do not receive evidence 
based recommendations for care (Komajda 
et al., 2005), are discharged prematurely, dis-
charged without follow up care, and the failure 
to provide support services in the community 
increases the risk of rehospitalisation for those 
individuals.
Factors that decrease the risk of readmission
Multidisciplinary health care providers includ-
ing registered nurses (de la Porte et al., 2007; 
Naylor et al., 2004; Sisk et al., 2006; Thompson, 
Roebuck, & Stewart, 2005) cardiologists (Ahmed 
et al., 2003; Philbin, Weil, Erb, & Jenkins, 1999) 
and pharmacists (Lopez Cabezas et al., 2006) pro-
viding collaborative input into care, can improve 
outcomes. Management of individuals with 
CHF by advanced practice clinicians and special-
ist providers (Blue et al., 2001; Fonarow et al., 
1997; McDonald et al., 2001) have been shown 
to decrease the risk of being rehospitalised. HF 
management programs (HF-MP; Kimmelstiel 
et al., 2004; Piepoli et al., 2006) and multidis-
ciplinary teams (Martineau, Frenette, Blais, & 
Sauve, 2004; O’Connell, Crawford, & Abrams, 
2001) have been shown to decrease the risk of 
rehospitalisation. Managing individuals with 
chronic diseases holistically within a health care 
team has the potential to capture individuals who 
have social and psychological risk factors and not 
only biological risk factors.
System factors
Factors that increase the risk of readmission
The drivers for funding of health care services 
can alter not only the individual’s risk of rehos-
pitalisation but also the threshold of providers to 
recommend hospitalisation. The distance of resi-
dence of an individual from a hospital, impacts 
on rehospitalisation. Harris et al. (2008) identi-
fi ed that the closer an individual was to a hospital 
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Limitations
This review has several limitations. Firstly, a meta-
analysis was not performed so it is not possible 
to discuss effect size of individual factors due to 
heterogeneity in study design, endpoints, inter-
ventions and methods of outcome assessment. 
Furthermore, participants within HF RCTs may 
not always be representative of real world popula-
tions. The use of RCTs could possibly have also 
inferred a bias as many registries may identify pre-
dictors of rehospitalisation in the usual care envi-
ronment (Gluud, 2006). Potentially, registry data 
may shed light on factors such as insurance status 
and models of care delivery that may impact on 
clinical outcomes. Also, this literature review was 
conducted in 2008. As such, a limitation of this 
study is that no literature appears following 2008.
CONCLUSION
Heart failure is a complex and heterogeneous syn-
drome requiring comprehensive management to 
prevent hospitalisation. Based on this review and 
the increasing recognition of risk factors being 
important in identifying individuals at risk, there 
is a need for strategies to be implemented within 
the community to target individuals at risk. In 
spite of the increasing recognition of the social 
determinants of health and the acknowledgement 
that HF is a complex and commonly cardiogeriat-
ric syndrome, limited data is available to describe 
the infl uences of these factors on health outcomes 
and should be considered in the development of 
future risk prediction models.
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in prominence not only in increasing the risk 
of hospitalisation but also infl uencing the clini-
cian’s threshold to admit an individual to hospi-
tal (McDonagh et al., 2011).
The heterogeneity of the HF syndrome infl u-
ences the applicability of current risk reduction 
models (Giamouzis et al., 2011). In addition, 
treatment changes such as the introduction of 
implantable cardiac defi brillators can contrib-
ute to changing the illness trajectory for HF. 
What has emerged from this review and oth-
ers (Giamouzis et al., 2011; Ross et al., 2008) 
is the need to increase the scope of current risk 
prediction models to address non-clinical fac-
tors. Deriving consensus from the perspective 
of patient, provider and systems issues may 
contribute to this increased understanding and 
the development and validation of risk predic-
tion models that incorporate this broad perspec-
tive. As measures such as 30 days readmission 
increasingly become the metric of organisational 
performance, accurately measuring baseline 
risk and intervening with individuals at high-
est risk is an important focus for future health 
services research (Bisognano & Boutwell, 2009). 
Providing greater consideration to socioeco-
nomic and cultural factors in appraising risk 
may assist in targetting those at highest risk. 
Ghali et al. (2003) have identifi ed the impor-
tance of considering sex differences, culture and 
ethnicity in contributing to the burden of HF. 
Many of the non-clinical reasons associated with 
increased hospitalisation relate to poor adher-
ence and failure to implement self-management 
programmes. The importance of considering 
self-care in management plans is increasingly 
underscored (Riegel et al., 2009). The reasons 
why individuals choose not to adhere to rec-
ommended guidelines for HF management are 
multi-factorial and often relate to patient, pro-
vider and system factors (Hauptman, 2008; 
McEntee et al., 2009). This complexity should 
not result in the failure to include these factors 
in empirically derived models that are tested in a 
range of contexts, both hospital and community. 
Further research should focus on identifying the 
relative and absolute predictive value of these 
factors.
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Background 
• Risk prediction models are used to identify at risk individuals[1]. 
• Risk prediction models or scores are classified as either absolute or relative[1]. 
• Current risk prediction models for rehospitalisation have been developed with 
North American cohorts[2]. 
 
What this publication adds 
• This review identifies factors within current risk prediction models. 
• This review discovered the discrepancy with risk factors incorporated into risk 
model design. 
• This review pinpoints the limited amount of factors that are replicated in the risk 
models that were reviewed. 
• Currently, there is no absolute risk score for rehospitalisation. 
 
Where to from here? 
• Studies in the exploration of risk factors need to expand the lens of focus to include 
provider and system factors. 
• Administrative data sets and randomised control trials (RCTs) dominate as the 
sources for factors that are included in risk prediction models. Using innovative 
sources such as clinical expertise may expose risk factors for rehospitalisation that 
have yet to be identified from administrative data sets and RCTs. 
52 
 
ELSEVIER PUBLISHING RIGHTS STATEMENT 
Policy: An author may, without requesting permission, use the preprint for personal use, 
internal institutional use, and permitted scholarly posting.  
Personal Use: Use by an author in the author’s classroom teaching (including distribution 
of copies, paper or electronic), distribution of copies to research colleagues for their 
personal use, use in a subsequent compilation of the author’s works, inclusion in a thesis or 
dissertation, preparation of other derivative works such as extending the article to book-
length form, or otherwise using or reusing portions or excerpts in other works (with full 
acknowledgment of the original publication of the article)[3]. 
 
See Appendices  for Elsevier Publishing Rights Statement 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
53 
 
References 
1. Steyerberg, E.W., Clinical Prediction Models: A practical approach to 
development, validation, and updating.  2009, New York: Springer. 
2. Ross, J.S., et al., Statistical Models and Patient Predictors of Readmission for 
Heart Failure: A Systematic Review. Arch Intern Med, 2008. 168(13): p. 1371-
1386. 
3. Elsevier, Ways to Use Journal Articles Published by Elsevier: A Practical Guide. In 
E. L. Connect (Ed.), Library Connect Editorial Office. 2011, The Library Connect 
team, in collaboration with the Elsevier Global Rights Department: San Diego. 
 
 
  
AW
r
f
V
P
P
S
P
S
a
U
b
c
d
e
R
N
C
f
1
dustralian Critical Care (2012) 25, 31—40
hat  are  the  factors  in  risk  prediction  models  for
ehospitalisation  for  adults  with  chronic  heart
ailure?
asiliki  Betihavas  RN,  BN,  MNa,b,∗,
atricia  M.  Davidson  RN,  BA,  Med,  PHDa,c,
hillip  J.  Newton  RN,  BN  (Hons),  PhDa,
teven  A.  Frost  RN,  BN,  MPHb,
eter  S.  Macdonald  MBBS,  PhD,  MD,  FRACPd,
imon  Stewart  PhD,  NFESC,  FAHA,  FCSANZe
Curtin  Health  Innovation  Research  Institute,  The  Centre  for  Cardiovascular  and  Chronic  Care,  Curtin
niversity, Sydney,  Australia
The  University  of  Western  Sydney,  School  of  Nursing  and  Midwifery,  Sydney,  Australia
St  Vincent’s  and  Mater  Health,  Sydney,  Australia
St  Vincent’s  Hospital  and  Victor  Chang  Cardiac  Research  Institute,  Sydney,  Australia
Preventative  Health,  Baker  IDI  Heart  and  Diabetes  Institute,  Melbourne,  Australia
eceived  15  December  2010;  received  in  revised  form  19  April  2011;  accepted  20  July  2011
KEYWORDS
Heart failure;
Primary prevention;
Risk factors;
Patient readmission
Summary
Background:  Risk  prediction  models  can  assist  in  identifying  individuals  at  risk  of
adverse  events  and  also  the  judicious  allocation  of  scare  resources.  Our  objective
was  to  describe  risk  prediction  models  for  the  rehospitalisation  of  individuals  with
chronic  heart  failure  (CHF)  and  identify  the  elements  contributing  to  these  models.
Methods:  The  electronic  data  bases  MEDLINE,  PsychINFO,  Ovid  Evidence-Based
Medicine  Reviews  and  Scopus  (1950—2010),  were  searched  for  studies  that  describe
models  to  predict  all-cause  hospital  readmission  for  individuals  with  CHF.  Search
terms  included:  patient  readmission;  risk;  chronic  heart  failure,  congestive  heart
failure  and  heart  failure.  We  excluded  non-English  studies,  pediatric  studies,  and
publications  without  original  data.
Results:  Only  1  additional  model  was  identified  since  the  review  undertaken  by  Ross
and  colleagues  in  2008.  All  models  were  derived  from  data  sets  collected  in  the
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Introduction
Hospitalisation  is  common  in  individuals  with
chronic heart  failure  (CHF).  In  people  over  the  age
of 65  years  CHF  is  the  leading  cause  of  admis-
sion to  the  hospital.1—3 In  Europe,  where  the
prevalence of  CHF  is  estimated  to  be  15  million,4
hospitalised  individuals  with  CHF  accounts  for  5%
of hospital  admissions  and  2%  of  the  total  health
care  expenditure.4 Though  the  incidence  of  CHF
in Australia  is  unknown,  the  prevalence  is  esti-
mated  to  be  263  000  within  a  population  of  21
million.5 Within  the  Australian  population,  2.5%  of
Australians  aged  between  55  and  64  years  have  CHF,
this figure  rises  to  8.2%  for  individuals  over  the  age
75.5 Therefore,  the  prevalence  of  CHF  increases
with age  as  individuals  are  living  longer  with  CHF.
These factors  impact  the  individual,  health  care
and community  sectors.  The  potential  exists  for  an
escalation  in  the  number  of  individuals  who  will  be
at an  increased  risk  of  hospitalisation.
Many of  these  hospitalisations  are  rehospital-
isations which  are  likely  to  be  predictable  and
therefore  possibly  preventable.  Chronic  care  man-
agement  programs  utilising  multidisciplinary  teams
have demonstrated  decreased  rehospitalisation
rates in  individuals  with  CHF.6 Begg  and  colleagues7
identified  that  individuals  with  CHF  who  had  never
been hospitalised  had  a  25%  lower  case  fatality  than
those who  had  a  history  of  hospitalisation.  Although
all patients  with  a  history  of  hospitalisation  for  CHF
are at  a  high  risk,  there  are  some  individuals  with
greater vulnerability  and  some  of  these  factors  are
shown in  Table  1.
Risk prediction modelsRisk  prediction  models  use  factors  to  calculate  or
predict an  outcome.  Alternate  names  for  predic-
tive models  include:  nomograms;  clinical  prediction
t
i
i
pV.  Betihavas  et  al.
re  followed  from  60  days  to  18  months.  The  only  common
on  in  the  models  identified  by  Ross  and  colleagues  were
s  and  a  history  of  prior  hospitalisation.  The  additional
nclude  the  non  clinical  factors  of  social  instability  and
ictors  of  rehospitalisation.
urden  of  hospitalisation  in  CHF,  there  are  limited  tools
ing  risk.  Developing  risk  prediction  models,  based  on
 characteristics  may  assist  in  identifying  individuals  in
risk  and  in  need  of  targeted  interventions  to  improve
Australia  (a  division  of  Reed  International  Books  Australia
ian  College  of  Critical  Care  Nurses  Ltd.
ules  and  prognostic  models.8 These  models  are
sually developed  from  large  data  sets  using  logistic
egression  modelling9 encompassing  a  combination
f categorical  and  continuous  variables.10 Unlike
iagnostic models  which  are  often  cross-sectional  in
esign and  use  patient  factors  to  predict  an  under-
ying diagnosis,11 predictive  models  incorporate  the
easurement  of  time,  are  generally  longitudinal,
nd aim  to  determine  the  likelihood  of  the  future
vent  occurring  within  a given  population.  Risk  can
e assessed  in  either  relative  or absolute  condi-
ions. The  term  relative  risk  is  synonymous  with  risk
atio, rate  ratio  or  forces  of  morbidity.  Relative  risk
s the  risk  of  the  endpoint,  such  as  disease,  death,
eadmission,  among  those  exposed  versus  the  risk
f the  endpoint  among  the  unexposed.11 Conversely
bsolute risk,  is  the  probability  of  an  event  in  a  pop-
lation under  study,  as  contrasted  with  the  relative
isk.11 As  a  result,  these  scores  or  values  allow  a
rediction  to  be  made  to  assist  in  clinical  decision
aking.
Risk prediction  models  identify  individuals  and
haracteristics  which  are  considered  at  greater
isk. Currently,  prediction  models  are  used  to
inpoint  a  given  population’s  risk  and  direct  initia-
ives to  those  individuals.  The  identification  of  at
isk individuals,  allows  for  the  implementation  of
trategies  to  reduce  the  risk  of  the  endpoint.  The
enefit  of  using  risk  prediction  models  is  that  inter-
entions and  treatment  can  be  targeted  to  those
t greater  risk,  resulting  in  greater  efficiency  in
esource utilisation.12 Absolute  risk  models  incor-
orating  variables  including:  organizational  system;
ealth care  providers  and  patient  factors  mayions. The  benefits  of  risk  prediction  models  are:  to
dentify individuals  at  varying  levels  of  risk;  inform
ndividuals  about  their  options  for  management  and
otential outcomes;  and  guide  management  and
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Table  1  Factors  influencing  rehospitalisation  in  heart  failure.
Decreases  the  risk  of  rehospitalisation  Increases  the  risk  of  rehospitalisation
Disease  management  delivery  systems28,29 Poor  adherence  by  cardiologists  and  primary  care
physicians40 with  treatment  recommendations41
Appropriate  use  and  adherence  to  evidence-based
pharmacotherapy30—33
New  onset  anemia42
Beta-blocker  use33 Persistent  hyponatremia43
ACE  inhibitor  use34 Co  morbidities44
Home  follow  up  by  a  nurse  practitioner35 Age45
Multidisciplinary  teams  involved  in  managed  care36,37 Social  and  economic  factors  related  to  poverty  influencing
adherence  to  treatment46
Post  discharge  care38 The  cost  of  pharmaceutical  therapies47
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ssessment.  This  article  seeks  to  identify  risk  reduc-
ion models  and  identify  common  data  elements.
ethod
 systematic  review  was  published  by  Ross  and
olleagues13 to  identify  risk  prediction  models
nd we  replicated  this  method  to  search  for  risk
rediction  models  with  the  assistance  of  a med-
cal librarian.  The  electronic  databases  Medline,
ubMed, Scopus,  PsychINFO,  and  the  Evidence-
ased Medicine  Reviews  on  Ovid  were  searched
sing MeSH  terms  patient  readmission,  risk  and
eart failure.  We  used  the  medical  subject  head-
ng (MeSH)  term  patient  readmission  (exploded)  and
he key  words  readmi$  and  rehosp$  (using  ‘‘$’’  for
runcation).  In  every  data  base  except  for  Medline
 was  used  as  a  truncation  instead  of  $.  Then  linked
he terms  with  ‘‘or’’.  Secondly,  we  searched  using
he MeSH  term  risk  (exploded)  and  the  key  words,
odel$,  predict$,  use$,  util$,  and  risk$.  Follow-
ng the  second  search  we  linked  the  terms  with
‘or’’. Our  third  search  included  the  MeSH  term
eart  failure,  congestive  (exploded).  The  fourth
earch  combined  the  term  results  from  the  patient
eadmission,  risk  and  HF  searches.  Inclusion  crite-
ia for  the  search  were:  publications  from  1950  to
010, readmission  among  individual  patients  hospi-
alised for  CHF  as  primary,  secondary  or  composite
utcome. We  excluded:  data  without  quantita-
ive endpoints,  publications  without  original  data,
bstracts,  pediatric  studies,  non-English  studies,
nd any  experimental  studies.esults
ollowing  removal  of  duplications,  our  search
ielded 1002  results.  Our  search  strategy  identified
s
9
ttory  of  hospitalisation20
nly 1  additional  model14 since  the  review  of  Ross
nd colleagues.13 Table  2  summarizes  these  models
nd the  derivation  is  discussed  below.
Chin  and  Goldman15 developed  an  11  point  scor-
ng system  from  25  candidate  variables  in  their  risk
core for  death  or  all  cause  readmission  to  any  hos-
ital within  60  days.  The  variables  were  obtained
rospectively between  1993  and  1994  from  257
atient  medical  records  and  questionnaires  from
atients  who  had  an  unplanned  admission  with  CHF
rom a single  hospital.
Philbin  and  DiSalvo16developed  a  15  point  scor-
ng system  from  60  candidate  variables  (looking
t patient  characteristics,  hospital  features,  pro-
ess of  care  and  clinical  outcomes)  in  their  risk
core for  CHF  specific  readmission  within  1  year.
he variables  were  obtained  retrospectively  from
he Statewide  Planning  and  Research  Coopera-
ive System  (SPARCS)  using  administrative  data  on
2,731 patients  with  International  Classification  of
iseases 9-Clinical  Modification  Codes  (ICD-9)  col-
ected in  1995  by  the  New  York  State  Department
f Health  from  236  New  York  State  hospitals.
Krumholz  and  colleagues17 developed  a  mul-
ivariate model  with  32  variables  that  identified
actors that  would  predict  readmission  within  6
onths following  hospital  discharge.  During  the
erivation  phase  of  the  study  the  variables  were
btained  from  9  acute  care  Connecticut  hospi-
als from  patients  n  = 1129  with  ICD-9-CM  codes
or heart  failure.  All  patients  were  Medicare  fee-
or-service  patients,  in  the  year  1994.  For  the
alidation  phase,  12  Connecticut  hospitals  n  =  1047
n the  year  1995  were  used.  Endpoints  were  6 month
ll-cause  readmission,  heart  failure-related  read-
ission, and  readmission  and  death  combined.
18Felker and  colleagues developed  a  statistical
core from  41  candidate  variables  derived  from
49 patients  admission  data  from  78  centers  within
he United  States  who  were  participants  in  the
34
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Table  2  Risk  scores.
Source  Study  type  Data  source  Study  location  No.  of
hospitals/no.  of
patients
Study  outcome  Follow-up
period
aChin  and  Goldman15 Prospective
cohort
Medical  record
review
Boston,  U.S.A. 1/257 All-cause
readmission  or
death
60  days
aPhilbin  and  DiSalvo16 Retrospective
cohort
SPARCS,  from
the  New  York
State
Department  of
health  (1995)
New  York
State,  U.S.A.
236/42713 HF-specific
readmission
1 year
aKrumholz  et  al.17 Retrospective
cohort
MEDPAR  file
from  HCFA  and
medical
record  review
Connecticut,
U.S.A.
18/1129  in
derivation  cohort
and  1047  in
validation  cohort
All-cause
readmission
6  months
aFelker  et  al.18 RCT  cohort  Collected
during  RCT
U.S.A.  78/949  All-cause
readmission  or
death
60  days
aYamokoski19 RCT  cohort  Collected
during  RCT
U.S.A.  and
Canada
26/373  All-cause
readmission
6  months
Amarasingham  et  al.14 Prospective
cohort
Electronic
medical
record  review
Texas,  U.S.A.  1(136)/1372  All-cause
readmission  or
death
18  months
Existing scores adapted from Ross and colleagues with permission13.
SPARCS — Statewide Planning and Research Cooperative System.
HF — heart failure.
MEDPAR — Medicare provider analysis and review.
HCFA — health care financing administration (now the Centers for Medicare and Medicaid services).
RCT — randomised controlled trial.
a Table adapted with kind permission of the Journals of the American Medical Association from Archives of Internal Medicine.
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ahat  are  the  factors  in  risk  prediction  models  
utcomes  of  a  Prospective  Trial  of  Intravenous  Mil-
inone for  Exacerbations  of  Chronic  Heart  Failure
OPTIME-CHF).  This  risk  stratification  aimed  to  pre-
ict 60  day  mortality  or  the  composite  of  death  and
ehospitalisation  at  60  days.
Yamokoski  and  colleagues19 developed  a  statis-
ical model  from  18  candidate  variables  derived
rom  373  patients  with  class  IV  CHF  enrolled  in
he Evaluation  Study  of  Congestive  Heart  Failure
nd Pulmonary  Artery  Catheterization  Effective-
ess (ESCAPE)  trial  that  was  conducted  in  26  CHF
nd transplant  centers  in  the  United  States  and
anada.  This  sub-study  compared  the  model  against
he nurses  and  physicians  estimation  of  readmission
sing their  own  clinical  judgment  following  review
f patient  case  reports.  The  endpoints  being  pre-
icted were  all  cause  readmission  at  6  months.
ehospitalisation  was  not  predicted  well  by  the
odel, nurses  or  physicians.
Amarasingham  and  colleagues14 developed  and
alidated  a  model  using  non  clinical  and  clinical
ata  extracted  from  electronic  medical  records  of
372 index  admissions  in  a  major  urban  hospital
uring the  period  of  January  2007—August  2008.
 data  linkage  service  enabled  subjects  readmit-
ed to  1  of  136  hospitals  within  the  study  region
o be  identified  and  included  in  the  analysis.  The
isk stratification  model  was  designed  to  predict
eath or  all-cause  readmission  within  30  days  of
ischarge.  In-hospital  deaths  were  not  included  in
he final  model  nor  were  subjects  that  died  within
0 days  of  hospitalisation  without  readmission  to
ospital. The  final  model  was  developed  using  a
onceptual  framework  based  on  experience  and
ndings  from  a  literature  review.  The  model  utilised
linical  and  non  clinical  variables  and  was  vali-
ated  against  The  Centre  for  Medicaid  and  Medicare
ervices  model  (CMS)  and  the  Acute  Decompen-
ated Heart  Failure  Registry  (ADHERE).  Non  clinical
actors  identified  as  predictors  of  rehospitalisa-
ion included  increasing  age,  the  number  of  home
ddress  changes,  a  history  of  depression  or  anxiety
nd cocaine  use.
Final  risk  predictors  were  diverse  within  each
odel. Chin  and  Goldman15 listed  the  risk  predic-
ors as  reasons  for  acute  clinical  deterioration  prior
o hospitalisation  and  only  used  data  obtained  from
he index  hospitalisation.  No  data  was  reviewed  for
atients who  had  subsequent  admissions.  Amaras-
ngham  and  colleagues14 were  the  only  other  study
o use  index  admission  at  a  single  hospital  to  recruit
ubjects.  However,  through  data  linkage  software,
hey  were  able  to  use  subsequent  rehospitalisa-
ions of  subjects  at  other  facilities  within  the  area.
he use  of  successive  rehospitalisations  included
n the  model  design  is  important  as  a history  of
v
C
d35
ospitalisation  has  been  shown  to  be  a  predictor  of
ehospitalisation.20 Felker  and  colleagues18 iden-
ified independent  predictors  for  all  cause  read-
ission  or  death.  However,  unlike  Krumholz  and
olleagues17 variables  added  that  the  researchers
heorized would  be  associated  with  outcomes
ere age  and  ejection  fraction  (EF).  Indepen-
ent predictors  of  death  or  rehospitalisation  at
0 days  were  prior  congestive  heart  failure  hos-
italisations  within  12  months  p =  0.0002,  lower
ystolic  BP  p  = 0.0001,  elevated  blood  urea  nitro-
en p  =  0.0001,  lower  hemoglobin  p  =  0.006,  and  a
istory of  percutaneous  coronary  intervention  (PCI)
 =  0.05.18
Krumholz  and  colleagues17 was  the  only  study
hat used  a  validation  cohort  following  the  find-
ng of  4  factors  in  their  derivation  study  that  had
trong bivariate  association  for  increased  risk  for
ll cause  rehospitalisations.  Four  of  the  32  vari-
bles were  found  to  be  significant  risk  predictors  of
eadmission 6  months  after  discharge.  These  were
rior admission  within  1  year  p =  0.012,  history  of
iabetes mellitus  (DM)  p =  0.07,  prior  heart  failure
 =  0.03,  and  creatinine  >2.5  mg/dL  at  discharge
 =  0.0001.17 Amarasingham  and  colleagues14 val-
dated  their  model,  however  unlike  Krumholz
nd colleagues  who  used  an  entirely  different
ohort for  the  validation  phase,  Amarasingham
nd colleagues14 used  prior  validated  models,  the
MS risk  adjustment  models  and  ADHERE  mortal-
ty model  to  test  the  validity  of  their  electronic
eadmissions  model.
Yamokoski  and  colleagues19 stated  blood  urea
nd nitrogen  (BUN)  and  high  dose  diuretics  at
ischarge  were  independent  predictors  for  rehos-
italisations.  Though  these  factors  have  been
dentified  as  predictors  in  previous  studies21,22 they
ere not  replicated  in  any  other  model  within
his review.  Amarasingham  and  colleagues14 as
ell as  Chin  and  Goldman15 identified  that  single
tatus was  a predictor  of  rehospitalisation.  Fur-
hermore,  the  category  of  race  was  identified  by
oth Amarasingham  and  colleagues14 and  Philbin
nd colleagues16 as  a predictor  of  rehospitalisation.
he mappings  of  predictors  of  readmission  across
he 6  published  models  are  summarized  in  Table  3.
iscussion
t is  important  for  clinicians  to  identify  individuals
t risk  of  readmission.  Currently,  there  is  no  indi-
idual absolute  risk  prediction  model  for  adults  with
HF predicting  hospital  readmission.
The use  of  administrative  data  sets  for  model
evelopment have  been  used  by  Philbin  and
36
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Table  3  Factors  within  models  that  were  predictive  of  rehospitalisation.
Risk prediction
factors  within
models
Single
marital
status
Charlson
comorbidity
index  score
Initial  systolic
BP ≤ 100 mm hg
No  ST-T
wave
changes  on
initial  ECG
Black
race
Hispanic
race
Medicare
insurance
Medicaid
insurance
Commercial
payment
method
Self-pay  Home  health
care services
after
discharge
CHD
Chin and Goldman15      
Philbin and
DiSalvo16
    
Krumholz and
colleagues17
Felker  and
colleagues18
Yamokoski  and
colleagues19
Amarasingham  and
colleagues14
        
Risk prediction
factors  within
models
Valvular
heart
disease
Diabetes
mellitus
Renal
disease
Chronic
lung
disease
Idiopathic
cardiomyopathy
Prior
cardiac
surgery
Use  of
telemetry
during index
hospitalization
Creatinine  >  2.5  mg/dL
at discharge
Prior
admission
within  1
year
No. of  prior
inpatient
admissions
No.  of prior
emergency
room visits
No.  of prior
outpatient
visits
Chin and Goldman15
Philbin and
DiSalvo16
        
Krumholz and
colleagues17
  
Felker and
colleagues18

Yamokoski and
colleagues19
Amarasingham  and
colleagues14
   
Risk prediction
factors  within
models
Presented  to
emergency
department
6 a.m.—6  p.m.
for index
admission
Low
systolic
BP
Prior
HF
Elevated
BUN
Low  Hb History
of PCI
High
dose
diuretic
at  dis-
charge
aTabak48
mortal-
ity
score
(per  10
point
increase)
History
of
depres-
sion or
anxiety
Male
sex
Residence
census
tract  in
lowest
socio
economic
quintile
History
of
cocaine
use
No. of
home
address
changes
History
of
leaving
against
medical
advice
Used  a
health
system
phar-
macy
Age
(per 10
year)
History
of
missed
clinic
visit
Chin and Goldman15
Philbin and DiSalvo16
Krumholz  and
colleagues17

Felker and
colleagues18
    
Yamokoski and
colleagues19
 
Amarasingham and
colleagues14
              
BP — blood pressure; ECG — electrocardiogram; CHD — coronary heart disease; HF — heart failure; BUN — blood urea nitrogen; Hb — haemoglobin; PCI — percutaneous coronary
intervention.
a Tabak Mortality Model48 is specific to heart failure individuals and scores their severity of illness.
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30 day  readmission  rate  as  a quality  indicator  ofhat  are  the  factors  in  risk  prediction  models  
iSalvo16 as  well  as  Krumholz  and  colleagues.17
sing  real  world  data  such  as  administrative  and
egistry  data  may  assist  in  developing  models  that
an assist  in  clinical  decision  making.  Results  or
cores produced  from  these  models  would  poten-
ially  not  have  been  possible  to  replicate  nor  be
s applicable  to  the  wider  community  if  the  data
ad come  from  a  cohort  in  a  randomised  con-
rol trial  (RCT).23 However,  Philbin  and  DiSalvo16
bserved  CHF  specific  readmission  as  their  end-
oint whereas  the  remaining  four  studies  did  not.
ength  of  follow  up  also  varied  between  studies.
he minimum  duration  for  follow  up  was  in  the  stud-
es conducted  by  Chin  and  Goldman15and  Felker
nd colleagues18 with  60  days.  This  was  followed
y Yamokoski  and  colleagues19 and  Krumholz  and
olleagues17 with  6 months.  Philbin  and  DiSalvo16
ad  a  follow  up  period  of  1  year  but  this  was  retro-
pective  in  design.  Amarasingham  and  colleagues14
tudy  was  conducted  over  an  18  month  period.  No
odel has  extended  beyond  18  months  in  follow
p. A  longer  longitudinal  study  may  identify  the
ower of  individual  factors  contributing  to  risk.
t present,  models  are  limited  in  their  predic-
ion, in  that  they  provide  scores  or  only  identify
actors that  precede  readmission.  Three15—17 of
he 6  existing  scores  or  prediction  factors  were
reated  prior  to  the  beta-blocker  era  and  may
herefore be  outdated  requiring  further  replica-
ion in  today’s  clinical  setting  to  verify  their
ccuracy. Furthermore,  Yamokoski  and  colleagues19
hose  study  was  conducted  after  the  introduc-
ion of  beta  blockers  for  CHF  acknowledged  that
‘rehospitalisations  was  not  predicted  well  by.  . .the
rognostic model’’  p.  11.  As  such,  accuracy  of  the
odels prediction  of  rehospitalisation  for  adults
ith CHF  was  poor  and  unfortunately  may  be
nsuitable  to  be  used  in  contemporary  clinical
ractice. Additionally,  the  data  was  derived  from
he Evaluation  Study  of  Congestive  Heart  Failure
nd Pulmonary  Artery  Catheterization  Effective-
ess (ESCAPE)  trial  (which  was  prematurely  stopped
n 2003)  where  the  majority  of  participants  were
nd stage  CHF.  Though  Felker  and  colleagues18
eveloped  a  risk  model  for  all  cause  readmission,
hey have  not  individualised  the  risk  score.  As
uch, the  model  is  only  stratifying  risk  predictions
nd may  not  be  as  accurate  in  observed  individ-
al outcomes.  Their  model  was  developed  during
 derivation  study  and  therefore  has  not  been
ested to  show  that  it  is suitable  for  the  purpose
or which  it  was  developed  (all  cause  readmis-
ion).
A striking  feature  of  this  review,  was  the  mini-
al agreement  in  the  variables  that  were  predictive
h
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f  readmission  across  the  6  models.  Only  a  history
f diabetes  mellitus;  an  elevated  BUN;  and  a  his-
ory of  prior  admission  to  hospital  within  1 year,
ingle marital  status  and  race  were  predictive  in
ore than  one  model.  However,  the  replication  of
isk predictors  did  not  occur  in  more  than  2  models
or any  given  predictor.  The  reasons  for  this  lack  of
onsistency  may  include  differences  in  the  baseline
opulation  and  data  sources.
Though  Krumholz  and  colleagues17 identified  a
istory of  prior  hospital  admission  as  a predictor,  it
as Felker  and  colleagues18 who  identified  a  prior
HF specific  admission  as  being  significant.  How-
ver, Krumholz  and  colleagues17 predictor  of  prior
ospital  admission  was  only  identified  within  the
erivation  study.  The  finding  was  not  replicated
n the  validation  study.  Felker  and  colleagues18
nd  Chin  and  Goldman’s15 risk  prediction  mod-
ls comprised  two  composite  endpoints,  death  and
ehospitalisation  within  60  days.  Amarasingham
nd colleagues14 electronic  readmission  model  also
stimated  the  composite  endpoints  of  death  or
eadmission,  however,  their  model  predicted  the
ndpoints  within  30  days  of  hospital  discharge.
onsequently,  these  models  may  have  limited  pre-
ictive variables  for  rehospitalisation  alone.  To
ate, none  of  these  approaches  are  absolute  risk
cores or absolute  risk  models.
The lack  of  individual  absolute  risk  prediction
odels for  readmission  is  problematic.  If  predictors
r absolute  risk  of  hospital  readmission  for  individ-
als with  CHF  was  identified  and  made  known  to
linicians  and  patients,  then  tailoring  care  accord-
ng to  risk  may  occur.  At  present,  risk  models  or
cores to  predict  risk  of  readmission  are  limited  in
he range  of  factors  incorporated  in  model  devel-
pment.  Factors  are  predominantly  focused  on
atient characteristics  and  predominantly  biomed-
cal. Psychosocial  factors  including  a history  of
epression24 or  marital  status,25 which  have  been
hown  to  influence  health  status  and  therefore  hos-
italisation,  were  only  included  in  1 of  the  final
odels.  Although  care  settings  were  identified  in
he method  of  each  research  paper,  no  model
ncorporated this  factor  into  model  design.  Study
ocation  is  relevant  as  the  clinical  area26 will  influ-
nce what  resources  are  available  including  health
are personnel,  diagnostic  tools  and  access  to  diag-
ostic and  management  strategies.  Study  location
ill also  influence  length  of  hospital  stay  and  hos-
ital readsmission.27 In  Australia,  hospitals  use  theospital performance.  Hospitals  that  prematurely
ischarge individuals  as  a consequence  of  inade-
uate  resources  with  limited  community  discharge
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follow-up  may  result  in  rehospitalisation  of  individ-
uals. As  a  result,  availability  of  resources  influences
assessment  and  management  of  individuals  within
each facility  and  hence  outcomes.  Therefore,  a
model or  score  that  integrates  characteristics  of
patient factors,  services,  including  the  organiza-
tion  and  health  care  system(s)  as  well  as  providers
of health  care  to  determine  absolute  risk  for
individuals readmitted  to  hospital,  has  the  poten-
tial of  accurately  identifying  individuals  at  high
risk.
Through  incorporating  an  absolute  risk  predic-
tive model  in  the  delivery  of  care,  individuals  as
well as  health  care  providers  and  policy  makers  can
revise their  approaches  to  health  care  and  detect
patients  at  risk  of  deterioration  or  rehospitalisation
and implement  interventions  accordingly.  To  date,
there is  no  validated  model  to  predicting  the  abso-
lute risk  of  rehospitalisation  in  CHF  and  this  is  an
important  area  for  future  investigation  to  improve
health  outcomes,  particularly  within  the  context  of
the Australian  health  care  system.
Limitations
The  limitations  of  this  literature  review  are,  that
though this  is  not  a  systematic  review,  and  as  such,
may not  explore  the  literature  with  as  much  rigor,
this literature  review  was  undertaken  using  search
terms from  a  previous  systematic  review  exploring
risk prediction  models.  Since  the  publication  of  that
systematic  review  by  Ross  and  colleagues,13 only
1 additional  paper  was  identified  that  discussed
the development  and  validation  of  a  new  model
that aimed  to  predict  the  risk  of  rehospitalisation.
All studies  that  were  identified  in  this  literature
review are  North  American  in  focus.  Replicating  risk
predictions  using  these  current  risk  models  in  pop-
ulations  outside  of  North  America  may  not  result  in
similar outcomes.  All  the  studies  had  short  follow
up periods.  No  study  went  further  than  18  months.
Longer  longitudinal  studies  may  uncover  risk  factors
that are  relevant  to  patient,  provider  and  system
elements. No  risk  factors  were  replicated  in  more
than 2  models.  As  such,  the  varied  number  of  risk
factors made  comparison  of  individual  risk  factors
difficult.  Therefore,  further  study  is  required  exam-
ining larger  cohorts  within  longitudinal  studies  that
are not  predominated  by  North  American  popula-
tions with  longer  follow  up  periods.  Widening  the
extent  of  factors  being  integrated  into  risk  model
design  to  include  patient  and  also  provider  and
system  elements  has  the  potential  to  identify  and
accurately  predict  individuals  with  CHF  at  risk  of
rehospitalisation.V.  Betihavas  et  al.
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An overview of risk prediction 
models and the implications 
for nursing practice
Chronic heart failure (CHF) is a costly (Stewart et al, 2002), debilitating and deadly (Stewart et al, 2001) clinical syndrome and is a major public health issue. 
The syndrome of CHF is characterised by a high symptom 
burden, such as breathlessness and fatigue and functional 
impairment (Dickstein et al, 2008). Of particular relevance 
to nursing, CHF is the leading cause of hospitalisation for 
individuals over the age of 65 years within the developed 
world (Rodriguez-Artalejo et al, 1997; Adams et al, 2005). 
Due to an ageing population, the number of adults that will 
be affected by CHF is projected to rise. This entails that 
emergency department presentations for individuals with 
shortness of breath, weakness or confusion will increase. 
This projected rise in hospitalisation rates of adults with 
CHF will have an impact on nursing practice. 
Hospitalisation is not only a marker of adverse outcome 
but of importance to health-care planning and it has been 
shown that many of these admissions are preventable 
(Braunstein et al, 2003). In addition to costs and pressures 
on scarce resources, hospitalisation can have poor out-
comes, particularly in the elderly because of the high risk 
of adverse events, such as falls (Vincent et al, 2001; 
Brennan et al, 2004). Increasingly there is a focus on rates 
of hospitalisation and lengths of stay as markers of organ-
isational performance. In spite of fiscal considerations and 
demands for efficiencies, targeting and monitoring at-risk 
patients through early interventions with the aim of 
decreasing hospital admissions and emergency room 
presentations will lessen the financial and social burden 
on the individual and the community (McMurray and 
Stewart, 2002). Therefore, developing valid and reliable 
risk models is of importance to allow identification of 
individuals at highest risk and assist in developing and 
implementing appropriate models of care. 
Appropriate models of care should consider not only 
clinical characteristics but also available resources. The 
overall aim of risk models should be to target those at risk 
and by doing so, reduce adverse events that include rehos-
pitalisation or emergency department presentation(s).
There are limited empirical means to allow clinicians to 
identify those with heart failure at highest risk of rehospi-
talisation. Furthermore, no current risk model provides an 
individual with an absolute risk score for rehospitalisation. 
This limits the application of current models to individu-
als to assess their risk for rehospitalisation. The following 
is a description of risk models and the implications for 
nursing.
Current risk prediction models for chronic 
heart failure
Currently, methods are not widely available in clinical 
practice to discriminate between levels of risk in many 
conditions, but particularly CHF. Absolute risk is the cal-
culation of an individual’s risk of the event occurring over 
a given time (Sedgwick, 2001), whereas relative risk, also 
referred to as the risk ratio, is the comparison between two 
groups, one with the risk factor, and one without, in esti-
mating the risk of the event occurring (Sedgwick, 2001). 
While relative risk models provide a method of comparison, 
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Abstract
Chronic heart failure is a common and costly condition and is one of 
the most common causes of hospitalisation and emergency 
department presentations in the elderly. This paper discusses risk 
prediction models in chronic heart failure, their utility in clinical 
practice and describes the implications for nursing practice. Based 
on a review of the literature, a description is presented of current risk 
models for chronic heart failure; the use of risk models in other 
conditions and the benefits of applying valid and reliable measurement 
tools in clinical practice. Consideration is given for clinical as well as 
non-clinical factors being incorporated into risk prediction models.
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Study authors Study type Study region Study independent predictors
Amarasingham et al, 
2010
Prospective USA Age (per 10 years)
History of cocaine use
History of depression
History of leaving against medical advice
History of missed clinic visit
Male sex
Number of home address changes
Presented to emergency department 6 am–6 pm for 
index admission
Residence census tract in lowest socioeconomic quintile
Tabak* mortality score (per 10-point increase)
Used a health system pharmacy
Chin and Goldman, 
1997
Prospective USA Charlson** comorbidity index score
Initial SBP <100 mmHg
No ST-T wave ECG changes
Single marital status
Felker et al, 2004 RCT USA BUN (per 5 mg/dl)
Heart failure hospitalisation <1 year
SBP (per 10 mmHg)
Keenan et al, 2008 Retrospective USA Acute coronary syndrome
Arrhythmias
Asthma
Atherosclerosis
Cardiorespiratory failure
Chronic obstructive pulmonary disease
Diabetes
Electrolyte/fluid/acid–base disorders
History of CABGs
Hemi/paraplegia/paralysis/functional disability
Other/unspecified heart disease
Renal failure
Stroke
Urinary tract disorders
Vascular disease
Valvular and rheumatic disease
Table 1. 
Current risk models in chronic heart failure
absolute risk models provide an individual risk score of 
the end outcome (Gail and Pfeiffer, 2005). 
A risk prediction model is a tool that describes the asso-
ciation between factors, to calculate the probability of an 
outcome or event (Steyerberg, 2009). Predictive models 
also include a temporal element and aim to predict future 
risk in a given population. Identifying the level of risk 
would allow for the implementation of interventions to 
reduce adverse outcomes. An emerging literature suggests 
that patient (Keenan et al, 2008), provider (Jaarsma, 2005) 
and system (Adams et al, 2005) factors influence the risk 
of hospitalisation. Although risk prediction models have 
been developed, there has been minimal consideration of 
the political, financial and social determinants in ascer-
taining risk. 
Current models that classify the risk of hospitalisation 
have been derived from either randomised controlled tri-
als (RCTs) or administrative data sets (Table 1). Predictors 
identified in these models are primarily biomedical, clini-
cal factors such as age and a history of diabetes. 
Furthermore, the predictors incorporated into each of the 
models are diverse on comparison. The accuracy of a 
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Study authors Study type Study region Study independent predictors
Krumholz et al, 2000 Retrospective USA Prior admission within 1 year
Prior heart failure
O’Connor et al, 2005 RCT/registry USA Age (per 10 years)
Heart failure hospitalisation <1 year
Nitrates
Philbin and DiSalvo, 
1999
Retrospective USA Black race
Diabetes mellitus
Ischemic heart disease
Medicaid insurance
Medicare insurance
Renal disease
Requiring home health services 
Valvular disease
Pocock et al, 2006 RCT USA Bundle branch block 
Cardiomegaly
Diabetes 
Oedema
Ejection fraction
Heart failure hospitalisation
HF diagnosis > 2 years
NYHA class III
NYHA class IV
DBP (per 10 mmHg)
* Tabak et al, 2007
** Charlson et al, 1987
RCT = randomised controlled trial; BUN = blood urea nitrogen; SBP = systolic blood pressure; CABGs = coronary artery 
bypass graft surgeries; NYHA class = New York Heart Association functional classification of heart failure; DBP = diastolic 
blood pressure
Table 1 continued. 
Current risk models in chronic heart failure
model to predict is measured by the area under the curve 
(AUC) also referred to as the c-index. The c-index ranges 
from 0.5 which shows no predictive ability of the model to 
1, which shows perfect discrimination (Cook, 2008). The 
highest c-index in these risk models (Pocock et al, 2006). 
This implies that there are possibly risk prediction factors 
that may yet be undiscovered, or currently not included in 
existing risk models. Therefore, undertaking further 
research to identify and incorporate predictors that extend 
to providers and systems may further accurately predict 
the risk of hospitalisation and mortality for individuals 
with CHF, particularly in community settings (Giamouzis 
et al, 2011). Identifying individuals in the community at 
risk of hospitalisation and then implementing strategies 
through multidisciplinary interventions has the potential 
to prevent adverse events that include readmission to hos-
pital or presentation to the emergency department. 
To date, risk prediction models for CHF have limited 
uptake. This may be explained by the heterogeneity in data 
elements across studies (Ross et al, 2008) and failure to see 
the relevance and applicability of items to specific care 
contexts (Ghali et al, 2010). Furthermore, the generalisa-
bility of study cohorts may not be replicable in clinical 
settings. All the CHF risk prediction models were derived 
from studies conducted within the USA. Unlike Australia, 
New Zealand, the UK and many European countries, the 
USA does not offer universal health coverage. As a result, 
risk models created from cohorts within the USA may not 
be applicable within the clinical areas of these countries as 
the systems of health-care delivery differ.
Therefore in order to meet the needs of an ageing popu-
lation with increasing chronic conditions, prediction 
models considering the perspective of patient, provider 
and system factors are likely justified. For the purposes of 
this paper, patient factors relate to the multidimensional 
facets of individuals including physical, social, psycho-
logical, cultural, and existential characteristics; provider 
factors include those relating to health professionals pro-
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viding formal care-giving for example skill mix, profes-
sional groups such as nurses or doctors, and system fac-
tors will pertain to factors relating to the organization, 
funding and policy milieu of the health-care system deliv-
ery (Betihavas et al, 2011). Risk models considering 
patient, provider and system issues have the potential to 
improve outcomes at all levels; at the micro (hospitalisa-
tion increases the risk of mortality and adverse outcomes 
for patients (Brennan et al, 2004)), the meso (CHF is the 
leading cause of hospitalisation in those over the age of 65 
years (Adams et al, 2005)), and the macro (where the hos-
pitalisation is the biggest cost for society (Bundkirchen 
and Schwinger, 2004)). 
Phases in risk model development
In the context of developing risk prediction models it is 
important to consider the strengths and weaknesses of 
various approaches. There is generally two phases when 
designing a risk model: the derivation and the validation 
phase. The development or derivation phase involves a 
cohort of individuals to generate items, whereas the vali-
dation phase is the process of assessing that the developed 
model tests what it is intended to test or predict. However, 
there can be problems when comparisons are made 
between development and validation cohorts. Of interest 
is the difference in heterogeneity between development 
and validation cohorts, which may account for the poor 
generalisability, over-fitting or over-optimism in predic-
tion model development (Moons et al, 2004). 
Limitations with current risk models in 
chronic heart failure
There exists a gap in the literature between risk predictive 
models in hospitalisation for patients with CHF. Presently, 
there is no model that incorporates the diverse perspective 
of patient, provider and system factors to predict an indi-
vidual with CHF at risk of hospitalisation. Existing predic-
tive models do not include political, financial and social 
determinants in conjunction when ascertaining risk. A 
report from the World Health Organization Commission 
on Social Determinants of Health (CSDH) identified 12 
social factors that impact on individuals and communities 
and contribute to wellbeing in determining health out-
comes (CSDH, 2008). These social determinants of health 
do have a bearing on individuals with CHF and may be 
used to identify the risk of hospitalisation. 
Furthermore, the recognition of the need for health care 
reform has led to the uptake of the Chronic Care Model 
(Bodenheimer et al, 2002; Coleman et al, 2009). Aims of 
the Chronic Care Model are maintaining health and qual-
ity of life for individuals with chronic conditions. This 
approach is a proactive multidimensional approach with 
input at a community, organisational, clinical and patient 
level. A review by Tsai et al (2005) reported on 112 studies, 
(21 of which focused on CHF) that incorporated at least 
one element of the Chronic Care Model in practice. The 
incorporation of at least one element led to better out-
comes for patients within the 21 CHF studies that were 
reviewed.. Therefore, incorporating elements of the 
Chronic Care Model in a risk prediction model may be 
efficacious.
Favoured models predominantly classify risk of hospi-
talisation as determined by patient factors that include 
clinical variables (Philbin and DiSalvo, 1999; Krumholz et 
al, 2000). These predictors are primarily patient factors. 
The reasons for this are the reliance on RCTs for deriva-
tion cohorts. Incorporating predictors that extend to pro-
viders and services may further accurately predict the risk 
of hospitalisation for individuals with CHF (Ross et al, 
2008; Giamouzis et al, 2011). As such, there are discrepan-
cies in current estimates of risk prediction for hospitalisa-
tion, possibly due to the limited determinant factors 
researchers have at present integrated in their predictive 
models. 
Risk prediction models for other 
conditions
Often it is useful to look to other clinical areas that have 
used similar conceptual approaches. In the intensive care 
unit (ICU) predictors for readmission occur predominantly 
with patients who already have an increase in the severity of 
their illness and have responded poorly to treatment. In the 
study by Cooper et al (1999) CHF was the most common 
reason for non-surgical patients being readmitted to the 
ICU. Furthermore, a systematic review by Rosenberg et al 
(2001) identified patients readmitted to ICUs to be associ-
ated with increased mortality rates, longer length of hospital 
stay and a poorer quality of life following their discharge. In 
a prospective UK study (Harrison et al, 2007) a prediction 
model, the Intensive Care National Audit & Research 
Centre (ICNARC) model that would predict admission to 
the ICU was developed from pre existing risk models. These 
models include the Acute Physiology and Chronic Health 
Evaluation 11 (APACHE 11), APACHE 111, Simplified 
Acute Physiology Score 11 (SAPS 11) and the Mortality 
Probability Model 11 (MPM 11). Combining patient factors 
from the existing models, the ICNARC prediction model 
was found to perform better in prediction and had a lower 
c index (0.003) when compared to the models from which 
it was developed. 
In a retrospective Australian study (Ho et al, 2008) a 
nomogram was formed from pre-selected predictors that 
enabled the estimation of median survival time for patients 
with acute illnesses and long-term survival probabilities. 
The Predicted Risk, Existing Diseases, and Intensive Care 
Therapy (PREDICT) model was developed from APACHE 
11 scores and patient factors. The cohort was derived from 
patients within an ICU setting where patients with CHF 
accounted for 7.4% (n=11 930) of the sample size. Within 
this study, age and comorbidities were found to be the two 
variables that determined long-term prognosis. 
At present, models that predict patient’s risk of readmis-
sion to the ICU have been developed from prior models 
with additional patient variables added and then tested 
within the clinical area of ICU. With the advancement in 
technology and knowledge gained from research, which 
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Key Points
 w The incidence of chronic heart failure (CHF) is likely to rise due to an 
ageing population
 w CHF is the leading cause of hospitalisation for the elderly
 w Current risk models for hospitalisation are predominantly biomedical 
in focus
 w In other areas of health care, risk models have been updated from 
existing risk prediction models
 w Incorporating patient, provider and system factors into risk model 
design may identify individuals at risk for rehospitalisation
has then been implemented into health care, these current 
models have been upgraded from existing models to 
ensure their predictability in today’s clinical area of ICU. 
(No current heart failure risk prediction model has been 
updated or modified from previous heart failure risk mod-
els.) As such, the benefit associated with the improvement 
in risk predictive models is the awareness of factors that 
contribute to patient deterioration and endeavours made 
to prevent this breakdown in health status.
Problems have also arisen when attempts have been 
made to generalise a risk score. One such example has 
been the adaptation of the Framingham risk score. The 
Framingham risk score aims to estimate the 10-year risk of 
developing cardiovascular disease (Wilson et al, 1998). 
However, limitations of the Framingham model include 
the cohort from which the model was developed as the 
majority of study participants are predominantly white 
middle-class Anglo-Saxons. The Framingham score also 
fails to identify any biomarkers that acknowledge genetic 
predisposition to cardiovascular disease. Furthermore, the 
Framingham risk score was identified as having overesti-
mated the mortality risk of men when comparisons were 
made during the National Health and Nutrition 
Examination Survey (Liao et al, 1999). Another model 
predicting cardiovascular risk is the Reynolds risk score 
model (Ridker et al, 2007). Yet, a limitation of the 
Reynolds model is its derivation from a cohort of only 
women with a history of diabetes (Ridker et al, 2007). 
These examples underscore the importance of deriving 
data from valid, contemporaneous and appropriate deri-
vation cohorts. 
Summary of what makes a good risk 
prediction model
Risk models should aim to target at risk individuals and 
provide justification for management and treatment. 
However, in clinical practice, risk models that were created 
from RCTs may not be replicable or as accurate outside of 
RCT cohorts. One such example is found within the area of 
breast cancer. There currently exist two streams to assist 
clinicians when risk-assessing women for breast cancer. The 
first is the risk prediction model known as the Gail and 
Claus model (Gail et al, 1989), which aims to predict a 
woman’s risk of developing breast cancer. The second are 
four risk models (Couch et al, 1997; Shattuck-Eidens et al, 
1997; Frank et al, 1998; Parmigiani et al, 1998) that estimate 
the probability of a woman carrying the BRCA1 or BRCA2 
gene. However, when all four models were applied to risk-
predict one family, incongruent results occurred (Domchek 
et al, 2003). Disparate results have occurred in other areas 
of nursing when numerous clinical models have been used 
to predict adverse outcomes. 
Myers and Nikoletti (2003) tested the reliability and 
validity of two falls risk models. The models were inaccu-
rate in their predictions within the clinical area and were 
not able to predict the individuals at risk of falling and 
those who were not. Clark et al (2009) argued (in relation 
to CHF-MP) that types of programmes, populations and 
care settings were not incorporated into analyses. To suc-
cessfully predict risk, particularly in community-based 
settings, models should integrate patient, provider and sys-
tem factors. This amalgamation of patient, provider and 
system factors into risk models has the potential to target 
at-risk individuals more accurately and enable nurses to 
streamline disease management of individuals.
Suggestions for how a risk prediction 
model for CHF may be developed 
Nurses are increasingly compelled to identify individuals 
at risk and implement appropriate strategies. Currently, 
methods are ad hoc and variable and lack sensitivity. This 
is reflected in the high burden of hospitalisation for CHF. 
At present, risk models for individuals with CHF at risk of 
hospitalisation are based on RCTs and administrative data 
sets and include predominately clinical factors, (Chin and 
Goldman, 1997; Philbin and DiSalvo, 1999; Krumholz et 
al, 2000; Felker et al, 2004; Yamokoski et al, 2007; 
Amarasingham et al, 2010) one such clinical factor being 
age. A comprehensive nursing assessment takes into con-
sideration both clinical and non-clinical factors and par-
ticularly in the elderly social situations and caregiver 
access (Naylor et al, 2004). In addition to assessing these 
factors, it is also important to assess an individual’s level of 
need (Davidson et al, 2004). For example, an individual 
may have a high symptom burden and experience frailty 
but have a low level of need of accessibility and availability 
of clinical services. Further, the absence of a designated 
general practitioner is a major barrier to effective commu-
nity-based care and is an important consideration. 
Therefore, these factors need to be considered in health-
care planning at the micro, meso and macro levels.
The challenge remains to develop reliable and valid 
assessment tools with clinical utility and predictive valid-
ity. As the burden of chronic and complex conditions 
continue to increase, the metric of assessment of risk and 
models of assessing and managing risk need to be refined. 
Nurses play a critical role in planning and coordinating 
care and are cognisant of the need to address both clinical 
and non-clinical factors. Currently, multiple risk assess-
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ment tools exist for a plethora of reasons, such as falls and 
delirium (Oliver et al, 2006) and these are focused on 
events in the acute care setting. Broadening the focus of 
this assessment is important in empirically managing 
patients at risk.
Nurse-led interventions have shown to be beneficial in 
improving health outcomes in CHF (Stromberg et al, 
2003) but there are challenges in treatment allocation 
(Lim et al, 2005) and variability in implementation has 
been recognised (Dietz, 2004). Assessing the risk of indi-
viduals may assist in the allocation of sparse specialist 
resources. The use of risk prediction models in clinical 
practice is to aid in clinical decision making; targeting of 
at-risk populations and streamlining and rationalising 
management of at-risk individuals. Accurate risk predic-
tion models that enable accurate prediction need to reflect 
real-life populations. At present, risk prediction models 
are limited in their prediction of those at risk of rehospi-
talisation. This limitation has implications for clinicians 
making decisions that have consequences for at risk indi-
viduals. This review has identified the need to further 
refine and develop models for risk assessment that are reli-
able, valid and demonstrate utility for clinicians.
Conclusions
As the burden of heart failure considers being a major 
concern globally, developing methods to tailor and target 
interventions are crucial. A risk prediction model inte-
grating patient, provider and system factors into model 
design has the potential to accurately target individuals at 
risk. Current risk reduction models have demonstrated 
limited utility as they focus on predominately clinical fac-
tors. Developing an absolute risk reduction model has the 
potential to improve health outcomes by identifying indi-
viduals at the highest risk of adverse outcomes such as 
hospitalisation.
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The chapter following this provides the actual journal published in Heart, Lung and 
Circulation by Elsevier. The publication identifies risk factors for rehospitalisation for adults 
with chronic heart failure (CHF) as perceived by heart failure experts. 
 
 
 
Background 
• The development of a questionnaire requires the generation of items relevant to 
the question[1]. 
• Current  CHF  risk  models  for  rehospitalisation  are  developed  primarily  from 
administrative data sets and RCTs[2]. 
• The high rate of rehospitalisation of individuals with CHF is not being addressed by 
current risk models[3]. 
 
What this publication adds 
• This study confirmed that no further risk factors were identified from experts in 
 
CHF research/management. 
 
•  This is the first study to utilise expert opinion to rank patient, provider and system 
risk factors for rehospitalisation in adults with CHF. 
• Experts  ranked  poor  adherence  to  medications  as  a  high  risk  predictor  for 
rehospitalisation. 
• Experts  ranked  having  private  health  insurance  as  a  low  risk  predictor  for 
rehospitalisation. 
 
Where to from here? 
• Integrating the findings from the Predictors of Readmission in Heart Failure Survey, 
the literature review and factors identified from current models, a risk model for 
the prediction of rehospitalisation for adults with CHF will be developed using the 
W.H.I.C.H cohort. 
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Importance  of  Predictors  of  Rehospitalisation  in
Heart  Failure:  A  Survey  of  Heart  Failure  Experts
Vasiliki Betihavas, RN, BN, MNa,b,∗, Phillip J. Newton, RN, BN(Hons), PhDc,
Steven  A. Frost, RN, BN, MPHa, Evan Alexandrou, RN, MPHa,b, Peter S. Macdonald, MD,
FRACPd and Patricia M. Davidson, RN, BA, Med, PhDc,e
a The University of Western Sydney, School of Nursing and Midwifery, Sydney, Australia
b Curtin Health Innovative Research Institute, Curtin University, Sydney, Australia
c Centre for Cardiovascular & Chronic Care, Faculty of Nursing, Midwifery & Health, University of Technology, Sydney, Australia
d St Vincent’s Hospital and Victor Chang Cardiac Research Institute, Sydney, Australia
e St Vincent’s and Mater Health, Sydney, Australia
Aims: We investigated the opinion of clinical experts and researchers involved in chronic heart failure disease man-
agement  regarding the ranking of patient, provider and system factors that predict the risk of rehospitalisation.
Methods: Item generation for the online survey was informed by a literature review and current risk prediction models.
Consultation with experts was undertaken via a secure online survey platform. Invitations to participate in the 10 question
online  survey were sent through Listserves of professional nursing and medical associations within Australia and New
Zealand.
Results:  Data were collected in August 2011. A total of 119 respondents completed the survey. Respondents ranged
from  researchers, registered nurses, cardiologists and allied health personnel. A mean importance score was used to  rank
risk  factors for rehospitalisation. Risk factors that scored high for predicting the risk for rehospitalisation included poor
adherence  to medications (9.04) and prior hospitalisation for heart failure (8.33). Having private health insurance (4.8)
and  being female (4.9) scored lower in  influencing rehospitalisation for adults with heart failure.
Conclusions: No new risk factors were identified from the experts in predicting the risk of rehospitalisation. The survey
results  will contribute to the development of a nomogram to convey prognostic information related to  adults with heart
failure  that will guide clinicians in management decisions.
(Heart, Lung and Circulation 2013;22:179–183)
©  2012 Australian and New Zealand Society of Cardiac and Thoracic Surgeons (ANZSCTS) and the Cardiac Society
of  Australia and New Zealand (CSANZ). Published by Elsevier Inc. All rights reserved.
Keywords.  Expert opinion; Heart failure; Hospital readmission; Risk factor
Introduction
Chronic  heart  failure  (CHF)  is  a  complex  syndrome  thatpredominantly  affects  the  elderly  [1].  Advances  in
treatments,  particularly  the  use  of  beta-blockers  [2,3]  and
angiotensin  converting  enzyme  (ACE)  inhibitors  [4]  mean
that  individuals  are  surviving  longer.  The  burden  of  hos-
pitalisation  for  CHF  increases  with  age  and  is  responsible
for  a  significant  burden  on  both  individuals  and  society
[5,6].  As  a  consequence,  targeting  those  at  the  greatest
risk  of  adverse  events  and  rehospitalisation  is  important.
A  range  of  patient,  provider  and  system  factors  contribute
to  this  risk  [7].  To  date,  existing  risk  prediction  models  pre-
dominately  have  focussed  on  patient  factors  [8]  including:
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previous  co-morbidities  [9],  previous  hospitalisations  [10]
and  age  [11].  A  risk  prediction  model  for  rehospitalisa-
tion  incorporating  patient,  provider  and  system  factors  has
the  potential  to  target  individuals  at  the  highest  risk.  In
addition  to  describing  factors  in  existing  risk  prediction
models,  it  is  also  important  to  consider  the  views  of  indi-
viduals  involved  in  the  care  of  individuals  with  CHF.  We
therefore  sought  expert  consultation  as  it  is  important  to
acknowledge  expertise  as  a  strength  when  determining
factors  for  rehospitalisation  of  individuals  with  CHF.
The  aim  of  our  study  was  to  examine  the  opinion  of
experts  in  the  care,  management  and/or  research  of  indi-
viduals  with  CHF.  We  sought  consultation  to  validate
risk  factors  from  the  perspective  of  patient,  provider  and
system  that  predicted  the  risk  of  rehospitalisation  of  indi-
viduals  with  CHF.
Ethics  Approval
Ethics  approval  for  the  CHF-Risk  study  was  granted  from
a  university  ethics  committee.  Participants  were  emailed  a
©  2012  Australian  and  New  Zealand  Society  of  Cardiac  and  Thoracic
Surgeons  (ANZSCTS)  and  the  Cardiac  Society  of  Australia  and  New
Zealand  (CSANZ).  Published  by  Elsevier  Inc.  All  rights  reserved.
1443-9506/04/$36.00
http://dx.doi.org/10.1016/j.hlc.2012.05.008
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Score 1 - 10
AnaemiaAngina
AnxietyArrythmias
Atrial fibrillationCachexia
Chronic obstructive pulmonary diseaseCognitive impairment
Culturally and linguistically diverse backgroundDepression
DiabetesFailure to optimise medication dosage
Female sexHigh doses of diuretics
Hypertension
HypotensionLack of social support
Lack of specialist provider in care planningLiving alone
Living in rural and remote regionsLow ejection fraction
Low English language literacyLow level of education
Low serum sodiumMale sex
More than seven scheduled medicationsNo access to a heart failure multidisciplinary team
No access to home visits from health providersNo private health insurance
No regular community pharmacy contactNo regular primary care physician
NYHA class IIINYHA class IV
OsteoarthritisPoor adherence to medications
Poor functional status
Poor health literacyPrior hospitalisation for heart failure
Private health insuranceRenal impairment
Substance abuse
0 1 2 3 4 5 6 7 8 9 10
Figure 1. Box plots of score of importance give to predictors of rehospitalisation in heart failure. Boxes represent distance between 25th and 75th
percentile, with median “|”. Solid points are mean and lowest and highest values given by “x”.
cover  letter  explaining  the  purpose  of  the  survey.  Consent
was  implied  by  the  participants  who  chose  to  undertake
the  survey.  This  study  conformed  to  the  guidelines  as  set
out  by  the  National  Health  and  Medical  Research  Council
of  Australia  [12].
Methods
Sample
Consultation  with  experts  in  heart  failure  was  undertaken
via  a  secure  online  survey  platform.  Experts  in  heart  failure
were  professionals  with  extensive  skills  and  knowledge
developed  through  practice  and/or  research  over  time.
The  sampling  frame  of  participants  was  sought  through
Listserves  of  the  National  Heart  Foundation  (of  Australia)
(NHF),  The  Australasian  Cardiovascular  Nurses  College
(ACNC)  and  the  Cardiac  Society  of  Australia  and  New
Zealand  (CSANZ).  The  total  number  of  potential  partic-
ipants  emailed  could  not  be  confirmed.  However,  a  total
of  131  participants  attempted  the  survey  with  119  hav-
ing  completed  the  survey.  The  respondents  varied  from
researchers,  registered  nurses,  cardiologists  and  allied
health  personnel  who  disclosed  within  the  questionnaire
that  they  were  involved  in  either  research  or  disease  man-
agement  of  individuals  with  heart  failure  (Fig.  1).
Design
The  survey  was  derived  from  risk  factors  identified  from  a
literature  review  (currently  under  review),  and  risk  factors
from  existing  prediction  models  [9–11,13–18].  Questions
related  to  the  demographics  of  the  responders  was  also
featured  in  the  survey.  The  aim  of  this  was  to  verify  the  clin-
ical  and/or  research  expertise  of  the  responders  in  relation
to  heart  failure  disease  management.
Item  Generation
Item  generation  was  a two-step  process.  The  first  step  of
the  Predictors  of  Readmission  in  Heart  Failure  Survey  included
the  literature  review  (currently  under  review)  and  the
identification  of  risk  factors  from  current  risk  prediction
models  [19].
The  second  step  required  items  to  be  categorised  into
themes  and  then  reduced  to  single  items  or  questions.  This
was  done  to  create  a  manageable  survey  without  remov-
ing  imperative  domains  or  themes.  Item  generation  within
the  survey  was  created  by  the  researchers  (VB,  PJN,  and
PMD).  The  items  were  specific  to  risk  classification  and
risk  predictors.  The  final  items  were  relevant  to  assist  in
the  identification  of  patient,  provider  and  system  factors
for  the  risk  of  rehospitalisation  in  adults  with  chronic  heart
failure.
Piloting  and  Validation  by  An  Expert  Panel
Experts  have  previously  been  used  to  validate  instrument
development  [20,21].  The  piloting  and  testing  of  the  sur-
vey  was  conducted  with  the  assistance  of  clinically  current
clinicians  and  researchers  who  were  actively  involved  in
CHF  disease  management.  The  use  of  current  experts  was
sought  with  the  aim  of  creating  a  relevant  survey  that
would  accurately  identify  risk  factors  for  rehospitalisation.
Study  conceptualisation  and  content  measurement  was
addressed  by  informing  the  panel  of  the  focus  of  the  instru-
ment  and  the  intended  use  of  the  survey  and  by  whom.
Piloting  of  the  survey  was  conducted  to  increase  the  like-
lihood  of  appropriate  items  being  placed  in  the  survey,
identify  errors  and  to  increase  the  likelihood  of  accurate
risk  factors  for  rehospitalisation  being  identified  when  the
survey  was  released  to  a  larger  panel.
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Table  1.  Responders  to  the  Predictors  in  Heart  Failure  Survey.
Responders N
Registered Nurses 49
Doctors 8
Allied Health Personnel 34
Researchers 28
The  final  survey  consisted  of  10  questions  adminis-
tered  online.  Responses  were  either  ordinal  or  used  Likert
scales.  The  questions  related  to:  commenting  on  the  high
risk  classification  developed  by  the  NHF  and  CSANZ;  the
presence  of  a  heart  failure  service  program;  postcode  of
employment;  identification  of  occupation;  years  engaged
in  CHF  care;  time  allocated  to  the  care  of  individuals  with
CHF;  setting  of  employment;  and  the  strength  of  factors
predicting  the  risk  of  rehospitalisation.  Using  a  secure
password  protected  online  platform,  Survey  Monkey©,
participants  were  emailed  the  link  to  the  survey.  Partici-
pation  was  voluntary  and  the  surveys  were  anonymous.
Three  email  reminders  were  sent  following  the  initial
email.
Data  Analysis
Quantitative  data  were  analysed  using  descriptive  statis-
tics  that  included,  frequencies  and  means.
Results
In  August  2011,  the  Predictors  of  Readmission  in  Heart  Fail-
ure  Survey  was  emailed  to  members  from  the  Australian
and  New  Zealand  professional  bodies  of  the  NHF,  ACNC,
and  CSANZ.  The  survey  was  closed  in  September  2011  fol-
lowing  no  responses  after  nine  days.  The  survey  yielded
119  responses.  Responders  varied  from  registered  nurses,
doctors,  allied  health  personnel  and  researchers  and  are
shown  in  Table  1.
Descriptive  statistics  were  used  to  rank  the  experts  opin-
ion  of  the  predictors  for  rehospitalisation  in  adults  with
heart  failure.  There  were  41  predictors  for  rehospitalisa-
tion  that  survey  respondents  were  asked  to  rank  from  high
risk  to  low  risk  and  these  are  presented  in  Table  1.  The
predictor  that  was  ranked  by  the  experts  as  being  the  high-
est  risk  predictor  for  rehospitalisation  was,  having  a  poor
adherence  to  medications  (9.04).  The  experts  ranked  hav-
ing  no  private  health  insurance  (4.82)  as  the  least  predictive
factor  for  rehospitalisation.
Discussion
Identifying  factors  that  predict  rehospitalisation  of  adults
with  CHF  is  important,  because  rehospitalisation  is
associated  with  increased  mortality  and  further  rehospi-
talisation.  In  this  survey  which  used  experts  to  provide
their  opinion  on  the  strength  of  risk  factors  for  rehospi-
talisation,  we  have  found  no  further  factors  that  identify
an  adult’s  risk  of  rehospitalisation  compared  to  previously
published  series  [8].  Experts  used  their  own  personal  expe-
rience  and  knowledge  to  validate  the  risk  factors  predictive
of rehospitalisation.  Poor  adherence  to  medication  was
ranked  as  the  highest  predictor  for  rehospitalisation.
Poor  adherence  to  medication  has  been  discussed  in  the
literature  [22].  Adverse  events  such  as  mortality  [23]  and
rehospitalisation  [24,25]  are  outcomes  from  poor  adher-
ence  to  medication.  This  predictor  may  have  been  ranked
the  highest  due  to  the  emphasis  being  placed  on  guideline
adherence  by  professional  bodies  [26–28]  and  concurrence
with  current  literature.  Whereas  having  no  private  health
insurance  was  ranked  the  least  predictive.  This  may  be
due  to  Australia  and  New  Zealand  having  universal  health
coverage.  This  risk  factor  may  have  been  ranked  higher  if
the  study  had  been  completed  by  experts  who  work  in
health  care  systems  that  do  not  offer  universal  health  cov-
erage.  Literature  conducted  in  the  United  States,  a  country
which  offers  no  universal  health  coverage,  has  identified
that  insurance  status  to  be  a predictor  of  rehospitalisation
[29].
This  study  is  important  as  it  has  asked  experts  to  rank
risk  factors  for  rehospitalisation  for  adults  with  heart  fail-
ure.  However,  in  other  areas  of  health,  experts  have  been
consulted  on  identifying  risk  factors.  One  such  example
is  The  World  Health  Organisation  (WHO)  seeking  expert
consultation  in  identifying  risk  factors  for  metabolic  syn-
drome  [30].  Furthermore,  an  online  Delphi  technique  was
used  to  identify  intensivist’s  opinion  in  the  ordering  of
chest  X-rays  in  intensive  care  units  [31].  The  use  of  expert
consultation  within  this  study  was  two-fold.  Firstly,  for
experts  to  validate  current  risk  prediction  factors  and  sec-
ondly,  to  identify  any  factors  not  previously  mentioned
within  the  literature.
The  present  study’s  findings  must  be  interpreted  within
the  context  of  its  strengths  and  limitations.  The  strength
of  this  survey  is  that  item  generation  followed  a compre-
hensive  review  of  the  literature  and  an  online  survey  was
used  to  access  a  wide  range  of  participants.  Strengths  of
the  survey  included  that  the  objective  of  our  survey  was
clear  and  well  defined.  Expert  opinion  was  obtained.  Indi-
viduals  who  were  clinically  current  within  the  delivery  of
disease  management  and  research  of  CHF  were  sought.
Terms  used  within  the  survey  were  terminology  specific  to
health  care  providers.  The  survey  was  initially  piloted  and
following  feedback,  adjustments  were  then  made.  Terms
were  clear,  concise  and  unambiguous.  The  time  required
to  complete  the  survey  was  short  (<10  min),  this  may  have
contributed  to  an  increase  in  the  response  rate.
The  methods  of  survey  administration  preclude  repor-
ting  participation  rates  and  therefore  the  external  validity
of  the  questionnaire.  Further,  this  review  only  seeks  the
perspective  of  health  professionals.  Through  the  ques-
tioning  of  individuals  with  CHF,  insight  may  have  been
gained  to  further  determine  risk  factors  that  predict
rehospitalisation.  The  Chronic  Care  Model  recognises  the
importance  of  input  from  individuals  with  chronic  dis-
eases  into  disease  management  [32].  Furthermore,  the
disparity  between  individuals’  needs  and  the  system
designed  to  implement  care  and  the  providers  who  do  so
may  be  clearer  to  individuals  with  CHF.
Experts  used  within  the  survey  were  located  in  Australia
and  New  Zealand.  The  factors  identified  from  these
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experts  may  be  specific  and  relevant  to  an  Australian  and
New  Zealand  context  only.  Undertaking  the  survey  in
areas  such  as  Europe  and  North  America  may  have  yielded
other  factors  currently  unidentified.  In  addition,  as  the  sur-
vey  was  conducted  online,  experts  without  access  to  the
internet  may  have  been  excluded.
Conclusion
In  summary,  the  results  of  the  survey  suggest  that
expert  consultation  between  Australian  and  New  Zealand
researchers  and  clinicians  identified  a  poor  adherence
to  medications  and  a  history  of  prior  hospitalisation  as
high  predictors  for  the  risk  of  rehospitalisation.  The  impli-
cations  for  policy,  practice  and  future  research  suggests
the  importance  of  addressing  and  monitoring  medication
adherence  and  preventing  rehospitalisation  for  individ-
uals  within  the  community  through  targeting  those  at
highest  risk.
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Background 
• There  is  a  growing  burden  (financial,  physical,  and social)  associated with CHF 
rehospitalisation[1]. 
 
• RCT participants often do not reflect “the real world” of individuals with CHF[2]. 
 
• Current risk models are derived from RCTs and administrative data sets[3]. 
 
• The W.H.I.C.H trial was a RCT seeking to determine the two most common forms of 
face-to-face CHF disease management strategies: multidisciplinary disease 
management delivered in a person’s home versus management delivered in a 
specialist CHF outpatient clinic[4]. 
 
What this manuscript adds 
• This study was the first to incorporate a novel approach to risk model design to 
predict rehospitalisation in adults with CHF. 
• This study was the first to develop an individual absolute risk prediction model for 
rehospitalisation in adults with CHF using factors identified from a literature review, 
previous risk models, expert opinion and testing within a RCT. 
• The absolute risk model was tested using the cohort of the W.H.I.C.H trial. 
 
• The C-statistic for the absolute risk model was 0.80. Previous models have been no 
higher than 0.75[5]. Therefore, there are still factors that are unidentified regarding 
risk prediction for rehospitalisation. 
 
Where to from here? 
• Emphasis of the Chronic Care Model is placed on the empowerment of individuals 
to contribute to the management of the chronic disease. Therefore, future study 
examining the perceptions of individuals with CHF to identify factors which they 
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believe predict rehospitalisation may be beneficial to disease management and 
timely. 
• Undertaking testing of the absolute risk model in larger cohorts within Europe and 
the United States, to identify the accuracy in populations outside of Australia. 
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Abstract 
 
Background: Frequent readmissions are a hallmark of chronic heart failure (CHF). We 
sought to develop an absolute risk prediction model for unplanned cardiovascular 
readmissions following hospitalization for CHF.  
Methods: An inception cohort was obtained from the WHICH? Trial, a prospective, multi-
centre randomized controlled trial which was a head-to-head comparison of the efficacy of 
a home based intervention versus clinic-based intervention for adults with CHF. A Cox’s 
proportional hazards model (taking into account the competing risk of death) was used to 
develop a prediction model. Bootstrap methods were used to identify factors for the final 
model. Based on these data a nomogram was developed.  
Results: Of the 280 participants in the WHICH? Trial 37 (13%) were readmitted for a 
cardiovascular event (including CHF) within 28 days, and a further 149 (53%) were 
readmitted within 18 months for a cardiovascular event. In the proposed competing risk 
model, factors associated with an increased risk of hospitalization for CHF were: age (HR 
1.07, 95% CI 0.90-1.26) for each 10-year increase in age; living alone (HR 1.09, 95% CI 0.74-
1.59); those with a sedentary lifestyle (HR 1.44, 95% CI, 0.92-2.25) and the presence of 
multiple co-morbid conditions (HR 1.69, 95% CI 0.38-7.58) for 5 or more co-morbid 
conditions compared to individuals with one documented co-morbidity). The C-statistic of 
the final model was 0.80. 
Conclusion: We have developed a practical model for individualizing the risk of short-term 
readmission for CHF. This model may provide additional information for targeting and 
tailoring interventions and requires future prospective evaluation.  
Key words: heart failure; hospitalization; risk assessment; risk factors; risk model 
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Background 
Chronic heart failure (CHF) is a major cause of morbidity and mortality and is a frequent 
cause of hospitalization [1]. High rates of hospitalization place a burden not only on the 
individual and their family but also society [2]. Increasingly readmission to the hospital is 
identified as an important marker of the quality of care, and highlights many of the 
vulnerabilities for patients in their transition from the hospital to the community. Reducing 
readmissions holds the potential of not only improving patient outcomes but also 
decreasing costs [3]. As many hospitalizations have been noted to be preventable, 
identifying those patients at most risk and developing interventions to prevent readmission 
have been a focus of clinicians and policy makers [3].  
Risk prediction models identify individuals and characteristics which are considered at 
greater risk for a particular event [4]. Identifying individuals with CHF at higher risk of 
readmission has the potential to decrease adverse events and costs [5]. A number of 
models have been developed [6-16] predicting the risk of adverse events including hospital 
readmission and death, yet these models have demonstrated only modest discriminative 
ability [3, 15]. The challenge of identifying individuals at the highest risk, particularly from 
administrative databases, has been noted and the need to identify factors, such as length of 
stay, which increase the sensitivity of these models considered [7]. In order to more 
accurately target individuals at risk of readmission to hospital after an admission with CHF, 
we sought to develop an absolute risk prediction model using data from a contemporary 
CHF trial. 
The Which Heart failure Intervention is most Cost-effective & consumer friendly in reducing 
Hospital care (WHICH?) Trial tested the hypothesis that compared to an equivalent clinic-
based program [CBI] of management, a home-based, nurse-led, post-discharge, 
multidisciplinary management program [HBI] for CHF patients would be more effective in 
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optimizing health outcomes due to a better overall understanding of the patient and their 
environment [17]. As part of the WHICH? Program, we wanted to identify those patients 
who were most at risk for readmission in the early (28 days) and medium (12 months) term.  
METHODS 
Subjects and setting  
The design and primary results for the WHICH? Trial have been published previously. [18, 
19]. Briefly, all patients admitted to participating centres were screened for study eligibility 
according to the following criteria: i) aged ≥ 18 years, ii) discharged to home with a 
diagnosis of CHF as confirmed by a cardiologist, iii) persistent moderate to severe 
symptoms (NYHA II-III) and iv) a recent history of ≥ 1 admission for acute heart failure. 
Individuals living outside a 30km radius of the hospital, those who had a terminal condition, 
were non-English speaking and/or were unable to provide informed consent were ineligible 
to participate. All events in the WHICH? Trial were reviewed by a blinded endpoint 
committee and adjudicated on the type (elective versus unplanned) and cause of all 
readmissions. The WHICH? Trial was undertaken according to the principles outlined in the 
Declaration of Helsinki and CONSORT guidelines for pragmatic trials [20, 21] (Trial no. 
418967). All WHICH trial participants provided written informed consent and ethics 
approval for the study was obtained from Curtin University Human Research Ethics 
Committee. All participants in the WHICH? Trial (n =280) were included in this analysis.  
Steps in model development 
Following a comprehensive review of current risk models [22] variables predicting 
readmission were identified.  To ensure relevance and appropriateness these variables 
were subsequently verified in an online survey of heart failure experts [23]. For the 
purposes of this analysis only unplanned cardiovascular readmissions were included in the 
model development.  
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Statistical methods 
A modified Cox’s proportional hazards model that included death as a competing risk was 
used to develop the multivariate prediction model, using the methods suggested by 
Therneau [24]. Data items, such as age and comorbidities, identified from previous 
literature and surveys of experts in CHF were forced into all models [11, 13]. Potential 
effect modification was assessed using interaction terms (none were significant at a 0.10 
level). Bootstrap methods were used to identify factors for our final model and presented 
in a nomogram. In this process, variables were selected using a backward-deletion-method, 
with a generous p-value for retention (0.2). This procedure was repeated 200-times, and 
predictors appearing in at least 60% of Bootstrap models were included in the final model 
[25] Verification of the proportional hazards assumption was based on a visual inspection of 
smoothed Schoenfeld residual plots [26]. 
Model validation 
The ability of the final model to discriminate between individuals who had been readmitted 
and those without a readmission, was assessed by the C-statistic [27]. Internal validation of 
the final predictive model included Bootstrap methods. This was done to assess how 
accurately the model would predict readmission in a similar population of individuals with 
CHF. In this method, a sub-sample of 50 patients was used to create a training model which 
was then applied to the whole data set to estimate biases between the observed and 
predicted rates of readmission. This was repeated 200 times to create a distribution of bias 
between predicted and observed rates, and to estimate the maximum calibration error 
[28]. The design package developed by Harrell was used to create the nomogram [28]. 
Using the final model a nomogram for predicting the probability of readmission for a 
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cardiovascular event within 28-days or 1-year, for an individual was developed. All analyses 
were undertaken using the R statistical language [29].  
RESULTS  
The WHICH? Trial participants were typically older (mean age 71 ± 14 years), male  (73%) 
and 73% with a left ventricular ejection fraction ≤45%. Nearly all participants (254; 91%) 
were prescribed an ACE inhibitor/angiotensin receptor blocker or a beta blocker, 154 (61%) 
of whom were prescribed the combination of both. The majority of patients were also 
prescribed a loop diuretic. There was a high degree of comorbidity (mean Charlson Index 
6.1 ± 2.4) (Table 1).  
Cardiovascular readmission and death 
37 individuals (13%) experienced a cardiovascular readmission within 28 days of index 
hospital discharge. A further 149 (53%) were readmitted due to CHF during the 18 months 
follow-up. Compared to those individuals who were not readmitted, those who were 
readmitted were older (p ≤0.001); had more comorbidity (as measured by the Charlson 
Index) (p ≤0.001); and reported a sedentary lifestyle at baseline (p ≤0.001). During the 18-
months of follow-up 69 (25%) of study participants had died.    
Model fit and clinical application 
The risk of readmission (as hazard ratios, with 95% confidence intervals) using the 
predictors of: age, sex, living alone, sedentary lifestyle, co-morbidities and years since 
diagnosis of CHF are shown in Table 2. Internal validation of the model using Bootstrap 
methods resulted in an estimated maximum calibration error of approximately 3% and 2% 
between predicted probabilities and observed frequencies of readmission at 28-days and 1-
year respectively.  
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A nomogram to individualize the risk of readmission is presented in Figure 1.  The C-statistic 
of the final model was 0.80. An example of the model application can be made with the 
following scenario: a 70 year-old female, who lives alone, has a sedentary lifestyle, has two 
co-morbidities, a history of diabetes mellitus and has had CHF for 10-years, has an 
approximate 12% risk of readmission at 28-days and 60% risk of readmission at 1-year for 
heart failure. 
This nomogram can be used by clinicians within the hospital or community settings to 
target at risk individuals and prevent unnecessary admissions to the hospital. 
DISCUSSION 
Identifying individuals with CHF at risk of readmission has become an important area of 
research [30]. Presently, there is no agreed model for risk-prediction that can be used to 
individualize the risk for readmission for people with CHF [22]. Prior prediction models have 
been limited and not necessarily applicable to ‘real world’ individuals with CHF. There has 
been little consistency of variables used to derive these models. This may be a consequence 
of the heterogeneity between populations and models of care delivery used to derive the 
models [22]. The C-statistic in prior models were no higher than 0.75 [14]. Therefore, it 
would appear that both in our model (C-statistic 0.80) and prior models, important risk 
factors for readmission have not been identified, thus warranting further investigation to 
understand what these unidentified factors are that may predict hospital readmission. It is 
likely, as CHF is a complex cardiogeriatric syndrome, that issues such as socioeconomic 
status, depression and geographical isolation contribute to the burden and the risk of 
readmission [31]. Our model included not only  traditional risk factors but also individual 
and health system factors. We found that older age, living alone, a sedentary lifestyle and 
the presence of multiple comorbid conditions were risk factors for readmission for a 
cardiovascular event. Despite this, our model still had limited discrimination. Like previous 
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models, we were limited by the items that were measured in the WHICH? Trial and factors 
which may be important to include in future model development might include factors such 
as the inability to undertake activities of daily living and frailty [32]. Further development of 
our model through the inclusion and testing of these factors may help to improve its 
discrimination.  
Ideally, the predicted risk of readmission would be used to stratify to allow for better 
targeting of resources to avoid readmission to hospital. The nomogram has the potential to 
be used both within the hospital and community setting. Due to the individualization of 
risk, clinicians could use such a tool to assess the risk of readmission in patients and adjust 
treatment accordingly, such as organizing a home visit in a timely manner. Importantly, the 
actual level of risk for readmission at which clinicians would decide to intervene and modify 
treatment in patients with CHF need to be identified. The nomogram derived from the 
WHICH? derivation cohort, is likely a useful instrument for clinicians to individualize risk for 
readmission for individuals with CHF but requires validation in prospective studies. 
There are some important limitations that need to be considered. Like previous models, the 
model and nomogram we have developed are limited by the characteristics and variables 
measured in the parent study. The WHICH? Trial was conducted at three metropolitan 
hospitals and individuals living beyond a 30 kilometre radius from the study centres and 
those living in assisted living facilities were excluded which limits the external validity of the 
model. Notwithstanding this, the WHICH? Trial was a pragmatic trial which recruited an 
elderly cohort, with multiple comorbidities who were receiving high rates of gold-standard 
pharmacotherapy. The use of unplanned cardiovascular readmissions in the model likely 
increases the utility of the nomogram for tailoring and targeting interventions for those at 
the highest risk. However, the failure to address all cause readmission may limit the 
capacity to identify risks that are not related to their cardiovascular burden. Also relatively 
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small number of participants had been readmitted at  28-days (n=37), therefore our 
prediction for readmission within this period needs to be validated by larger studies. 
A strength of this study is that the presentation of risk factors in a nomogram allows the 
individualization of risk for readmission in adults with CHF. Although these may appear 
apparent to the experienced clinician, data suggests that health professionals frequently 
fail to address these issues [33, 34] emphasizing the potential utility of a nomogram to 
calculate risk. Our method of identifying model variables, through multiple sources to 
develop the model including previously developed models [22] and expert opinion [23] 
increases the relevance to contemporary CHF care. However, the majority, if not all of the 
factors included in our nomogram are not modifiable. Therefore, future research to identify 
risk factors for readmission should include those with cognitive impairment and other 
limitations of functional activity that may preclude participation in a clinical study. And, a 
longitudinal study using an inception cohort of people with CHF who have been admitted to 
hospital could potentially identify more risk factors for readmission, particularly those that 
could be modified to reduce readmission rates.  
CONCLUSION 
This study has shown that older age, living alone, a sedentary lifestyle and the presence of 
multiple co-morbid conditions were risk factors for cardiovascular readmission. This model 
may provide additional information for targeting and tailoring interventions and requires 
future prospective evaluation. 
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Table 1.  Characteristics of study participants at baseline and readmission status. 
 Readmission status   
Characteristic No readmission 
(N=94) 
Readmitted 
within 28 days 
(N=37) 
Readmitted After 
28 days (N=149) 
Combined 
(N=280) 
P-value 
Age (years), median (IQR) 69 (57-77) 79 (71-82) 75 (66-83) 74 (64-81) < 0.001 
Female, % (n) 77% ( 72) 70% ( 26) 70% ( 105) 72% (203) 0.60 
Weight (kg), median (IQR) 78 (70-95) 77 (62-89) 77 (64-91) 77 (66-92) 0.40 
Height(cm), median(IQR) 172(165-178) 167 (158-172) 170 (160-177) 170 (162-178) 0.09 
Lives alone, % (n) 66% (62) 57% ( 21) 64% ( 96) 64% (179) 0.20 
Depression score, median (IQR) 6 (0-23) 0 (0-17) 12 (0-22) 8 (0-22) 0.60 
Cognitive Impairment, % (n) 39% (37) 49% (18) 50% (74) 46% (129) 0.30 
Sedentary, % (n) 62% (58) 86% (32) 82% (122) 76% (212) < 0.001 
Dizziness, % (n) 16% (15) 19% ( 7) 14% (21) 15% ( 43) 0.80 
Ascites, % (n) 18% (17) 11% ( 4) 9% (13) 12% ( 34) 0.09 
Na (mmol\L) , median (IQR) 138 (136-141) 138 (136-139) 139 (137-141) 139 (136-141) 0.20 
K (mmol\L), mean (SD 4.3 (4.0-4.6) 4.2 ( 4.0-4.3) 4.3 (4.0-4.6) 4.2 (4.0-4.5) 0.20 
Pulmonary Oedema, % (n) 57% (54) 62% (23) 38% (57) 48% (134) 0.002 
NYHA class II, % (n) 22% (21) 8% (3) 32% (48) 26% (72) 0.02 
NYHA class III, % (n) 59% (55) 68% (25) 58% ( 86) 59% (166)  
NYHA class IV, % (n) 19% (18) 24% ( 9) 10% (15) 15% ( 42)  
Hospital length of stay (days),  
median (IQR) 
6 (3-10) 7 (4-11) 6 (4-12) 7 (4-11) 0.50 
Current smoker, % (n) 12% (11) 3% (1) 8% (7) 9% (24) 0.50 
Caucasian/European decent, % 
(n) 
96% (90) 92% (34) 94% (140) 94% (264) 0.20 
Completed secondary education, 
% (n) 
17% (16) 22% (8) 20% (30) 19% ( 54) 0.70 
Creatinine (mmol/L), median 
(IQR) 
105 (90-139) 133 (109-149) 112 (88-146) 111 (90-146) 0.10 
Haemoglobin (g/L), median (IQR) 129 (112-145) 120(110-132) 128 (114-141) 128 (113-142) 0.20 
Charlson Index, median (IQR) 6 (4-7) 7 (6-8) 6 (5-8) 6 (5-8) <0.001 
Years of  heart failure, median 
(IQR) 
1 (0-3) 3 (1-5) 2 (0-3) 2 (0-3) 0.40 
SBP, median (IQR) 110 (100-130) 115 (96-131) 112 (100-130) 110 (100-130) 0.50 
DBP, median (IQR) 64 (60-72) 60 (52-70) 65 (60-75) 65 (60-74) 0.20 
Claudication, % (n) 6% (6) 14% (5) 9% (14) 9% (25) 0.30 
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Table 2. Final model for risk of readmission for a cardiovascular event 
 Hazard Ratios (95% Confidence 
Interval 
Predictors Crude Adjusted 
Age (each 10-year increase) 1.18 (1.05, 1.33) 1.07 (0.90, 1.26) 
Women versus men 1.12 (0.79, 1.60) 0.99 (0.67, 1.48) 
Lives alone  
No 
Yes 
 
1.0 (ref) 
1.07 (0.76, 1.51) 
 
1.0 (ref) 
1.09 (0.74, 1.59) 
Sedentary  
No  
Yes 
 
1.0 (ref) 
1.72 (1.12, 2.62) 
 
1.0 (ref) 
1.44 (0.92, 2.25) 
No. of comorbid conditions  
0-1 
 
1.0 (ref) 
 
1.0 (ref) 
2-4 1.32 (0.31, 5.62) 1.25 (0.29, 5.37) 
5+ 2.31 (0.57, 9.34) 1.69 (0.38, 7.58) 
Number of years with CHF 
< 10 
10+  
 
1.0 (ref) 
1.56 (0.93, 2.63) 
 
1.0 (ref) 
1.40 (0.83, 2.38) 
CHF=chronic heart failure 
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Figure 1. Nomogram for predicting the probability of readmission for a cardiovascular event in CHF 
patients at 28-days and 1-year. 
 
Instructions: For each characteristic, locate the individual’s profile on the appropriate axis. Using a 
pencil and a ruler, draw a line vertically up to the top “points” axis. Sum the points for the individual 
characteristics to create a total score. Using the total score, draw a line vertically down the “total 
points” axis through the “28-day risk of readmission” or “1-year risk of readmission” axis to obtain 
risk. For example, a 70 –year-old female (14 points), who lives alone (2 points), has a sedentary 
lifestyle (7 points); has two co-morbidities - a history of diabetes mellitus and heart failure (7 points); 
has a 10 year history of heart failure, (2 points); has a total point score of 29, corresponding to a 17% 
risk of readmission at 28-days and 69% risk of readmission at 1-year. 
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Discussion 
This thesis consisted of a series of five published manuscripts and 1 accepted for 
publication manuscript. These manuscripts have addressed the aims of the CHF-Risk Study. 
The following review/discussion chapter provides a summary of the six manuscripts. 
Limitations of the thesis are also noted. Consideration is also made for future directions for 
further research to be undertaken. A conclusion highlighting the thesis findings is made 
with direct application of the risk model into practice. 
Summary 
Rehospitalisation of individuals with CHF is a result of deterioration in symptoms 
and disease progression. This is either as a direct result from CHF such as fluid overload 
leading to impaired oxygen exchange or inadvertent and therefore unforseen such as an 
individual who presents to hospital following a motor vehicle accident. Komajda and 
colleagues[1] identified that adherence of physicians to the European guidelines for the 
treatment of CHF was a strong predictor of fewer cardiovascular hospitalisations. 
Furthermore, Fitzgerald and colleagues[2] identified that medication non adherence by 
adults with CHF was associated with an increased risk of cardiovascular hospitalisations and 
all-cause mortality. Therefore, adherence to guidelines has shown to reduce the risk of 
hospitalisation. Additionally, targeting individuals at risk of hospitalisation is crucial due to 
the adverse events that occur from a hospitalisation. In this thesis, some important means 
of identifying foreseeable risk factors related to cardiovascular problems for 
rehospitalisation in adults with CHF have been addressed. 
Some important findings of this thesis are: 
What is the current state of heart failure disease management in Australia?  
This thesis has shown the multifaceted role of nurses in disease management of 
individuals with CHF in Australia. Australia has a health care system that is supported by 
universal health coverage. However, it is a system in need of reform. The NHHRC reform 
goals if executed are projected to save the government $4 billion by 2032[3]. Within the 
health care budget, the primary cause for expenditure is directed at hospitalisation[4]. 
Hospitalisation costs are also the leading expenditures within the health care budgets of 
Europe and North America[5]. With an ageing population and an anticipated rise in 
diagnosis for CHF and subsequent hospitalisations, the need for identifying risk factors for 
rehospitalisation are paramount. Implementing the CCM[6] in CHF disease management 
strategies has the potential to monitor those individuals within the community at risk of 
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rehospitalisation. However, current practices are inconsistent with discharge criteria and 
follow-up and therefore individuals are at further risk of rehospitalisation[7]. Furthermore, 
CHF disease management programs are predominantly located within urban areas[8]. 
Utilising a best practice approach to develop policies that directly state what discharge 
criteria and follow–up is required within the community, is necessary to the disease 
management of individuals with CHF. Additionally, unlike other health professions such as 
medicine, there is a more even distribution of nurses across urban and remote areas[4]. 
Therefore, implementing policies to support and skill nurses within their practice to disease 
manage individuals within remote areas thereby operating CHF disease management 
programs that are evidence based, practical and appropriate to prevent rehospitalisation 
should be viewed by the health care authorities as an asset. 
What patient, provider and system factors have been previously identified within studies 
that predict the risk of hospitalisation for adults with CHF but have not been included in 
existing risk models? 
This thesis has shown that previous literature has predominantly focussed on 
patient specific characteristics that increase the risk of rehospitalisation. Some of these 
include: age[9], fluid overload[10] and co morbidities[11]. Currently, risk models are 
developed using primarily patient characteristics. However, factors that influence health 
are dynamic and do not occur in a vacuum. Identifying factors for rehospitalisation by 
expanding the lens to include provider(s) and system(s) factors may be beneficial to the 
CHF population and clinicians. Furthermore, to include factors that may perhaps decrease 
the risk of rehospitalisation may also prove to be beneficial in preventing rehospitalisation.  
Some examples of provider and system risk factors that decrease the risk of 
rehospitalisation include: collaborative input in disease management from multidisciplinary 
health care providers[12], and discharge planning[13]. 
What risk factors for rehospitalisation have been incorporated into previous 
models and which of these factors are replicated when comparing the risk 
models? 
This thesis has shown that prior to this study, there was no individual absolute risk 
model that predicted the risk of rehospitalisation for adults with CHF. Prior models[14-19] 
were all created in North America and tended to use patient focussed risk factors obtained 
from either administrative, registry data sets or through RCTs. Furthermore, there was a 
minimal consensus on the factors used in the risk models. Diabetes, elevated blood urea 
nitrogen (BUN), a previous hospitalisation within 1 year, single status and race were 
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replicated within the models. However, the replication of risk predictors did not occur in 
more than 2 models for any given predictor[20]. 
What is the value of having risk models in clinical practice?  
This thesis has shown that risk models are tools which aid clinicians in disease 
management decisions.   The use of risk prediction models in clinical practice is to aid in 
clinical decision making; targeting of at risk populations and streamlining and rationalising 
management of at risk individuals. Clinicians are able to target individuals at risk and 
rationalise interventions accordingly. However, current risk prediction models for CHF have 
been developed from factors identified purely within administrative data sets and RCTs and 
therefore, may not be replicable or as accurate outside the cohort from which the model 
was developed. Furthermore, it has been highlighted that risk predictors  should never be 
viewed in isolation[21]. Therefore, it is a combination of risk factors that contribute to 
rehospitalisation rather than a single factor. 
What is the perception of experts within CHF disease management and/or 
research as to the patient, provider and system factors that predict 
rehospitalisation for adults with CHF? 
This thesis has shown that experts within CHF disease management or/and 
research located in Australia or New Zealand did not identify any further risk factors for 
rehospitalisation for adults with CHF other than those derived from existing guidelines and 
the literature review[22]. Experts ranked risk predictors for rehospitalisation from highest 
(score of 10) to lowest (score of 1). The risk factor that respondents ascribed the highest 
risk was a poor adherence to medications. Poor adherence to medications is recognised 
throughout the literature as being a predictor for rehospitalisation[23]. However, having 
private health insurance scored the least. As Australia and New Zealand offer a system of 
universal health coverage, an emergency department presentation requiring interventions 
will not be influenced by the individual’s insurance status. Therefore, having private health 
insurance in Australia and New Zealand is a moot point for an emergency presentation. 
However, Philbin and DiSalvo[16] as well as Amarsingham and colleagues[14] incorporated 
insurance status within their risk models for rehospitalisation. As these risk models were 
developed using North American cohorts from a country that offers no universal health 
coverage, replicating these two models within an Australian and New Zealand context 
would be inappropriate. In addition, having the CHF-Risk model used by North American 
clinicians may be a limitation in its prediction as it was developed from a country offering 
universal health coverage.  
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How accurate is an absolute risk prediction model that is developed and tested 
using an RCT cohort compared to existing models? 
This thesis has shown that an individual absolute risk prediction model was 
developed from amalgamated factors identified  from a literature review, expert opinion 
and data obtained from an RCT. Risk factors identified as being predictive of 
rehospitalisation included: age; individuals living alone; those with a sedentary lifestyle; and 
multiple co-morbidities. The area under the receiver operating characteristic curve (AUC) or 
c statistic of the final model was 0.80. In prior risk models, the AUC was no higher than 
0.75[24]. This may imply that there are factors yet to be unmasked that in combination may 
better predict rehospitalisation. Hence the need for future investigation is paramount. It 
has been argued by Cook[25] that the c statistic may not be an appropriate guide to use 
when assessing models that predict future risk. However, Cook[25] also argues that 
eliminating a model on the basis of a low c statistic may be inappropriate. Therefore, 
though the risk model had a c statistic of 0.80, this value is consistent with prior risk models 
and as such should not be eliminated but further explored for clinical importance. 
Limitations 
The results of this thesis must be considered in the context of some potential 
limitations.  These limitations are: 
No systematic review or meta-analysis was undertaken to identify risk factors for 
rehospitalisation from the literature. Benefits of systematic reviews and/or meta-analysis 
include assessment of consistencies across studies; an increase in the power and precision 
in estimating effect size and risks; and generalizability of individual studies across 
participants and settings[26]. 
No input from individuals with CHF was made to identify their perception of risk 
factors that contribute to rehospitalisation. Prior studies[27-28] have acknowledged the 
benefits of incorporating patient perceptions in formulating disease management programs 
to predict outcomes. 
The cohort used to test the nomogram was 280 individuals from an RCT with an 18 
month follow-up. A longer longitudinal study with a larger cohort may have yielded 
additional association and/or causal findings[29].It is therefore possible that the results 
may not be representative of the entire spectrum of individuals with CHF. 
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In spite of these limitations, this thesis has drawn from evidence in the literature, 
expert knowledge and developed a nomogram which individualises the risk of 
rehospitalisation for adults with CHF.  
Future Directions 
As the proportion of the elderly population increases, chronic diseases which 
include CHF has been identified as a major public health challenge for the future[30]. The 
incidence of elderly diagnosed with CHF is projected to rise with the ageing of the baby 
boomer generation[31]. Goals for future research should be directed at decreasing the risk 
of individuals developing CHF[32]; identifying appropriate and practical disease 
management strategies for individuals that do develop CHF[33-34] and identifying at risk 
populations for adverse events[35]. Furthermore, implementing schemes that will 
accommodate individuals and communities when adverse events do occur. 
The following are some topics for future directions for further research in CHF, risk 
identification and CHF disease management that would be of value and useful to the 
individual with CHF and the community. 
Decreasing the risk of individuals developing CHF 
Primary health care campaigns aimed at increasing community awareness through 
diverse mediums including electronic and hard copy, regarding identifying risk factors for 
developing heart failure is paramount and timely. Heart failure is the leading cause for 
hospitalisation in the developed world for adults over the age of 65 years. However, 
community awareness of this is lacking. Furthermore, management of hypertension by 
individuals and reducing health disparities has the potential to decrease individuals 
developing CHF. In addition, Vitry and colleagues[36] have also reasoned for the 
dissemination of material and resources for individuals with CHF. Therefore, increasing 
access and equity to information and resources has the potential for individuals within the 
community to make informed decisions regarding their lifestyle/health that are positive 
and decrease potential adverse events. 
Identifying appropriate and practical disease management strategies for 
individuals that do develop CHF 
Utilising the CCM and incorporating individuals with CHF into heart failure disease 
management programs in conjunction with multidisciplinary teams within the community.  
The development of policies that is mandatory for clinicians to follow once an individual has 
been diagnosed with heart failure and/or discharge from hospital.   
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Identifying at risk populations for adverse events 
It is important for primary health care physicians and clinicians to identify at risk 
populations with CHF for adverse events such as rehospitalisation. However, populations 
and health care systems differ globally as such, a model developed in Australia may not be 
accurate in risk prediction when used on a population from a country which does not 
support universal health coverage. By altering the CHF-Risk Study’s design, CHF expert 
opinion would be obtained from clinicians/researchers globally (rather than just nationally 
as was done with the CHF-Risk study). Furthermore, acquiring the opinion from individuals 
with CHF as to what they perceive to be risk factors that predict rehospitalisation may 
uncover potential risk factors not previously identified in the literature. This would then be 
followed by the amalgamation of risk factors that have been identified to create a risk 
nomogram.   
Implementing schemes that will assist individuals and communities when adverse 
events do occur 
To prevent adverse events and identify the potential for rehospitalisation, it is 
imperative that individuals discharged into the community be reviewed as soon as possible. 
Using the nomogram developed within the CHF-Risk Study, clinicians and primary care 
physicians may implement strategies post discharge, such as telemonitoring with 
multidisciplinary interventions to observe individuals at risk of rehospitalisation at 28 days.   
 
Conclusion 
This thesis has sequentially developed a nomogram that provides an absolute risk 
score for rehospitalisation for adults with CHF at 28 days and 1 year post discharge. The 
results of this study indicate that important factors that were identified to be associated 
with an increased risk of rehospitalisation for adults with CHF were: age (for each 10-year 
increase in age); individuals living alone; those with a sedentary lifestyle and the presence 
of multiple co-morbid conditions. The nomogram may be used as a tool by clinicians and 
individuals to guide in disease management of adults with CHF and possibly prevent 
adverse events. 
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and policies pertaining to preprints, accepted author
manuscripts and published journal articles are described below.
PREPRINTS
Definition: A preprint is an author’s own write-up of research
results and analysis that has not been peer reviewed, nor had
any other value added to it by a publisher (such as formatting,
copy editing, technical enhancement and the like).
Policy: An author may, without requesting permission, use the
preprint for personal use, internal institutional use, and permitted
scholarly posting.
Personal Use: Use by an author in the author’s classroom
teaching (including distribution of copies, paper or
electronic), distribution of copies to research colleagues 
for their personal use, use in a subsequent compilation of 
the author’s works, inclusion in a thesis or dissertation,
preparation of other derivative works such as extending 
the article to book-length form, or otherwise using or 
reusing portions or excerpts in other works (with full
acknowledgment of the original publication of the article).
Internal Institutional Use: Use by the author’s institution for
classroom teaching at the institution (including distribution 
of copies, paper or electronic, and use in coursepacks and
courseware programs). For employed authors, the use by
their employing company for internal training purposes.
Permitted Scholarly Posting: Posting by an author on open
websites operated by the author or the author’s institution 
for scholarly purposes, as determined by the author, or 
(in connection with preprints) on preprint servers.
If an electronic preprint of an article is placed on a public
server prior to its submission to an Elsevier journal, this is not
generally viewed by Elsevier as prior publication; therefore,
Elsevier will not require authors to remove electronic
preprints of an article from public servers should the article
be accepted for publication in an Elsevier journal. 
However, please note that Cell Press and The Lancet have
different preprint policies and will not consider for 
publication articles that have already been posted publicly.  
Anyone with a question regarding preprint posting and
subsequent submittal of a paper to an Elsevier journal 
should consult that journal’s instructions to authors or 
contact its editor.
ACCEPTED AUTHOR MANUSCRIPTS
Definition: An accepted author manuscript (AAM) is the author’s
version of the manuscript of an article that has been accepted
for publication. It may include any author-incorporated changes
suggested through the processes of submission processing, peer
review, and editor-author communications. AAMs do not include
other publisher value-added contributions such as copy editing,
formatting, technical enhancements and, if relevant, pagination.
Policy: Authors retain the right to use the AAM for personal use,
internal institutional use and permitted scholarly posting (as
previously defined) provided these are not for purposes of
commercial use or systematic distribution. 
Commercial Use of AAMs: Use or posting for commercial
gain, whether for a fee or for free, or to substitute for the
services provided directly by the journal including:
• The posting by companies of their employee-authored
works for use by customers of such companies (e.g.,
pharmaceutical companies and physician-prescribers) 
• Commercial exploitation, such as directly associating
advertising with such posting or the charging of fees for
document delivery or access
Systematic Distribution of AAMs: Policies or other
mechanisms designed to aggregate and openly disseminate,
or to substitute for journal-provided services, including:
• The systematic distribution to others via e-mail lists or
listservers (to parties other than known colleagues),
whether for a fee or for free
• The posting of links to articles by commercial third parties
including pharmaceutical companies
• Institutional, funding body or government manuscript posting
policies or mandates that aim to aggregate and openly
distribute the work of its researchers or funded researchers
• Subject repositories that aim to aggregate and openly
distribute AAMs authored by researchers in specific
subject areas
Appropriate Bibliographic Citation: Authors posting an AAM
online should later add a citation for the published journal
article indicating that the article was subsequently published,
and may mention the journal title provided they add the
following text at the beginning of the document:
NOTICE: This is the author’s version of a work that was
accepted for publication in <Journal title>. Changes resulting
from the publishing process, such as peer review, editing,
corrections, structural formatting, and other quality control
mechanisms, may not be reflected in this document. Changes
may have been made to this work since it was submitted for
publication. A definitive version was subsequently published in
JOURNAL TITLE, VOLUME #, ISSUE #, DATE, DOI.
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HOW AUTHORS CAN REUSE THEIR OWN ARTICLES PUBLISHED BY ELSEVIER
Elsevier believes that individual authors should be able to
distribute their AAMs for their personal needs and interests,
e.g., posting to their websites or their institution’s repository,
e-mailing to colleagues. However, our policies do not permit the
systematic distribution of AAMs to ensure the sustainability of
the journals to which AAMs are submitted. Therefore, deposit in,
or posting to, subject-oriented or centralized repositories
(such as PubMed Central), or institutional repositories with
systematic posting mandates is permitted only under specific
agreements between Elsevier and the repository, agency or
institution, and only consistent with the publisher’s policies
concerning such repositories. 
PUBLISHED JOURNAL ARTICLES
Definition: A published journal article (PJA) is the definitive final
record of published research that appears or will appear in the
journal and embodies all value-adding publisher activities
including copy editing, formatting and, if relevant, pagination.
Policy: Elsevier guarantees each PJA’s authenticity. We work
with others (e.g., national libraries) to preserve them for posterity
and in perpetuity, and we invest to drive their usage. We strictly
apply an absolute guideline regarding their location: Every PJA
will reside only on a completely controlled site because this is the
only way that we as the publisher can guarantee that each PJA
is permanent, authentic and unaltered. 
An author may use the PJA for personal use and internal
institutional use as defined above. In the interest of safeguarding
the correct scientific record, Elsevier does not permit the posting
of PJAs (Elsevier-provided PDF or HTML files) on any open
websites. This is to ensure that the final published version of an
article, which has been edited and peer reviewed according to
the publishing standards of an Elsevier journal, is always
recognized as such only via the journal itself, whether in print or
electronic format. PJAs may not be used for commercial use or
for systematic distribution as defined on page 3. 
The posting of the PJA to websites to fulfill drug regulation
authority approval of therapeutic agents is not permitted in
accordance with the policy outlined above. Where applicable,
Elsevier permits the inclusion of an article title and abstract to
fulfill drug regulation authority requirements, provided this is
accompanied by a link to the PJA on the publisher’s website.
Depositing of articles to PubMed Central
Elsevier has established agreements with several funding bodies,
including the US-based National Institutes of Health, to ensure that
authors who publish in our titles comply with the requirements of
their funding bodies. Authors whose research was funded in whole
or part by these funding bodies are required to deposit their final
accepted manuscripts with PubMed Central (PMC), which may be
considered a special repository. As a service to our authors,
Elsevier deposits on their behalf their final accepted manuscripts
to PMC. Authors publishing with Elsevier should not directly
deposit their manuscripts or their final articles to PMC. 
At the moment, Elsevier has established agreements or policies
to ensure authors whose articles appear in Elsevier journals can
comply with manuscript archiving requirements of the following
funding bodies: 
Note: The list of funding bodies with which Elsevier has
agreements, such as the ones requiring deposit to PMC, may
grow and the requirements of some funding bodies may differ. 
For further details, please see www.elsevier.com/fundingbodies.
Other mandatory depositing of articles 
If an institution requires that all papers published by its faculty,
researchers or employees be deposited in its institutional
repository, a special arrangement or agreement with Elsevier 
is required.
If you are an institution or funding body and would like to discuss
putting in place an agreement with Elsevier, or an institution that
requires all papers published by its faculty, researchers or
employees be deposited in its institutional repository, please
contact universalaccess@elsevier.com.
• Arthritis Research UK
• Austrian Science Fund
• BBSRC
• British Heart Foundation 
• Cancer Research UK 
• Chief Scientist Office
• Department of Health UK
• ESRC
• Howard Hughes Medical Institute 
• Medical Research Council UK 
• National Institutes of Health
• Telethon
• Wellcome Trust
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Citations of articles
Each copy, print or electronic, or other use of an Elsevier-published article must include an appropriate bibliographic citation detailing
the article’s publication in an Elsevier journal. 
In the case of preprint posting of an article, the author may later add a citation, indicating the article was subsequently published by
Elsevier and mentioning the journal title. Such a citation must include the following text and must appear at the beginning of the document: 
NOTICE: This is the author’s version of a work accepted for publication by Elsevier. Changes resulting from the publishing process,
including peer review, editing, corrections, structural formatting and other quality control mechanisms, may not be reflected in this
document. Changes may have been made to this work since it was submitted for publication. The definitive version has been published
in JOURNAL TITLE, VOLUME #, ISSUE #, DATE, DOI. 
Find the DOI in the top left area on each article on
SciVerse ScienceDirect at www.sciencedirect.com.
Understanding and Using Digital Object Identifiers 
Digital Object Identifiers (DOIs) are links guaranteed to remain valid even if articles move between DOI-compliant
platforms, such as SciVerse ScienceDirect. 
Regardless of the publisher or author of an online publication, the structure of a DOI link is always the same, which makes
DOIs easy to use. 
DOI links have the following structure: http://dx.doi.org/doi. An example is http://dx.doi.org/10.1016/j.elerap.2011.05.004. 
A DOI entered in a Web browser must be preceded by http://dx.doi.org/. 
On ScienceDirect, the DOI appears in the top left area on each article. When Elsevier-published articles are cited, Elsevier
asks that their DOIs be included. Stating the DOIs may help current or future researchers find cited articles.
www.doi.org
doi:10.1016/j.elerap.2011.05.004 
How to Cite or Link Using DOI
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HOW PERSONS AFFILIATED WITH INSTITUTES WITH SCIVERSE SCIENCEDIRECT 
SUBSCRIPTIONS CAN USE ARTICLES FROM SUBSCRIBED CONTENT
Professional use of articles
Current SciVerse ScienceDirect subscription agreements allow
authorized users to access, search, browse and view subscribed
content, including articles from journals, and to print or download
a limited number of articles, abstracts and records. 
In general, Elsevier does not allow copying, printing or
downloading entire issues of journals or otherwise substantially or
systematically reproducing or retaining Elsevier-published articles. 
Local database retention of Elsevier-published articles is only
permitted if an institution or corporation has made an explicit
agreement with Elsevier to acquire retention rights or if the
institution or corporation has a digital rights license with a local
reproduction rights organization (RRO), e.g, the Copyright
Clearance Center in the US or the Copyright Licensing Agency in
the UK. For more information on your local RRO and what it can
offer, visit the International Federation of Reproduction Rights
Organisations’ website at www.ifrro.org.
Scholarly sharing of articles
Current ScienceDirect subscription agreements permit authorized
users to transmit excerpts of subscribed content, such as an
article, by e-mail or in print, to known research colleagues for the
purpose of scholarly study or research. Recipients of such
scholarly sharing do not themselves have to be affiliated with an
institute with a ScienceDirect subscription agreement. 
Coursepacks and eReserves
Any academic or government institute with a current
ScienceDirect subscription can incorporate links to subscribed
content, including full-text articles, into electronic coursepacks
or eReserve lists for use in connection with courses offered for
academic credit by the subscribing institute. 
For any similar use for a noncredit course or one offered by a
corporation, an institute or corporation must obtain prior written
permission from Elsevier and a fee may be required. Anyone
interested in such permission should contact the Elsevier Global
Rights Department at permissions@elsevier.com. 
Links to articles
Any institute with a current ScienceDirect subscription may provide
links on the institute's home page, library website or online catalog
to subscribed Elsevier journals or articles. The ScienceDirect Info
site offers shortcut URLs to help information professionals put in
place deep links to subscribed Elsevier journals or articles. For
more information, see www.info.sciverse.com/sd/shortcutlinks.
Interlibrary loan
The interlibrary loan (ILL) policy for electronic journals is included
in each institution’s agreement with Elsevier for ScienceDirect. In
short, the provision allows and provides for the use of electronic
journal articles as a source for fulfillment of ILL requests, with some
restrictions. A summary of Elsevier’s current ILL policy follows. 
Elsevier grants subscribing institutes the right to use articles from
subscribed ScienceDirect content as source material for ILLs
subject to the following conditions: 
• Each ILL request must come from an academic or other noncommercial,
noncorporate research library located in the same country as the subscriber. 
• Each requested article must be printed by the subscriber (not applicable
to US customers) and mailed, faxed or transmitted by Ariel (or a similar
ILL system) to the requesting library.  
If a corporate or commercial entity is seeking a ScienceDirect
article, instead of requesting ILL, that entity may use
ScienceDirect’s Pay per View service on a guest basis. For
details, see www.info.sciverse.com/sd/ppv. Please also refer to
http://www.myelsevier.com.
Live reference
If they are both affiliated with the same institute, then a librarian
can take a user electronically to any Elsevier article to which that
institute has subscribed access. The librarian can also e-mail an
Elsevier article, included in the library’s subscription, to the user. 
If, however, someone logs in to chat and is not affiliated with the
same institute as the librarian, then that user is not an authorized
user at the librarian's institute. The librarian thus cannot link the
user directly to Elsevier articles or e-mail Elsevier articles to the
user. The librarian can, however, explain to the user how to
request Elsevier articles through ILL or acquire them through
ScienceDirect's Pay per View service. 
Use by library guests
Any institute with a current ScienceDirect subscription may allow
members of the general public to use terminals physically located
at that institute’s library to access, search, browse, view and
print articles in subscribed Elsevier journals. Libraries may
impose their own usage restrictions on such “walk-in users.”
Commercial entities that wish to make copies for commercial
purposes should obtain authorization from the publisher or
organizations such as the Copyright Clearance Center.
Learn how to set up shortcut links to SciVerse
ScienceDirect journals or articles by visiting
www.info.sciverse.com/sd/shortcutlinks.
Ways to Use Journal Articles Published by Elsevier (2011)
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Bibliographic references
Anyone may, in a bibliography, list a citation for an article
published by Elsevier. 
Short quotes and reproduction of material from articles
Anyone may in written work quote from an article published by
Elsevier, as long as the quote comprises only a short excerpt
such as one or two sentences. An appropriate citation, including
the journal title, must be provided.
If the intended use is for scholarly comment, noncommercial
research or educational purposes, an institution or academic
may, without seeking permission from Elsevier, use: 
• a single text extract of fewer than 100 words or a series of
extracts totaling no more than 300 words
• a maximum of two figures from a journal article or a total of
five from a journal volume
These guidelines reflect Elsevier’s endorsement of the
International Association of Scientific, Technical & Medical
Publishers' 2008 guidelines for quotation and other academic
uses of excerpts from journal articles. Find more details on these
guidelines at www.stm-assoc.org/document-library/ (see
Guidelines for Quotations from Journal Articles).
If the intended use or the material needed differs from the
categories described above, Elsevier’s prior written permission
must be obtained. The requestor must provide details of how and
where the requested material will be used, such as in a thesis or
dissertation or other publication. 
Anyone may request permission via Rightslink, the Copyright
Clearance Center’s service available at the top of the HTML
version of every journal article on ScienceDirect. Alternatively, 
e-mail requests to permissions@elsevier.com. 
Photocopies of articles
National copyright laws generally permit photocopying of an
article for personal use. 
Elsevier requires permission and a fee for all other photocopying,
including multiple or systematic copying, copying for advertising
or promotional purposes, copying for resale and copying for all
forms of document delivery. Special rates are available for
educational institutions wishing to make photocopies for
nonprofit classroom use. 
Anyone may request permission via Rightslink, the Copyright
Clearance Center’s service available at the top of the HTML
version of every journal article on ScienceDirect. Alternatively, 
e-mail requests to permissions@elsevier.com. 
Purchase of individual articles
Anyone may use Pay per View on ScienceDirect and purchase
individual full-text journal articles. This service allows guest
users, as well as registered users at subscribing institutes, to
purchase direct access to articles. HTML and PDF access is
instant and available for 24 hours on ScienceDirect; in addition,
purchased articles can be downloaded and stored locally for
future use. 
Reprints of articles
To purchase individual or commercial reprints of an article
published by Elsevier, anyone may request permission via
Rightslink, the Copyright Clearance Center’s service available at the
top of the HTML version of every journal article on ScienceDirect.
Alternatively, e-mail requests to reprints@elsevier.com. 
Find Rightslink instructions on Elsevier’s website
at www.elsevier.com/authors/askpermission.
Find Elsevier policies at:
www.elsevier.com/principlesandpolicies.
C O N T A C T   I N F O R M A T I O N
Natalie Qureshi, Rights Manager
Global Rights 
Elsevier
PO Box 800 Oxford OX5 1GB, UK
Phone: (+44) 1865.843830 
Fax: (+44) 1865.853333 
permissions@elsevier.com
Colleen DeLory, Editor
Library Connect Publications 
Elsevier
525 B Street, Suite 1800 
San Diego, CA 92101, USA 
Phone: (+1) 619.699.6283 
Fax: (+1) 619.699.6380 
libraryconnect@elsevier.comw
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RECOMMENDED RESOURCES
Authors’ Rights 
www.elsevier.com/authors/rights 
Elsevier Funding Body Agreements & Policies
www.elsevier.com/fundingbodies 
Since 2007 Elsevier has partnered with the Copyright
Clearance Center’s Rightslink service to offer a variety of
options for reusing Elsevier content. Rightslink provides
end-to-end digital rights licensing and reprint services
enabling publishers and other content providers to offer
their copyrighted material online. This digital solution
enables customers to access digital, copyrighted content
directly from a publisher’s online publication and secure
instant copyright permissions – and the content itself –
quickly, easily and legally.
Access Rightslink by clicking on the Permissions &
Reprints icon above the article title. 
When you are in Rightslink and you request to use Elsevier-published content
in another publication, please ensure you select “Author of New Work” before
choosing your intended publisher from the list available.
International Association of Scientific, Technical & Medical
Publishers (2008). Guidelines for quotation and other academic
uses of excerpts from journal articles. 
http://www.stm-assoc.org/document-library/ 
Resource Center
www.elsevier.com/authors/resources
LCP04-2011.1
Sign Up for a Free Subscription to the 
Library Connect Newsletter
http://libraryconnect.elsevier.com/subscribe
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econtent Management Copyright Permission 
See below  for econtent Management copyright permission request letter. 
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econtent Management Copyright Permission Granted 
 
……………………………………………………………………………………………………………………………………………… 
From: Ansonet Saunders [mailto:accounts@e-contentmanagement.com]  
Sent: Friday, 1 March 2013 11:26 AM 
To: Vasiliki Betihavas 
Subject: Requesting permission 
 
Dear Vasiliki, 
 
Thank you for your e-mail.  
Since you are a co-author to the article you have access to the Peer reviewed 
article with a link to our website at no cost.  
However, this is only granted for use in your thesis with no open access to others. 
Kind Regards. 
 
Ansonet Saunders 
Customer Accounts 
eContent Management Pty Ltd 
Scholarly Research for the Professions 
 
……………………………………………………………………………………………………………………………………………… 
 
From: Vasiliki Betihavas [mailto:Vasiliki.Betihavas@utas.edu.au]  
Sent: Friday, 1 March 2013 11:39 AM 
To: Ansonet Saunders 
Subject: RE: Requesting permission 
 
Dear Asonet,  
Many thanks for your email. 
 
Thank you for the copyright permission. I will note this in the thesis as recommended. I am 
clarifying the comment no open access to others. In Australia all PhDs are placed online via 
the Australian Digital Thesis Program (ADT). This would mean that the manuscript would be 
viewed via the ADT program.  
 
Looking forward to hearing from you at your earliest convenience. 
 
Kind regards, Vasiliki 
 
……………………………………………………………………………………………………………………………………………… 
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From: Ansonet Saunders [mailto:accounts@e-contentmanagement.com]  
Sent: Monday, 11 March 2013 2:01 PM 
To: Vasiliki Betihavas 
Subject: RE: Requesting permission 
 
Dear Vasiliki, 
 
As long as the peer reviewed manuscript is used it would not be a problem.  
 
Kind Regards. 
 
Ansonet Saunders 
Customer Accounts 
eContent Management Pty Ltd 
Scholarly Research for the Professions 
 
 
........................................................................................................................................... 
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MA Healthcare Limited Copyright Permission 
 
MA Healthcare Limited LICENSE 
TERMS AND CONDITIONS 
Mar 18, 2013 
 
 
 
This is a License Agreement between Vasiliki B Betihavas ("You") and MA Healthcare 
Limited ("MA Healthcare Limited") provided by Copyright Clearance Center ("CCC"). The 
license consists of your order details, the terms and conditions provided by MA Healthcare 
Limited, and the payment terms and conditions.  
All payments must be made in full to CCC. For payment instructions, please see 
information listed at the bottom of this form. 
License Number 3106840893573 
License date Mar 13, 2013 
Licensed content publisher MA Healthcare Limited 
Licensed content publication British Journal of Cardiac Nursing 
Licensed content title An overview of risk prediction models and the implications for 
nursing practice 
Licensed copyright line Copyright © 2012, MA Healthcare Limited 
Licensed content author Vasiliki Betihavas, Phillip J Newton, Patricia M Davidson 
Licensed content date Jun 1, 2012 
Volume number 7 
Issue number 6 
Type of Use Thesis/Dissertation 
Requestor type Author of requested content 
Format Electronic 
Portion chapter/article 
Rights for Main product 
Duration of use Life of current edition 
Creation of copies for the 
disabled 
no 
With minor editing privileges no 
For distribution to Worldwide 
In the following language(s) Original language of publication 
With incidental promotional 
use 
no 
The lifetime unit quantity of 
new product 
0 to 499 
Specified additional 
information 
Thank you in advance... 
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The requesting 
person/organization is: 
Vasiliki Betihavas 
Order reference number  
Title of your thesis / 
dissertation  
Predicting risk: developing and testing of a nomogram to predict 
hospitalisation in chronic heart failure (CHF- Risk Study). 
Expected completion date  Mar 2013 
Expected size (number of 
pages) 
100 
Total 0.00 USD  
Terms and Conditions  
Terms and Conditions 
Introduction 
The publisher for this copyrighted material is MA Healthcare Ltd, St Jude’s Church, Dulwich 
Road, London SE24 0PB, United Kingdom. By clicking "accept" in connection with 
completing this licensing transaction, you agree that the following terms and conditions apply 
to this transaction (along with the Billing and Payment terms and conditions established by 
Copyright Clearance Center, Inc. ("CCC"), at the time that you opened your CCC account and 
that are available at any time at http://myaccount.copyright.com.  
Limited License 
Publisher hereby grants to you a non-exclusive license to use this material. Licenses are for 
one-time use only with a maximum distribution equal to the number that you identified in the 
licensing process; any form of republication must be completed within 365 days from the date 
hereof (although copies prepared before then may be distributed thereafter); and any electronic 
posting is limited to a period in accordance with the period stated in your license application.  
Geographic Rights: Scope 
Licenses may be exercised anywhere in the world. 
Altering/Modifying Material 
You may not alter or modify the material in any manner, except where otherwise permitted by 
the license granted. You may use, within the scope of the license granted, one or more 
excerpts from the copyrighted material, provided that the process of excerpting does not alter 
the meaning of the material or in any way reflect negatively on the publisher or any writer of 
the material. You may not translate the material into another language, except where otherwise 
permitted by the license granted.  
Reservation of Rights 
Publisher hereby grants to you a non-exclusive license to use this material. Licenses are for 
one-time use  
 
Limited License 
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Publisher reserves all rights not specifically granted in the combination of (i) the license 
details provided by you and accepted in the course of this licensing transaction, (ii) these terms 
and conditions and (iii) CCC's Billing and Payment terms and conditions.  
Limited Contingent on Payment 
While you may exercise the rights licensed immediately upon issuance of the license at the 
end of the licensing process for the transaction, provided that you have disclosed complete and 
accurate details of your proposed use, no license is finally effective unless and until full 
payment is received from you (either by publisher or by CCC) as provided in CCC's Billing 
and Payment terms and conditions. If full payment is not received on a timely basis, then any 
license preliminarily granted shall be deemed automatically revoked and shall be void as if 
never granted. Further, in the event that you breach any of these terms and conditions or any of 
CCC's Billing and Payment terms and conditions, the license is automatically revoked and 
shall be void as if never granted. Use of materials as described in a revoked license, as well as 
any use of the materials beyond the scope of an unrevoked license, may constitute copyright 
infringement and publisher reserves the right to take any and all action to protect its copyright 
in the materials.  
Copyright Notice: Disclaimer 
You must include the following copyright and permission notice in connection with any 
reproduction of the licensed material: "From [SOURCE JOURNAL]. Copyright © [DATE OF 
PUBLICATION] MA Healthcare Ltd. Reproduced by permission of MA Healthcare Ltd"  
Warranties: None 
Publisher makes no representations or warranties with respect to the licensed material and 
adopts on its own behalf the limitations and disclaimers established by CCC on its behalf in its 
Billing and Payment terms and conditions for this licensing transaction.  
Indemnity 
You hereby indemnify and agree to hold harmless publisher and CCC, and their respective 
officers, directors, employees and agents, from and against any and all claims arising out of 
your use of the licensed material other than as specifically authorized pursuant to this license.  
No Transfer of License 
This license is personal to you and may not be sublicensed, assigned, or transferred by you to 
any other person without publisher's written permission.  
No Amendment Except in Writing 
This license may not be amended except in a writing signed by both parties (or, in the case of 
publisher, by CCC on publisher's behalf).  
 
Objection to Contrary Terms 
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Publisher hereby objects to any terms contained in any purchase order, acknowledgment, 
check endorsement or other writing prepared by you, which terms are inconsistent with these 
terms and conditions or CCC's Billing and Payment terms and conditions. These terms and 
conditions, together with CCC's Billing and Payment terms and conditions (which are 
incorporated herein), comprise the entire agreement between you and publisher (and CCC) 
concerning this licensing transaction. In the event of any conflict between your obligations 
established by these terms and conditions and those established by CCC's Billing and Payment 
terms and conditions, these terms and conditions shall control.  
Other Terms and Conditions 
None 
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Statement of Contribution of Others 
This is a Thesis by publication. A number of researchers contributed in part to the 
publications included within this thesis. However, the actual research undertaken and the 
preparation of the manuscripts was solely my own work (except where duly 
acknowledged). The co-authors statements are provided in the appendix.  It is 
acknowledged that all co-author jointly published manuscripts included in this thesis 
provided their consent for the inclusion of each manuscript in this thesis.  All other work 
included in this thesis, not part of published papers or those accepted for publication is 
entirely my own work, except where duly acknowledged. The contribution of every author 
to each of the publications included in this thesis is outlined below:   
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Copyright Permission by American College of Physicians 
 
 
 
ROECP1117266 
February 18, 2013 
 
University of Western Sydney, 
Parramatta Campus 
Locked Bag 1797 
Penrith South DC NSW 1797 
  
Dear Ms. Betihavas: 
Thank you for your request for print format of the following from Effective Clinical Practice: 
Figure 1: Edward H. Wagner, MD, MPH, Chronic Disease Management: What Will It 
Take To Improve Care for Chronic Illness? Effective Clinical Practice, Aug/Sept 
1998, Vol 1 
Permission is granted to republish the preceding material with the understanding that you 
will give appropriate credit to Effective Clinical Practice as the original source of the 
material. Any translated version must carry a disclaimer stating that the American College 
of Physicians is not responsible for the accuracy of the translation. This permission grants 
non-exclusive, worldwide rights for this edition / volume in print format only.  ACP does not 
grant permission to reproduce entire articles or chapters on the Internet. This letter 
represents the agreement between ACP and Curtin University for request ROECP1117266 
and supersedes all prior terms from the requestor. 
Thank you for your interest in Effective Clinical Practice. If you have any further questions 
or would like to discuss the matter further, please contact me at 856-489-8555 or fax 856-
489-4999. 
Sincerely, 
Gina Brown 
Permissions Coordinator 
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Copyright Permission by Archives of Internal Medicine 
See next page for Copyright Permission by Archives of Internal Medicine 
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Online Survey Questionnaire for Publication 5  
See next page for online survey questionnaire for publication 5 
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Ethics approval 
See next page for Ethics approval by Curtin University Human Research Ethics Committee 
  
  
To Ms Vasiliki Betihavas 
From  Professor Dianne Wynaden 
Subject  Approval: SON&M16-2010 
Date  28th   May 2010 
Copy Professor Patricia Davidson 
 
 
Thank you for your “Form C application for your Research with Minimal Risk (Ethical 
Requirements)” project titled “PREDICTING RISK: DEVELOPING AND TESTING OF 
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